Cloning, Expression of Δ5-Elongase gene from Pavlova sp. CCMP459 and Determination of polyunsaturated fatty Acid production in Physcomitrella patens by Pichit Chodok
i 
 
 
 
 
 
 
Cloning, Expression of ∆5-Elongase Gene from Pavlova sp. CCMP459 and 
Determination of Polyunsaturated Fatty Acid Production in  
Physcomitrella patens   
 
 
 
 
 
 
 
 
Pichit  Chodok 
 
 
 
 
 
 
 
 
 
 
A Thesis Submitted in Partial Fulfillment of the Requirements for the Degree of 
Doctor of Philosophy in Pharmaceutical Sciences 
Prince of Songkla University 
2012 
Copyright of Prince of Songkla University 
ii 
 
Thesis Title Cloning, Expression of ∆5-Elongase Gene from Pavlova sp. 
CCMP459 and Determination of Polyunsaturated Fatty Acid 
Production in Physcomitrella patens  
Author Mr. Pichit  Chodok  
Major Program Pharmaceutical Sciences 
  
 
Major Advisor : Examining Committee : 
 
………………………………………….….. ……………………………...........Chairperson 
(Dr. Sireewan  Kaewsuwan) (Assoc. Prof. Dr. Wanna  Choorit) 
 
Co-advisor : 
 
………………………………………............ ………………………………………...…........ 
(Assist. Prof. Dr. Akkharawit  Kanjana-Opas)(Dr. Sireewan  Kaewsuwan) 
 
 ……………………………………….….......... 
 (Assist. Prof. Dr. Akkharawit  Kanjana-Opas) 
 
 ……………………………………………....... 
 (Assist. Prof. Dr. Juraithip  Wungsintaweekul) 
 
The Graduate School, Prince of Songkla University, has approved this 
thesis as partial fulfillment of the requirements for the Doctor of Philosophy Degree 
in Pharmaceutical Sciences 
 
 
 
..………………………....…….                                                                                      
(Prof. Dr. Amornrat  Phongdara)                         
Dean of Graduate School 
 
 iii 
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บทคดัย่อ 
 
กรดอะดรีนิก และกรดโอเมกา้ 3 โดโคซาเพนทาอีโนอิกเป็นกรดไขมนัไม่อิ*มตวั
สูงในกลุ่มโอเมกา้ 6 และโอเมกา้ 3 ตามลาํดบั ที*มีศกัยภาพนาํไปใช้เป็นยารักษาโรค ปัจจุบนัมี
การศึกษากระบวนการชีวสังเคราะห์ของนํB ามนัจากพืช ตลอดจนการศึกษาทางดา้นพนัธุวิศวกรรม
ของพืชกนัอยา่งแพร่หลาย ดงันัBนการปรับเปลี*ยนวถีิชีวสังเคราะห์ของกรดไขมนัเพื*อให้พืชผลิตกรด
ไขมนัไม่อิ*มตวัสูงชนิดใหม่จึงเป็นทางเลือกหนึ*งที*น่าสนใจ การศึกษาครัB งนีB ไดน้าํยีน ∆5-elongase 
จากสาหร่าย Pavlova sp. CCMP459 ที*เกี*ยวขอ้งกบัการสังเคราะห์กรดไขมนัไม่อิ*มตวัสูงที*มีความ
ยาว 22 คาร์บอน มาศึกษาในมอส Physcomitrella patens เพื*อให้มอสผลิตกรดอะดรีนิกและกรดโอ
เมกา้ 3 โดโคซาเพนทาอีโนอิก พบวา่ยีน ∆5-elongase สามารถแสดงออกไดใ้น P. patens ภายใต้
การควบคุมของ 35S promoter จาํนวน 2 ชุดซํB ากนั โดยทาํให้ P. patens สามารถผลิตกรดอะดรีนิก
ไดเ้ท่ากบั 0.15±0.04 ถึง 6.97±0.74 มิลลิกรัมต่อลิตร จากสารตัBงตน้กรดอะราชิโดนิคที*มีอยูใ่น P. 
patens และจากการปรับปรุงสภาวะของการเพาะเลีBยง transgenic P. patens C6 โดยวิธี response 
surface methodology (RSM) พบวา่ P. patens สามารถผลิตกรดอะดรีนิกไดเ้พิ*มขึBนอยา่งมีนยัสําคญั
ทางสถิติไดเ้ท่ากบั 4.48 มิลลิกรัมต่อลิตร มากกว่าสภาวะที*ไม่ไดมี้การปรับปรุงการเพาะเลีB ยงถึง 
10.6 เท่า (0.42 มิลลิกรัมต่อลิตร) นอกจากนีB ยงัพบว่าการปรับปรุงวิถีชีวสังเคราะห์ด้วยยีน ∆5-
elongase จากสาหร่าย Pavlova sp. ร่วมกบัการเติมนํB ามนัพืช พบว่าประสบความสําเร็จในการ
กระตุน้ให้ P. patens สร้างทัBงกรดอะดรีนิกและกรดโอเมกา้ 3 โดโคซาเพนทาอีโนอิก โดยสะสม
กรดอะดรีนิกและกรดโอเมกา้ 3 โดโคซะเพนทาโนอิกเพิ*มขึBนถึง 24.3 และ 11.7 มิลลิกรัมต่อลิตร 
ตามลาํดบั หรือ 2.3 และ 1.1 เปอร์เซ็นตข์องกรดไขมนัรวม ตามลาํดบั การศึกษานีB จึงเป็นรายงาน
แรกในการผลิตกรดโอเมกา้ 3 โดโคซะเพนทาโนอิกซึ* งเป็นสารตัBงตน้ในการสังเคราะห์โดโคซาเฮก
ซาอีโนอิก (ดีเอชเอ) ใน P. patens  
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ABSTRACT 
 
Adrenic acid (ADA) and ω-3 docosapentaenoic acid (ω-3 DPA), an ω-
6 and ω-3 polyunsaturated fatty acids (PUFAs), respectively, has attracted much 
interest due to their pharmaceutical potential. Exploiting the wealth of information 
currently available in planta oil biosynthesis, and coupling this information with the 
tool of genetic engineering, it is now feasible to deliberately alter fatty acid 
biosynthetic pathways to generate unique oils in commodity crops. In this study, a ∆5-
elongase gene from the algae Pavlova sp. CCMP459 related to the biosynthesis of 
C22-PUFAs was targeted to enable production of ADA and ω-3 DPA in the moss 
Physcomitrella patens. Heterologous expression of this gene under the control of a 
tandemly duplicate 35S promoter in P. patens resulted in the production of C22-
PUFA, ADA (0.15±0.04 to 6.97±0.74 mg/l) from endogenous arachidonic acid 
(ARA). In an attempt to maximize ADA production in transgenic P. patens C6, 
medium optimization by the response surface methodology (RSM), resulted in a 
significant elevation of ADA (4.48 mg/l) production under optimum conditions, 
which was 10.6-fold higher, respectively, than production rates in the non-
optimization study (0.42 mg/l ADA). Therefore, metabolic engineering with a gene 
from a marine algae Pavlova sp. encoding ∆5-elongase together with vegetable oil 
supplementation successfully activated both ADA and ω-3 DPA in P. patens. The 
accumulation of ADA and ω-3 DPA were dramatically increased to 24.3 and 11.7 
mg/l, respectively, and accounted for 2.3 and 1.1% of total fatty acids, respectively. 
To the best of our knowledge, this is the first report on producing ω-3 DPA, 
docosahexaenoic acid (DHA) precursor, in P. patens. 
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CHAPTER 1 
 
INTRODUCTION 
 
1.1 General introduction 
Long-chain (C≥20) polyunsaturated fatty acids (LC-PUFAs) including 
the omega-3 (ω-3) eicosapentaenoic acid (EPA, 20:5 ∆5,8,11,14,17) and docosahexaenoic 
acid (DHA, 22:6 ∆4,7,10,13,16,19) are essential to human health and development. Several 
studies have indicated that deficiencies in these fatty acids increase the risk of 
cardiovascular disease (vonSchacky, 2006), hypertension (Ueshima et al., 2007), 
inflammatory diseases, rheumatoid arthritis (Simopoulos, 2002) and neuropsychiatric 
disorders including dementia and depression (Freeman et al., 2006; Schaefer et al., 
2006). DHA is an ω-3 PUFA found in fish and certain algae, makes up 60% of the 
fatty acid in human neuronal cell membranes, and is particularly concentrated in 
synaptic membranes (Bazan and Scott, 1990) and in myelin sheaths (Ansari and 
Shoeman, 1990).  DHA is essential for prenatal brain development as well as normal 
healthy brain functioning. Supplemental DHA has also been shown to have a 
protective effect against cognitive decline or Alzheimer’s disease (AD) which may 
involve triacylglycerols (TAGs) lowering (Kelley et al., 2007; Cunnane et al., 2009). 
Furthermore, DHA has strong medical benefit implications since it has been 
positively linked to the prevention of numerous human afflictions including cancer 
and heart disease (Stilwell and Wassall, 2003). 
Humans, particularly infants, are unable to synthesize DHA and other 
LC-PUFAs to any great extent and must therefore obtain them through their diet. The 
human consumption of LC-PUFAs is steadily increasing, but the production of fish 
oil, the main source of LC-PUFAs for human consumption, is declining (Takeuchi, 
2001). Generally, the cost of the commercial processing, refining, and stabilizing the 
fish oils is very high, and the decline in production due to over-fishing continues to 
drive up the cost of fish oils (Sargent and Tacon, 1999). The recent finding of toxic 
compounds in fish oil has further raised safety concerns on the consumption of fish 
oils (Guallar et al., 2002).  
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Increasing demand has consequently raised an interest in obtaining 
these PUFAs from alternative sources that are more economical and sustainable. Plant 
oils could be a sustainable alternative source of fatty acids. However, plants do not 
synthesize LC-PUFAs owing to the lack of ∆6- and ∆5-position-specific desaturase 
and the absence of an elongase. Plant oils are therefore rich in C18-PUFAs, linoleic 
acid (LA, 18:2 ∆9,12), α-linolenic acid (ALA, 18:3 ∆9,12,15) and γ-linolenic acid (GLA, 
18:3 ∆6,9,12), but not in LC-PUFAs, EPA and DHA (Wallis et al., 2002). An attractive 
possibility is to genetically engineer plants to produce LC-PUFAs.   
In algae, DHA can be synthesized from EPA in a two-step process that 
involves: (a) the elongation of EPA by ∆5-elongase to generate ω-3 docosapenaenoic 
acid (ω-3 DPA, ∆7,10,13,16,19): and (b) the desaturation of ω-3 DPA by a ∆4-desaturase 
to generate DHA (Pereira et al., 2004b). A number of elongases have been identified 
from mammals, zebra fish, marine and fresh water teleost fish that can recognize and 
elongate multiple chain-length PUFAs, such as C18-, C20- and C22-PUFAs (Leonard et 
al., 2000; Agaba et al., 2004; Agaba et al., 2006). Recently, elongases specific for 
C20-PUFAs have been identified from algae and demonstrated to function in the 
production of DHA (Meyer et al., 2004; Pereira et al., 2004b).  
In addition, the moss Physcomitrella patens produces several PUFAs, 
especially  arachidonic acid (ARA, 20:4 ∆5,8,11,14) and EPA (Kaewsuwan et al., 2006) 
which are C20-PUFAs required for the synthesis of the LC-PUFAs, adrenic acid 
(ADA, ∆7,10,13,16) and ω-3 DPA, respectively by ∆5-elongase (Pereira et al., 2004b). 
Although ADA is a minor fatty acid in the brain, it is suggested to be an important 
component for myelination of neural tissue (O’Brien and Sampson, 1965) and also 
serves as an eicosanoid precursor in tissue (VanRollins et al., 1985). Moreover, ω-3 
DPA is a precursor of DHA which has attracted much interest due to its 
pharmaceutical potential mentioned above.  
Development of transgenic oil plants capable of producing C22-PUFAs, 
ADA and ω-3 DPA is therefore an attractive route to improve commercial-scale DHA 
production. In this study the primary step for activation of C22-PUFAs, ADA and ω-3 
DPA, from C20-PUFAs, ARA and EPA, respectively in P. patens is carried out by 
heterologous expression of the marine algae Pavlova sp. ∆5-elongase and vegetable 
oil supplementation. 
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1.2 Objectives 
1.2.1 To clone the algae Pavlova sp. ∆5-elongase gene 
1.2.2 To construct the plant expression vector and obtain the stable transgenic P. 
patens producing C22-PUFAs, ω-6 ADA and ω-3 DPA 
1.2.3 To determine the polyunsaturated fatty acid products of Pavlova sp. ∆5-elongase 
gene in P. patens 
1.2.4 To optimize the medium composition for high production of ω-6 ADA and ω-3 
DPA in transgenic P. patens 
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CHAPTER 2 
 
LITERATURE REVIEW 
 
2.1 Physcomitrella patens (Hedw.) B.S.G. 
  The moss Physcomitrella patens, non-vascular and multicellular 
organism, is a monoecious land plant belonging to the Funariaceae (Bryophyte). Both 
sexual organs, male (antheridia) and female (archegonia) are produced on the same 
gametophore (Cove, 2005; Frank et al, 2005). P. patens is widely distributed in 
temporal zones. Its isolate is available from Japan, Australia, Africa, North America 
and Europe (Cove, 2005; McDaniel et al., 2010). It’s an ephemeral moss that 
develops in late summer from overwintered spores and grows on banks of ponds, 
lakes and rivers that have been exposed by lowering water levels (Cove, 2005). 
However, it develops sexual organs in the fall, triggered by lowered temperatures and 
shortened days (Hohe et al., 2002a). Recently, P. patens the first bryophyte and the 
fourth land plant genome of which has been completely sequenced (Rensing et al., 
2008) after Arabidopsis, rice and poplar (Reski, 2005). The haploid genome size of P. 
patens is estimated to be around 511 Mbp (Schween et al., 2003) distributed among 
27 chromosomes (Reski et al., 1994), which is about three fold bigger than the 
Arabidopsis genome (Cho et al., 2007). 
Interestingly, P. patens was originally chosen as a model system to 
study a variety of plant gene functions (Table 2.1). Among them P. patens emerged as 
a powerful model species for molecular genetics due to (Prigge and Bezanilla, 2010): 
First, this moss has a dominant haploid gametophyte in its life cycle and a very high 
frequency of integrate transformed DNA molecules by homologous recombination, 
enabling gene targeting studies to be performed to analyze gene function (Schaefer 
and Zryd, 1997; Schaefer, 2001; Cove, 2005; Kamisugi et al., 2006). Second, P. 
patens is easily propagated vegetatively. At any developmental stage, if P. patens 
tissues, such as protonemata, gametophores or sporophytes, are mechanically 
disrupted, then the cells in the disrupted area change into chloronemal apical cells 
producing a new filamentous network. As a consequence, mutant strains with a wide 
range of developmental defects can be maintained indefinitely. Additionally, tissues
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Table 2.1 Various gene functional studies in P. patens. 
 
Functional characterization Gene Reference 
Auxin homeostasis 
Cellulose biosynthesis 
Chloroplast division, chloroplast shaping,  
cell patterning, plant development and  
gravity sensing 
Fatty acid biosynthesis 
 
 
Favonoid biosynthesis 
 
Hexose metabolism 
Jasmonic acid (JA) and (9S, 13S)-12- 
oxo-phytodienoic acid (cis-(+)-OPDA) 
biosynthesis 
N-glycosylation 
 
 
Sulfate assimilation 
GH3-like proteins 
Cellulose synthase 
Filamentous temperature-sensitive Z (ftsZ) 
 
 
∆
6
-desaturase 
∆
6
-elongase 
∆
5
-desaturase 
Chalcone synthase 
C9-aldehydes 
Hexokinases 
Allene oxide cyclases 
 
 
N-acetylglucosaminyl-transferase I,  
α1,3-fucosyl-transferase and 
β1,2-xylosyltransferase 
Adenosine 5’-phosphosulfate reductase 
Sulfate reductase 
Bierfreund et al., (2004); Ludwig-Muller et al., (2009) 
Roberts and Bushoven, (2007); Wise et al., (2011) 
Gremillon et al., (2007); Suppanz et al., (2007); Martin et 
al., (2009a); Martin et al., (2009b) 
 
Girke et al., (1998) 
Zank et al., (2002) 
Kaewsuwan et al., (2006) 
Jiang et al., (2006); Koduri et al., (2010) 
Stumpe et al., (2006) 
Nilsson et al., (2011) 
Stumpe et al., (2010) 
 
 
Koprivova et al., (2003) 
 
 
Koprivova et al., (2002) 
Wiedemann et al., (2010) 
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can be disrupted by cell wall-digesting enzymes, producing a suspension of single 
cells known as protoplasts. Given osmotically controlled medium, protoplasts rebuild 
their cell walls and then regenerate into protonemal tissue. Third, transformation of 
DNA is routine in P. patens. It is generally performed by polyethylene-glycol (PEG)-
mediated transformation of protoplasts (Schaefer et al., 1991). Stable transformants, 
with the transformed DNA integrated into the genome, can be selected within 4-6 
weeks, which is remarkably fast compared with any other plant system. DNA can 
integrate by homologous recombination or randomly if the transformed DNA lacks 
any sequences homologous to the genome. However, the efficiency of generating 
non-targeted stable transformants is one-tenth of that achieved when mediated by 
homologous recombination (Schaefer, 2001). 
 
2.1.1 The life cycle of P. patens (Cove, 2000; Frank et al., 2005; 
Prigge and Bezanilla, 2010) 
  The life cycle of P. patens is characterized by an alternation of two 
generations, the haploid gametophyte and the diploid sporophyte (Figure 2.1). 
However, this moss has a dominant haploid gametophyte in its life cycle. In the 
sporophyte stage, a large number of haploid spores of P. patens are produced by 
meiosis from the diploid generation. P. patens germinates from a haploid spore, 
producing a linear array of cells that branch and generate a filamentous, two-
dimensional, network known as protonemal tissue. The stem cell for this network is at 
the apex of each filament, and each filament grows by polarized growth, or tip 
growth, secreting necessary cell wall components at the apex. The first cell type to 
emerge from the spore is the chloronema cells. These cells can be easily recognized as 
they contain 50-100 fully developed chloroplasts, and cell plates that form between 
dividing cells are transverse to the axis of the cell. Subsequent tissue differentiation is 
dependent on phytohormone levels (Decker et al., 2006).  
As the plant continues to grow, apical cells transition from 
chloronemata to caulonemata in an auxin-dependent manner (Ashton et al., 1979). 
Caulonemata are faster growing cells that contain fewer less-developed plastids and 
cell plates that are positioned at an oblique angle to the long axis of the cell. The 
branching of protonemal tissue occurs at subapical cells, producing another
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Figure 2.1 The life cycle of P. patens (modified from Cove, 1992). Scale of the bars: 
50 µm for pictures 1, 2, 9 and 10; 0.5 mm for pictures 4, 5, 6 and 7; 1.0 mm for 
pictures 8 and 11; 1.0 cm for picture 3. 
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chloronemal cell. Further development proceeds by the formation of buds which are 
initially composed of a three-faced apical cell (a transition from two-dimensional 
filament growth to three-dimensional shoot development). This bud forms the initial 
meristem for development of the leafy adult gametophyte and then the formation of 
the sexual organs at the top of a single gametophore. Male gametes, known as 
spermatozoids are produced in the antheridia and swim to fertilize the female gametes 
(oogonia or egg cells) within an archegonium.  
After fertilization, the zygote develops into the diploid generation, the 
sporophyte, which is composed of a short seta topped with a spore capsule. Within the 
capsule, meiosis occurs and at maturity, about 4000 haploid spores are produced and 
released into the environment (Engel, 1968). The life cycle of P. patens can be 
completed in culture in about 8-12 weeks (Figure 2.1). 
 
2.1.2 Culture conditions of P. patens (Cove, 2000; Frank et al., 2005) 
  The nutritional requirements of P. patens are simple. It can be 
cultivated either on solid or in liquid media containing only inorganic salts (Figure 
2.2a and 2.2b). It is routinely grown on agar-gelled medium in Petri dishes or in liquid 
medium in Erlenmeyer flask as well as bioreactor (Figure 2.2c). 
Upon cultivation on solid medium, the plant undergoes normal 
developmental progression resulting in the formation of leafy gametophores. Starting 
from protonema tissue, gametophore development is initiated by the formation of bud 
consisting of a three-faced cell. Plant tissue cultures of gametophores can be 
maintained by sub-culturing the gametophores at monthly intervals. 
  Liquid cultures can be started either from protonemal tissue or 
gametophores, by inoculating liquid medium with the respective tissue. However, P. 
patens also shown a high capacity for regeneration and therefore mechanical 
disruption of the tissue leads to predominant growth of protonemal tissue in liquid 
medium, providing a routine method for sub-culturing (Grimsley et al., 1977). Liquid 
cultures can be maintained in Erlenmeyer flask in small volumes or plants can be 
grown in semi-continuous bioreactor cultures for large-scale production of moss 
material (Hohe and Reski, 2002). At any stage, moss material from liquid cultures can 
be used to set up cultures on solid medium. Protonema cultures may also be 
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maintained by inoculating protonemal filaments onto cellophane sheets overlying 
solid medium. For routine use of P. patens, it is recommended that plant cultures are 
kept on solid medium as a backup system or spores are kept which can be used to 
initiate new culture lines.  
In addition, medium-term storage of P. patens can be achieved by 
cultivating plant on solid medium at low temperatures (4-15oC) and low light 
conditions (20 µmol/m2/s1). Long-term storage of P. patens was shown to be reliably 
working via cryopreservation (Schulte and Reski, 2004). 
 
 
 
Figure 2.2 P. patens is routinely grown on agar-gelled medium in Petri dishes (a) or in 
liquid medium in Erlenmeyer flask (b) as well as bioreactor (c). 
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2.1.3 Cultivation of P. patens in Petri dishes and Erlenmeyer flask 
for small-scale production (Frank et al., 2005)   
P. patens can be grown on agar-containing medium in Petri dishes on 
basal mineral media devoid of any organic compounds (Figure 2.2a). The media used 
by different researcher groups only vary in minor constituents. Two media which are 
most commonly used for standard growth of P. patens are BCD medium (Ashton and 
Cove, 1977) and Knop medium (Reski and Abel, 1985). Solid cultures may be started 
with inocula from young protonemal tissue or any gametophytic tissue. This obtained 
tissue can be disrupted with a sterilized blender and inoculated the tissue homogenate 
into fresh medium. Growth into the agar medium can be prevented by overlaying the 
medium with cellophane, simplifying the subsequent harvesting of tissue and then the 
plants are cultured in a growth chamber at 25±1oC under a 16/8 h light/dark 
photoperiod with a light intensity of 50-70 µmol/m2/s1. Tissue obtained in this way 
and harvested 1 week after inoculation is composed a large number of chloronemal 
filaments and is excellent moss material for protoplasts, DNA, RNA or proteins 
isolation. In addition, maintenance of the plant is achieved by monthly sub-culturing 
of the plant tissue onto fresh medium. 
For small-scale propagation of moss material, P. patens can be 
cultivated in liquid medium in Erlenmeyer flask (Figure 2.2b). When initiating a 
primary liquid culture, a small flask is inoculated with two or three gametophores of 
P. patens, followed by disruption of the plant material using a suitable blender. To 
promote fast growth of the moss material, 3% (w/v) sucrose can be added (Chodok et 
al., 2010). Cultivation of plant in the presence of sucrose for long time periods should 
be avoided as the cultures show deviating differentiation compared to growth in basal 
mineral medium. At regular disintegration of the protonemal filaments, these cultures 
can be kept as long-term suspension cultures.      
 
2.1.4 Cultivation of P. patens in a bioreactor for large-scale 
production (Frank et al., 2005) 
  P. patens bioreactor cultures are useful for scale-up and to establish 
highly standardized growth conditions, as environmental parameters may affect 
growth kinetics, gene expression patterns and differentiation. The cultivation of P. 
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patens in bioreactors has been reported previously (Reutter and Reski, 1996; Cove et 
al., 1997). For long-term cultivation of P. patens on a laboratory scale, a semi-
continuous bioreactor has also been established for three reasons (Hohe et al., 2002a) 
(Figure 2.2c): (1) Protonema suspensions are used for protoplast isolation for large 
scale transformation (Hohe et al., 2001; Hohe and Reski, 2002a). (2) Bioreactor 
cultures represent a contained environment for the production of heterologous 
compounds (Reutter and Reski, 1996) and (3) Bioreactor culture offers a unique 
possibility for studying the effect of environmental conditions on growth and 
development (Hohe et al., 2002b).  
Standard Knop medium is appropriate for the growth of P. patens in 
bioreactors. The cultures are grown in stirred glass tank bioreactors (Figure 2.3c) with 
working volumes up to 12 l, equipped with a marine impeller. The cultures are aerated 
and growth at 25oC under a photoperiod regime of 16/8 h light/dark cycle with light 
supplied at the surface of the vessels. The cultures can be run semi-continuously, i.e., 
the suspension has to be harvested and replaced by an equal amount of fresh medium 
daily. The density of the cultures is controlled by determining the dry weight. For 
long-term cultivation of P. patens suspension cultures, the cell density in the 
bioreactor should be maintained between approximately 150 and 200 mg/l dry cell 
weight. The growth rate of the suspension cultures can be increased by aeration with 
air that is enriched with CO2 (Hohe et al., 2002a). Under these conditions, the growth 
rate can be doubled but, under non-controlled pH conditions, the pH of the culture 
may decrease markedly. The growth rate of liquid cultures is not affected within a pH 
ranging from 4.5 to 7.0, while the development of protonemal filaments is influenced 
by other pH value. Generally, cultures grown at low pH mainly consist of chloronema 
filaments, while increased pH values favor caulonema development (Hohe et al., 
2002a). 
 
2.2 Long chain-polyunsaturated fatty acids (LC-PUFAs) 
2.2.1 Definition and classification 
LC-PUFAs have a carbon backbone of at least 20 carbons in length 
and contain multiple double-bond desaturations. LC-PUFAs can be grouped into 
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either an omega-3(ω-3) or an ω-6 category based on the position of the first double 
bond from the methyl, or ω, fatty acid terminus (Table 2.2) (Petrie and Singh, 2011). 
 
2.2.2 Nomenclature 
2.2.2.1 Trivial (common) nomenclature 
A PUFA containing m carbon atoms and n double bonds, in 
which the final double bond is located X carbon atom from the methyl end of the fatty 
acid chain is named as Cm ω-x PUFA or m:n (ω-x) PUFA. 
 
2.2.2.2 Systematic nomenclature 
A PUFA containing m carbon atoms and n double bonds, with 
superscripts aZ, bZ, etc. indicating the positions of the double bonds (carbon atoms 
are numbered from the carboxyl end), Z (cis) configuration will be named as 
m:n∆aZ,bZ,…,dZ:.  
As an example, 22:4 ∆7,10,13,16 refers to the long-chain ω-6 ADA 
which contains 22 carbons and four double bonds, or desaturations, at the 7, 10, 13 
and 16 carbon positions from the carboxyl terminus. The structure of LC-PUFAs, 
their trivial (common) and systematic nomenclatures are shown in Table 2.2. 
 
2.3 LC-PUFAs sources 
2.3.1 Commercial sources of LC-PUFAs    
  Currently, the richest sources of ω-3-LC-PUFAs, such as EPA and 
DHA are oils extracted from marine fish such as mackerel, herring, salmon and 
sardines. These fish obtain their LC-PUFAs by consuming the LC-PUFA-rich 
microalgae and phytoplankton. Commercially, fish oils are available in the form of 
gelatin capsules or oily preparations, which contain 20% to 30% EPA and DHA 
(Trautwein, 2001) (Table 2.3).  
However, the production of ω-3 LC-PUFA from fish oil is hindered by 
limitation such as the steady declining fish population in oceans, taste, offensive odor, 
stability problems and high purification cost. In contrast, marine microalgae are the 
primary producer of ω-3 LC-PUFA in the ocean environment and marine fish usually 
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Table 2.2 List of ω-3 and ω-6 LC-PUFAs. 
 
Common name Systematic name Chemical structure 
ω-3 LC-PUFAs 
Eicosatetraenoic acid (ETA) 
 
 
 
∆
8
, ∆
11
, ∆
14
, ∆
17
- 
Eicosatetraenoic acid 
 
 
 
 
Eicosapentaenoic acid (EPA) 
 
 
∆
5
, ∆
8
, ∆
11
, ∆
14
, ∆
17
-
Eicosapentaenoic acid 
 
 
 
ω-3 docosapentaenoic acid 
(ω-3 DPA) 
 
∆
7
, ∆
10
, ∆
13
, ∆
16
, ∆
19
-
Docosapentaenoic acid 
 
 
 
Docosahexaenoic acid (DHA) 
 
 
∆
4
, ∆
7
, ∆
10
, ∆
13
, ∆
16
, ∆
19
-
Docosahexaenoic acid 
 
 
 
ω-6 LC-PUFAs 
Di-homo-γ-linolenic acid 
(DHGLA) 
 
 
∆
8
, ∆
11
, ∆
14
- 
Eicosatrienoic acid 
 
 
 
 
Arachidonic acid (ARA) 
 
 
∆
5
, ∆
8
, ∆
11
, ∆
14
-
Eicosatetraenoic acid 
 
 
 
Adrenic acid (ADA) 
 
 
∆
7
, ∆
10
, ∆
13
, ∆
16
-
Docosatetraenoic acid 
 
 
 
ω-6 docosapentaenoic acid 
(ω-6 DPA) 
 
∆
4
, ∆
7
, ∆
10
, ∆
13
, ∆
16
-
Docosapentaenoic acid 
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Table 2.3 Commercial sources of ω-3 and ω-6 LC-PUFAs. 
 
LC-PUFA Source Product Company 
ARA 
 
 
 
 
EPA 
 
 
 
 
 
DHA 
Single-cell oil 
 
Fermentation 
M. alpina 
 
Fish oil  
 
 
 
 
 
Tuna 
 
Fish oil 
Fish oil 
 
 
Crypthecodinium 
cohnii 
Fish oil 
Fish oil 
ROPUFA 
 
ARASCO 
 
 
Incromega 
 
Hi-EPA Oil 
Dry n-3® 
EPAX 0626 TG 
 
MilkarraTM 
 
ROPUFA 
Incromega 
 
Hi-DHA Oil 
DHASCO 
 
Dry n-3® 
EPAX 0626 TG 
Hoffmann-La Roche Ltd, 
Switzerland 
Gist-brocades, Holland 
Martek Biosciences Co. 
 
Croda Oleochemicals, 
England 
Scotia Lipids, Scotland 
BASF, Denmark 
PRONOVA, Norway 
 
Clover Co., Australia 
Hoffmann-La Roche 
Ltd., Switzerland 
Croda Oleochemicals, 
England 
Scotia Lipids, Scotland 
Martek Biosciences Co. 
 
BASF, Denmark 
PRONOVA, Norway 
Source: Alonso and Maroto (2000). 
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obtain EPA via bioaccumulation in the food chain. EPA and DHA oils can also be 
obtained from single cell organisms like microalgae and fungi. Diatoms such as 
Nitzschia, are good producers of EPA and dinoflagellates such as Crypthecodinium 
cohnii are used for commercial production of DHA (Barclay et al., 1994).  
Recently, only a few microalgae species have demonstrated industrial 
production of ω-3 LC-PUFA due to the low specific growth rate and low cell density 
of the microalgae grown under conventional photoautotrophic process. This mode is 
often limited by insufficiency of light caused by mutual shading of cells (Chen, 1996). 
Marine protists such as the Thraustochytrids can also make large amounts of DHA 
and are a potential source of DHA for human consumption (Barclay et al., 1994; 
Bajpai et al., 1991b). While ω-6-LC-PUFAs such as ARA can be found animal 
viscera, particularly porcine liver, adrenal glands and egg yolk (Gill and Valivety, 
1997). However, the ARA yield obtained is very low, and therefore difficult to 
industrialize. The production of ARA by microorganisms has therefore been gaining 
more interest. ARA is commercially produced by fermentation of oleaginous fungi 
such as Mortierella alpina, which contains approximately 40% (by wt.) of ARA in 
their oils (Kendrick and Ratledge, 1992; Streekstra, 1997). 
 
2.3.2 Alternative sources of LC-PUFAs  
The increasing demand has raised the interest in obtaining these LC-
PUFAs from alternate sources that are more economical and sustainable. Some 
microorganisms, including bacteria, fungi, and microalgae, are considered alternative 
sources of LC-PUFAs (Table 2.4). 
 
2.4 Biosynthesis of LC-PUFAs 
In aerobic pathway, initial fatty acid biosynthesis in plants is catalyzed 
by multisubunit fatty acid synthase (FAS) complexes that are present in the plastids. 
The final product of FAS is palmitoyl (16:0)-acyl carrier protein (ACP). Most of this 
palmitoyl-ACP is then elongated to stearoyl (18:0)-ACP by successive additions of 
two carbon atoms from acetyl-CoA. Still in the plastid, most of stearoyl-ACP is 
desaturated by the soluble plastidial stearoyl-ACP ∆9 desaturase to oleoyl (18:1 ∆9)-
ACP, which is the main product of the plastidial fatty acid synthesis and is exported
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Table 2.4 Alternative sources of ω-3 and ω-6 LC-PUFAs. 
 
Microorganism LC-PUFA Reference 
Bacteria 
Antarctic bacteria strain 651 
Aureispira maritima TISTR1715 
Schizochytrium limacinum OUC88 
Schizochytrium sp. S31 
Fungi 
Achlya sp. ma-2801 
Mortierella alpina 
M. alpina 
M. alpina ATCC32222 
M. alpina I49-N18 
M. alpina M18 
M. alpina ME-1 
M. alpina 1S-4 
Pythium irregulare ATCC1095 
P. ultimum strain #144 
Microalgae 
Chromonas sp. 
Cryptomonas sp. 
Isochrysis galbana 
Monodus subterraneus 
Rhodomonas sp. 
Diatom 
Amphora coffeaformis 
Chaetoceros sp. 
Fragilaria pinnata 
Navicula saprophila 
Nitzschia laevis 
Phaeodactylum tricornutum 
Non-seed lower plant 
Marchantia polymorpha 
Physcomitrella patens 
 
ARA, EPA 
ARA 
DHA 
DHA 
 
ARA 
ARA 
ARA 
ARA, EPA, DHA 
ARA 
ARA 
ARA 
ARA 
ARA, EPA 
ARA, EPA 
 
EPA, DHA 
EPA, DHA 
EPA, DHA 
EPA 
EPA, DHA 
 
ARA, EPA, DHA 
ARA, EPA, DHA 
ARA, EPA, DHA 
ARA, EPA 
EPA 
EPA 
 
ARA, EPA 
ARA, EPA 
 
Nichols et al., (1997) 
Saelao et al., (2011) 
Song et al., (2007) 
Wu and Lin, (2003) 
 
Aki et al., (1998) 
Zhu et al., (2003) 
Zhu et al., (2006) 
Jang et al., (2005) 
Yuan et al., (2002) 
Yu et al., (2003) 
Jin et al., (2009) 
Higashiyama et al., (1998) 
Cheng et al., (1999) 
Gandhi and Weet, (1991) 
 
Renaud et al., (1999) 
Yongmanitchai and Ward, (1989) 
Molina et al., (1992) 
Qiang et al., (1997) 
Renaud et al., (1999) 
 
Renaud et al., (1999) 
Renaud et al., (1999) 
Renaud et al., (1999) 
Kitano et al., (1997) 
Wen and Chen, (2000) 
Yongmanitchai and Ward, (1991) 
 
Shinmen et al., (1991) 
Kaewsuwan et al., (2006) 
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into the cytosol for oil synthesis in the endoplasmic reticulum (ER) (Browse and 
Somerville, 1991). Subsequently, oleic acid (OA, 18:1 ∆9) is then incorporated into 
phosphatidylcholine (PC) by the de novo pathway (Kennedy, 1961) or an acyl 
exchange mechanism known as “acyl editing” (Bates et al., 2009).  
OA is first ∆12-fatty acid desaturated to produce LA, which is in turn 
∆
15
-desaturated to produce ALA (Figure 2.3). Essential dietary fatty acids, LA and 
ALA are the respective substrates for the ω-6 and ω-3 LC-PUFA pathways, with the 
first committed step in both pathways being a ∆6-desaturation, which introduces a 
double bond between carbons sixth and seventh of LA and ALA, to produce GLA and 
stearidonic acid (SDA), respectively. All of these C18-fatty acids can be found 
naturally in angiosperms, although GLA and SDA are relatively rare and efforts have 
been made to engineer these short chain-PUFAs in to oilseed species. The C18-fatty 
acids GLA and SDA are further ∆6-elongated to the long-chain (C20) fatty acids 
DHGLA and ETA, respectively. This elongation normally consists of four 
consecutive enzymatic steps (condensation, ketoreduction, dehydration and 
enoylreduction), although the transgenic introduction of the condensing enzyme or 
‘elongase’ is sufficient to confer specificity to the entire elongation with the other 
elongation reaction components being supplied by the host organism. The products of 
the ∆6-elongation, DHGLA and ETA, are then ∆5-desaturated to ARA and EPA, 
respectively. ARA marks the end of the traditionally represented ω-6 LC-PUFA 
pathway, although ARA can be ∆5-elongated to docosatetraenoic acid or adrenic acid 
(ADA) which can finally be ∆4-desaturated to ω-6 docosapentaenoic acid (ω-6 DPA).  
Similarly, EPA can be ∆5-elongated to ω-3 DPA which is then ∆4-desaturated to 
produce DHA. This ∆6-pathway is the most commonly found aerobic pathway, 
however, an alternative ∆8-pathway also exists. In this pathway, LA and ALA are ∆9-
elongated to eicosadienoic acid (EDA) and eicosatrienoic acid (ETrA), respectively, 
which are then ∆8-desaturated to DHGLA and ETA. At this point, the ∆6- and ∆8-
pathways merge and subsequent desaturations and elongations continue as described 
above (Petrie and Singh, 2011). However, all these enzymes have been isolated from 
various organisms (Table 2.5). 
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Figure 2.3 A simplified scheme of LC-PUFAs biosynthesis pathways in lower eukaryotes (modified from Truksa et al., 2006).  
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Table 2.5 Functional PUFA biosynthesizing enzymes and their sources. 
 
Enzyme Type of 
organism 
Specie Substrate Product Reference 
∆
12
-fatty acid  
desaturase 
 
 
 
 
 
 
∆
6
-desaturase 
Fungi 
Diatom 
Plant 
 
 
Animal 
Insect 
 
Fungi 
 
Diatom 
 
 
 
Plant 
 
 
Fish 
Mucor rouxii, Rhizopus arrhizus 
Phaeodactylum tricornutum 
Camelina sativa, Gossypium 
hirsutum, Olea europaea 
Glycin max, G. hirsutum 
Caenorhabditis elegans 
Acheta domesticus, Tribolium 
castaneum 
Conidiobolus obscures, M. rouxii, 
R. nigricans 
Glossomastix chrysoplasta, 
Parietochloris incise, P. 
tricornutum, Thalassiosira 
pseudonana 
Marchantia polymorpha, 
Physcomitrella patens, Ribes 
nigrum 
Common carp, Gilthead sea bream, 
Rainbow trout, Turbot 
OA 
PA, OA 
OA 
 
PA, OA 
PA, OA 
PA, OA 
 
LA, ALA 
 
LA, ALA 
 
 
 
LA, ALA 
 
 
LA, ALA 
 
LA 
HAD, LA 
LA 
 
HDA, LA 
HDA, LA 
HDA, LA 
 
GLA, SDA 
 
GLA, SDA 
 
 
 
GLA, SDA 
 
 
GLA, SDA 
 
Passorn et al., (1999); Wei et al., (2004) 
Domergue et al., (2003) 
Kang et al., (2011); Zhang et al., (2009); 
Hernandez et al., (2005) 
Li et al., (2007); Pirtle et al., (2001) 
Peyou-Ndi et al., (2000) 
Zhou et al., (2008) 
 
Tan et al., (2011); Laoteng et al., (2005); 
Na-Ranong et al., (2005); Lu et al., (2009)  
Hsiao et al., (2007); Iskandarov et al., 
(2010); Domergue et al., (2002); Tonon et 
al., (2005)  
 
Kajikawa et al., (2004); Girk et al., (1998); 
Song et al., (2010) 
 
Zheng et al., (2004) 
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Table 2.5 Functional PUFA biosynthesizing enzymes and their sources (Continued). 
 
Enzyme Type of 
organism 
Specie Substrate Product Reference 
∆
6
-elongase 
 
 
 
 
∆
5
-desaturase 
 
 
 
 
 
∆
5
-elongase 
 
 
∆
4
-desaturase 
Fungi 
 
Plant 
 
Animal 
Algae 
Diatom 
 
Phytoplankton 
Plant 
 
Algae 
Phytoplankton 
Plant 
Algae 
 
Diatom 
Phytoplankton 
C. obscures, Mortierella alpina 
 
M. polymorpha, P. patens 
 
C. elegans 
Pavlova salina 
P. incise, P. tricornutum, T. 
pseudonana  
Emiliania huxleyi 
M. polymorpha, P. patens 
 
Pavlova sp. 
E. huxleyi 
M. polymorpha 
Isochrysis galbana, P. salina 
 
T. pseudonana 
E. huxleyi 
GLA, SDA 
 
GLA, SDA 
 
GLA, SDA 
DHGLA, ETA 
DHGLA, ETA 
 
DHGLA, ETA 
DHGLA, ETA 
 
ARA, EPA 
ARA, EPA 
ARA, EPA 
ADA, ω-3 DPA 
 
ADA, ω-3 DPA 
ADA, ω-3 DPA 
DHGLA, ETA 
 
DHGLA, ETA 
 
DHGLA, ETA 
ARA, EPA 
ARA, EPA 
 
ARA, EPA 
ARA, EPA 
 
ADA, ω-3 DPA 
ADA, ω-3 DPA 
ADA, ω-3 DPA 
ω-6 DPA, DHA 
 
ω-6 DPA, DHA 
ω-6 DPA, DHA 
Tan et al., (2011); Parker-Barnes et 
al., (2000) 
Kajikawa et al., (2004); Zank et al., 
(2002) 
Beaudoin et al., (2000) 
Zhou et al., (2007) 
Iskandarov et al., (2010); Domergue 
et al., (2002); Tonon et al., (2005)  
Sayanova et al., (2011) 
Kajikawa et al., (2004); Kaewsuwan 
et al., (2006) 
Pereira et al., (2004b) 
Sayanova et al., (2011) 
Kajikawa et al., (2006) 
Pereira et al., (2004b); Zhou et al., 
(2007) 
Tonon et al., (2005) 
Sayanova et al., (2011) 
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Table 2.5 Functional PUFA biosynthesizing enzymes and their sources (Continued). 
 
Enzyme Type of 
organism 
Specie Substrate Product Reference 
Bifunctional 
∆
12
,∆
15
  
desaturase 
 
Bifunctional 
∆
12/ω3- 
desaturase 
∆
9
-elongase 
∆
8
-desaturase 
 
 
∆
17
-desaturase 
Protozoa 
 
Basidiomycetes 
 
Fungi 
 
 
Phytoplankton 
Protozoa 
Algae 
Phytoplankton 
Fungi 
Acanthamoeba Castellanii 
 
Coprinus cinereus 
 
Fusarium graminearum,  
F. moniliforme,  
Magna porthegrisea 
E. huxleyi 
A. castellanii 
P. salina 
E. huxleyi 
Saprolegnia diclina 
PA, OA, HDA, LA 
 
PA, OA, HDA, LA 
 
PA, OA, HDA, LA, 
GLA, DHGLA 
 
LA, ALA 
EDA, ETrA 
EDA, ETrA 
EDA, ETrA 
ARA 
HDA, LA, 16:3, 
ALA 
HDA, LA, 16:3, 
ALA 
HDA, LA, 16:3, 
ALA, SDA, ETA 
 
EDA, ETrA 
DHGLA, ETA 
DHGLA, ETA 
DHGLA, ETA 
EPA 
Sayanova et al., (2006a) 
 
Zhang et al., (2007) 
 
Damude et al., (2006) 
 
 
Sayanova et al., (2011) 
Sayanova et al., (2006b) 
Zhou et al., (2007) 
Sayanova et al., (2011) 
Pereira et al., (2004a) 
16:3, Hexadecatrienoic acid.  
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2.5 Pharmacological activities of LC-PUFAs 
2.5.1 ARA and EPA  
ARA and EPA are LC-PUFAs that belong to the ω-6 and ω-3, 
respectively. In recent years, an interest in ARA and EPA has significantly increased 
due to their recognition as being beneficial for human health. They have been reported 
to play important functions as not only structural components of membrane 
phospholipids but also precursors of the eicosanoids of signaling molecules including 
prostaglandins, thromboxanes and leukotrienes in mammals.  
ARA is a biogenetic precursor of eicosanoids which are important 
modulators and mediators of a variety of essential physiological activities (Gill and 
Valivety, 1997). Eicosanoids derived from ARA perform a key role in modulating 
inflammation, cytokine release, immune response, platelet aggregation, vascular 
reactivity, thrombosis, and allergic phenomenon (Uauy et al., 2000). As a component 
of mature human milk, ARA is necessary for the neurological and neurophysiological 
development of both term (Carlson et al., 1993) and infants (Brick et al., 2000). It is 
therefore served as an important component in infant nutrition (Bougle et al., 1999; 
Nordoy, 1991).  
In addition, EPA plays an important role in higher animals and humans 
as a precursor of a group of eicosanoids which are crucial in regulating developmental 
and regulatory physiology. The eicosanoids are hormone-like substances including 
prostaglandins (PG), thromboxanes (TX) and leukotrienes (LT). EPA is precursors of 
eicosanoid compounds. However, the eicosanoids from these two fatty acids are 
different both structurally and functionally and are sometimes even antagonistic in 
their effects. A balanced uptake of EPA/ARA can prevent eicosanoid dysfunctions 
and may be effective in treating a number of illnesses and metabolic disorders (Gill 
and Valivety, 1997). There is evidence that EPA is a potential anticachexia and anti-
inflammatory agent (Calder, 1997; Babcock et al., 2000). EPA also possesses 
therapeutic activity against cardiovascular diseases. For example, EPA can prevent 
atherosclerosis by decreasing the level of low density lipoproteins (LDL) (Bonaa et 
al., 1992). EPA appears to affect the electrical behavior, rhythms and chemical 
responses of the heart and, thus, reduces the likelihood of heart attack and arrhythmias 
(abnormalities of the heartbeat). EPA is capable of reducing the tendency toward 
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thrombosis by reducing the level of fibrinogen, an activation factor in the occurrence 
of thrombosis (Hostmark et al., 1988). 
 
2.5.2 ADA 
In humans, ADA is the third most abundant fatty acid in the brain and 
it is particularly enriched in myelin lipid (O’Brien and Sampson, 1965; Martinez, 
1992; Wilson and Sargent, 1993). Rapid accumulation of ADA in brain, comparable 
to ARA accretion levels, occurs during the early postnatal period of brain growth 
spurt in human infants (Martinez, 1992). Human milk contains a small amount (-3 
mg/dl) of ADA (Jensen, 1996). While the specific functions of ADA are not yet clear, 
it is suggested to play an important role in myelination in neural tissues (O’Brien and 
Sampson, 1965; Martinez and Mougan, 1998), its abnormality being implicated in the 
pathogenesis of Alzheimer’s disease (Corrigan et al., 1998), and evidence from in 
vitro studies indicates that it serves as a substrate for dihomoeicosanoid formation 
tissues (Campbell et al., 1985; VanRollins et al., 1985). In addition, ADA is an 
abundant fatty acid in the vasculature that causes endothelium-dependent relaxation in 
bovine coronary arteries (Yi et al., 2007). ADA has also been found to significantly 
enhance tissue factor (TF) activity of thrombin-stimulated endothelial cells, and it is 
therefore a potential prothrombotic agent (Tardy et al., 1992). 
 
2.5.3 DHA 
DHA, an ω-3 LC-PUFA, is well known to be a major structural 
component of photoreceptors. DHA accounts for approximately 50% of the fatty acids 
found in photoreceptor rod outer segments (Fliesler and Anderson, 1983). This fatty 
acid is required for the satisfactory development of vision (Uauy et al., 2001) and its 
deficiency causes a loss of visual acuity (Birch et al., 1992b). Furthermore, DHA is 
reported to play a neuroprotective role against oxidative stress in photoreceptors 
(German et al., 2006a, German et al., 2006b; Rotstein et al., 2003) and to be 
important both for the maturation of retinal photoreceptors and for preventing 
photoreceptor apoptosis (Birch et al., 1992a) in the developing retina (Rotstein et al., 
1997). Dietary studies on ω-3 LCPUFAs have demonstrated that DHA deficiency 
results in delayed retinal development, visual impairment, retinal function 
24 
 
abnormalities, and disruption of rod outer segment membrane renewal in rats 
(Benolken et al., 1973; Rotstein et al., 1996; Wheeler et al., 1975), monkeys 
(Neuringer et al., 1984; Neuringer et al., 1986), and human infants (Birch et al., 
1992a; Uauy et al., 1990). Thus, dietary deficiencies in DHA is well known to have 
adverse effects on retinal development and photoreceptor function. However, the 
effects of dietary DHA on inner retinal function have not yet been fully investigated. 
 
2.6 Fatty acid chain elongation enzymes 
The terms such as elongase system, elongase, or fatty acid chain 
elongation system (FACES) all refer to the enzymes that are responsible for the 
addition of two carbon units to the carboxyl end of a fatty acid chain. Elongation of 
fatty acid, whether saturated, monounsaturated, or polyunsaturated, involves four 
enzyme activities: the keto-acyl-CoA synthase, the ketoacyl-CoA reductase, the 
hydroxyacyl-CoA dehydratase and the enoyl-CoA reductase (Figure 2.4).  
 
 
Figure 2.4 Microsomal elongation of PUFAs. PUFA elongation is a multistep process. Step1, which 
affects chain elongation through the condensation of a fatty acyl-CoA with malonyl-CoA, is rate-
limiting and substrate-specific as directed by the elongase polypeptide. Steps 2, 3 and 4 are acyl-
reductive processes (Modified from Cinti et al., 1992).  
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Fatty acid elongation is initiated by the condensation of malonyl-CoA 
with a long chain acyl-CoA, yielding a β-ketoacyl-CoA in which the acyl moiety has 
been elongated by two carbon atoms and it is considered to be rate limiting and 
specificity controlling with regard to chain length and pattern of double bonds. The 
formed β-ketoacyl-CoA is then reduced by β-ketoacyl CoA reductase to the β-
hydroxyacyl-CoA, which is dehydrated by dehydrase to an enoyl-CoA, and further 
reduced by enoyl reductase to yield the elongated acyl-CoA (Cinti et al., 1992). 
Elongase-type sequences involved in LC-PUFA biosynthesis were 
cloned from several organisms (Table 2.6). The alignment revealed that the predicted 
amino acid sequence of LC-PUFA elongase included the four conserved motifs 
KxxExxDT (Box 1), QxxFLHxYHH (Box 2) the extended histidine-rich box, 
suggested to be functionally important for PUFA elongation (Qi et al., 2002), 
NxxxHxxMYxYY (Box 3), and TxxQxxQ (Box 4), which are commonly of PUFA 
elongases (Meyer et al. 2004; Jakobsson et al. 2006).  
However, these conserved motifs were not found in other classes of 
plant microsomal elongases, β-ketoacyl CoA synthases, and fatty acid elongases 
(FAE) involved in extraplastidial elongation of saturated and monounsaturated fatty 
acids. Jackson et al. (1990) reported that the dilysine residues at -2 and -5 positioned 
from the C-terminus gave these PUFA elongase polypeptypes probable localized in 
the endplasmic reticulum (ER). However, based on their specificity to substrate fatty 
acids, elongase-like enzymes can be classified largely into three groups (Mayer et al., 
2004): one is specific to saturated and monounsaturated fatty acids (SFA and MUFA), 
another to PUFA of fixed chain-length (single-step), and the other is to PUFA with 
variable chain-lengths (multi-step) (Table 2.6). 
 
2.7 Gateway cloning for plant transformation (Nakagawa et al., 2009) 
  Gateway cloning technology is an application of the site specific 
reversible recombination reactions occurring during λ phage integration into and 
excision from Escherichia coli DNA (Figure 2.5) (Walhout et al., 2000). In the 
integration, the attP site (242 bp) of λ phage and the attB site (25 bp) of E. coli 
recombine and the λ phage genome is integrated into the E. coli genome. As a result, 
λ phage genome is flanked by the attL (100 bp) and attR (168 bp) sites (the BP
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Table 2.6 List of the various members of the ELO family of proteins. 
 
Group Sources Protein Conversion Reference 
SFA and MUFA 
 
 
 
 
 
 
 
 
Single-step 
 
 
 
 
 
 
 
 
Mortierella alpina 1S-4 
Saccharomyces 
cerevisiae 
 
 
Mouse 
Rat 
 
 
M. alpina 
M. alpina 1S-4 
Conidiobolus obscurus 
Isochrysis galbana 
I. galbana H29 
Pyramimonas cordata 
 
Pavlova viridis 
P. salina 
Pavlova sp. CCMP459 
M. alpina fatty acid elongase  
Yeast fatty acid elongase 1 
Yeast fatty acid elongase 2 
Yeast fatty acid elongase 3 
 
Mouse long-chain fatty acid elongase 1 
Rat fatty acid elongase 1 
Rat fatty acid elongase 2 
 
M. alpina γ-linolenic acid elongase 
M. alpina fatty acid elongase 
C. obscurus ∆6-elongase 
I. galbana elongase 
I. galbana ∆9-elongase 
P. cordata ∆6-elongase 
P. cordata ∆5-elongase 
P. viridis ∆5-elongase 
P. salina ∆5-fatty acid elongase 
 Pavlova sp. ∆5-fatty acid elongase 
C20-, C22-, and C24-SFA  
C14 to C16 
Up to C24 SFA/MUFA 
Broad SFA/MUFA, essential for C24  
to C26 
Broad SFA/MUFA up to C24 
C16–C20 MUFA/PUFA 
C16 and C18 SFA/MUFA 
 
GLA, SDA 
HDA, LA, ALA 
GLA, SDA 
LA, ALA 
LA, ALA 
GLA, SDA 
ARA, EPA 
EPA 
EPA 
ARA, EPA 
Sakuradani et al., (2008) 
Oh et al., (1997); Dittrich et 
al., (1998); Schneiter et al., 
(2000) 
 
Tvrdik et al., (2000) 
Inagaki et al., (2000) 
 
 
Parker-Barnes et al., (2000) 
Sakuradani et al., (2009) 
Tan et al., (2011) 
Qi et al., (2002) 
Li et al., (2011) 
Petrie et al., (2010a) 
 
Niu et al., (2009) 
Robert et al., (2009) 
Pereire et al., (2004b) 
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Table 2.6 List of the various members of the ELO family of proteins (Continued). 
 
Group Sources Protein Conversion References 
Single-step 
 
 
Multi-step 
Parietochloris incisa 
Physcomitrella patens 
 
Thraustochytrium 
aureum 
T. aureum 
Caenorhabditis elegans 
Zebrafish (Danio rerio) 
 
Atlantic salmon 
 
Atlantic salmon 
 
 
 
Mouse 
P. incisa ∆6-elongase 
P. patens elongase  
 
T. aureum ∆9-elongase 
 
T. aureum elongase 
C. elegans fatty acid elongase 
Zebrafish multifunctional fatty acid  
elongase 
Salmon fatty acyl elongase 5a 
 
Salmon fatty acyl elongase 5b  
 
Salmon fatty acyl elongase 2 
 
Mouse long-chain fatty acid elongase 2 
GLA, SDA 
GLA, SDA 
 
OA, LA, ALA, GLA, EPA 
 
LA, ALA, GLA, SDA 
C16 MUFA/C18 PUFA 
SDA, EPA, ω-3 DPA 
 
GLA, SDA, ARA, EPA, ADA, ω-3 
DPA 
GLA, SDA, ARA, EPA, ADA, ω-3 
DPA 
GLA, SDA, ARA, EPA, ADA, ω-3 
DPA  
C20 and C22 PUFAs 
Iskandarov et al., (2009) 
Zank et al., (2002) 
 
Lee et al., (2008) 
 
Kang et al., (2008) 
Beaudoin et al., (2000) 
Agaba et al., (2004) 
 
Hastings et al., (2005) 
 
Morais et al., (2009) 
 
 
 
Tvrdik et al., (2000) 
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reaction). In the reverse reaction, the phage DNA is excised from the E. coli genome 
by recombination between the attL and attR sites (the LR reaction). The BP reaction 
needs two proteins, the phage integrase (Int) and the E. coli integration host factor 
(IHF). The mixture of these two proteins is called BP clonase in the Gateway system. 
In the LR reaction, Int, IHF and one more phage protein, excisionase (Xis) are 
required, and this mixture is called LR clonase. The Gateway cloning method uses 
these att sites and clonases for construction of plasmid in vitro (Hartley et al., 2000; 
Walhout et al., 2000). 
 
 
 
Figure 2.5 Integration and excision of λ phage into and from the E. coli genome. The 
attP site (242 bp) of λ phage recombines with the attB site (25 bp) of E. coli (BP 
reaction), resulting in generation of attL (100 bp) and attR (168 bp) located at each 
end of the λ phage genome. The BP and LR reactions are reversible reactions 
(Nakagawa et al., 2009). 
 
In the early version of the Gateway system, four pairs of modified att 
sites were generated for directional cloning. They are attB1 and attB2, attP1 and 
attP2, attL1 and attL2, attR1 and attR2, and a recombination reaction can occur only 
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in combination of attB1 and attP1, attB2 and attP2, attL1 and attR1, or attL2 and 
attR2, since this recombination strictly depends on att sequences (Hartley et al., 2000; 
Walhout et al., 2000). In addition to these att sites, ccdB whose protein product 
inhibits DNA gyrase and a chloramphenicol resistance (Cmr) marker are used for 
selection and maintenance of Gateway vectors. Usually, att1 is located at the 5’-end 
of the open reading frame (ORF) and att2 is located at the 3’-end. This orientation is 
maintained in all cloning steps. Figure 2.6 shows the scheme of Gateway cloning. 
First, the attB1 and attB2 sequences are added to the 5’- and 3’-ends of the ORF, 
respectively, by adapter PCR. The product (attB1-ORF-attB2) is subjected to a BP 
reaction with a Donor vector, which possess an attP1- ccdB-Cmr-attP2 cassette. 
Because of the existence of the negative selection marker ccdB between attP1 and 
attP2, only the transformants harboring the recombined vectors carrying attL1-ORF-
attL2 (the entry clone) can grow on the selection plate. Once the entry clone is in 
hand, the ORF is rapidly transferred to a desired destination vector that possesses an 
attR1-Cmr-ccdB-attR2 cassette. Since destination vectors also contain ccdB between 
attR1 and attR2, and have a resistance marker that is different from that carried by the 
entry clone, only the recombined destination vectors carrying attB1-ORF-attB2 (the 
expression clone) will be selected. The Gateway cloning is designed so that the 
smallest att site, attB (25 bp), appears in the final product (the expression clone) to 
minimize the length of cloning junctions after the clonase reaction.  
Many destination vectors have been developed for different purposes 
such as vectors for expression in plants, vectors for fusion with reporter and epitope 
tags and vectors for RNAi (Curtis and Grossniklaus, 2003; Earley et al., 2006). In 
fusion constructs, the ORF is linked to a tag with eight or more amino acids encoded 
by the attB1 or attB2 sites. Because the reading frame of attB1 and attB2 is unified in 
the Gateway system, any entry clone incorporated into a destination vector is 
correctly fused to the tag sequence. As described above, Gateway cloning has great 
advantages: it is free from the need for restriction digestion, has a simple and uniform 
protocol, and offers high efficiency and reliability of cloning, easy manipulation of 
fusion constructs, and the existence of a variety of destination vectors for many 
purposes. The use of Gateway cloning has expanded in many fields of biological 
research in recent years. 
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Figure 2.6 Schematic illustration of Gateway cloning. The open reading frame (ORF) region is 
amplified by adapter PCR and the resulting attB1-ORF-attB2 fragment is cloned into pDONR221 by a 
BP reaction to generate an entry clone containing attL1-ORF-attL2. Subsequently, the ORF is cloned 
into desired destination vectors by an LR reaction to generate expression clones including tag fusion 
constructs. B1, attB1; B2, attB2; P1, attP1; P2, attP2; L1, attL1; L2, attL2; R1, attR1; R2, attR2; Pro, 
promoter; Ter, terminator (Modified form Nakagawa et al., 2009). 
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2.8 Plant genetic engineering for improved LC-PUFAs production 
There are several technical or scientific challenges can be engineered 
to accumulate adequate levels of LC-PUFAs in oilseed crops. These challenges are 
mainly focused on increasing the conversion of the native plant fatty acid substrates 
through to the LC-PUFAs of interest with as few intermediate fatty acids as possible. 
In theory, this simply requires the use of transgenic enzymes which have high 
conversion efficiencies. However, in practice, the conversion efficiencies of LC-
PUFA biosynthesis enzymes are not affected only by actual enzyme activity but also 
by factors such as substrate dichotomy, the requirement of some enzymes to use 
substrates from certain metabolic pools (Petrie and Singh, 2011).  
The biosynthesis of ω-6 and ω-3 LC-PUFAs in land plants was first 
reported in 2004 with publications describing the introduction of both the ∆8- and ∆6 
pathways. Qi et al. (2004) demonstrated the production of 3% EPA and 6.6% ARA in 
A. thaliana leaf tissue by a ∆8-pathway consisting of the I. galbana ∆9-elongase, 
Euglena gracilis ∆8-desaturase and M. alpina ∆5-desaturase with constitutive 35S 
promoters. This study demonstrated that production of LC-PUFAs in land plants was 
feasible, albeit in leaf tissue.  
Shortly after, Abbadi et al. (2004) published the production of LC-
PUFA in the seeds of tobacco and linseed by the ∆6-pathway. In this pathway, SDA 
(11.4%) and GLA (16.8%) were produced in linseed, although these fatty acids were 
not effectively ∆6-elongated with only 0.8% EPA and 1.0% ARA being produced. A 
number of studies that proofed the concept for LC-PUFA production in various plants 
was achievable and summarized in Table 2.7. 
 
2.9 Response surface methodology (RSM) 
Since the production of LC-PUFAs by microorganisms is strongly 
influenced by various chemical parameters, such as carbon and nitrogen sources, 
growth factors, and metallic ions and physical parameters such as temperature, culture 
pH and aeration. It is crucial to search for the key influencing factors among many 
related ones. There are two ways by which the problem of fermentation parameters 
may be addressed: classical and statistical methods. The classical method is based on 
the “one-factor-at-a-time” method in which one independent variable is studied while
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Table 2.7 LC-PUFAs production in various transgenic plants. 
 
Plant host Target gene New fatty acid production 
 (% of total fatty acid) 
Reference 
Arabidopsis thaliana 
 
 
 
A. thaliana 
 
 
 
Brassica juncea 
 
 
 
 
 
 
B. napus 
 
Isochrysis galbana ∆9-elongase, Euglena gracilis ∆8-
desaturase, Mortierella alpina ∆5-desaturase 
 
 
Danto rerio ∆5/ ∆6-desaturase, Caenorhabditis elegans ∆6-
elongase, Pavlova salina ∆5-elongase, P. salina ∆4-
desaturase 
 
Pythium irregulare ∆6-desaturase, Thraustochytrium sp. ∆5-
desaturase, Physcomitrella patens ∆6-elongase,  
Calendula officinalis ∆12-desaturase, Thraustochytrium sp. 
∆
6
-elongase, P. irregulare ω3-desaturase, Thraustochytrium 
sp. ∆4-desaturase, Oncorhynchus mykiss elongase, 
Thraustochytrium sp. lysophosphatidyl acyltransferase 
 
P. salina ∆5-desaturase, I. galbana ∆9-elongase, P. salina 
∆
8
-desaturase 
EDA (2.6%), ETrA (4.6%), DHGLA 
(1.3%), ETA (1.2%), ARA (6.6%),  
EPA (3.0%) 
 
GLA (0.4%), SDA (1.5%), DHGLA 
(1.5%), ETA (0.8%), ARA (1.0%), EPA 
(2.4%), ω-3 DPA (0.1%), DHA (0.5%) 
 
GLA (27.3%), SDA (2.2%), DHGLA 
(1.9%), ETA (1.1%), ARA (4.0%), EPA 
(8.1%), DPA (0.1%), DHA (0.2%) 
 
 
 
 
EDA (3.8%), ETrA (0.3%), DHGLA 
(1.0%), ARA (20.7%), EPA (0.8%) 
Qi et al., (2004) 
 
 
 
Robert et al., (2005) 
 
 
 
Wu et al., (2005a) 
 
 
 
 
 
 
Petrie et al., (2010a) 
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Table 2.7 LC-PUFAs production in various transgenic plants (Continued).  
 
Plant host Target gene New fatty acid production 
 (% of total fatty acid) 
Reference 
B. carinata line C90-
1163 (High erucic acid) 
 
 
B. juncea line 1424  
(Zero erucic acid) 
 
 
B. carinata line 10H3  
(Zero erucic acid) 
 
 
Glycine max 
 
 
 
Linum usitatissimum 
P. irregulare ∆6-desaturase, Thraustochytrium sp. ∆5-
desaturase, Thalassiosira pseudonana elongase 
 
 
P. irregulare ∆6-desaturase, Thraustochytrium sp. ∆5-
desaturase, T. pseudonana elongase 
 
 
P. irregulare ∆6-desaturase, Thraustochytrium sp. ∆5-
desaturase, T. pseudonana elongase 
 
 
M. alpina ∆5-,∆6-desaturases and GLELO elongase 
 
 
 
Phaeodactylum tricornutum ∆6-desaturase, P. patens ∆6-
elongase, P.  tricornutum ∆5-desaturase 
GLA (18.2%), SDA (3.2%), DHGLA (0.9%), 
ETA (1.0%), ARA (2.8%), EPA (9.3%), ω-3 
DPA (1.4%) 
 
GLA (19.9%), SDA (2.2%), DHGLA (1.8%), 
ETA (0.5%), ARA (4.3%), EPA (5.0%), ω-3 
DPA (0.4%) 
 
GLA (26.9%), SDA (5.4%), DHGLA (2.2%), 
ETA (2.5%), ARA (5.7%), EPA (20.4%), ω-3 
DPA (4.0%) 
 
GLA, EDA, DHGLA, ARA  
(11%) in somatic embryos 
(8.4%) in mature seeds 
 
GLA (16.8%), SDA (11.4%), DHGLA (1.2%), 
ETA (1.0%), ARA (0.9%), EPA (0.8%) 
Cheng et al., (2010) 
 
 
 
Cheng et al., (2010) 
 
 
 
Cheng et al., (2010) 
 
 
 
Chen et al., (2006) 
 
 
 
Abbadi et al., (2004) 
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Table 2.7 LC-PUFAs production in various transgenic plants (Continued). 
 
Plant host Target gene New fatty acid production 
 (% of total fatty acid) 
Reference 
Nicotiana benthamiana 
 
 
 
N. benthamiana 
 
 
 
N. benthamiana 
 
 
 
N. benthamiana 
 
Micromonas pusilla ∆6-desaturase, Pyramimonas cordata 
∆
6
-elongase, P. salina ∆5-desaturase 
 
 
Echium plantagineum ∆6-desaturase, P. cordata ∆6-
elongase,  
P. salina ∆5-desaturase 
 
Ostreococcus tauri ∆6-desaturase, P. cordata ∆6-elongase,  
P. salina ∆5-desaturase 
 
 
P. salina ∆9-elongase, ∆8-desaturase,  
∆
5
-desaturase, ∆5-elongase and ∆4-desaturase 
GLA (2.1%), ARA (0.6%), SDA (1.5%), 
ETA (0.6%), EPA (10.7%),  
ω-3 DPA (0.3%) 
 
GLA (4.4%), ARA (1.3%), SDA (2.4%), 
ETA (0.1%), EPA (3.4%),  
ω-3 DPA (0.2%) 
 
GLA (5.8%), ARA (1.2%), SDA (1.1%), 
ETA (0.4%), EPA (9.6%),  
ω-3 DPA (0.2%) 
 
EDA (1.7%), DHGLA (0.5%), ARA 
(2.4%), ADA (1.2%), ETrA (1.5%),  
ETA (0.2%), EPA (1.2%), ω-3 DPA 
(0.6%), DHA (0.7%) 
Petrie et al., (2010c) 
 
 
 
Petrie et al., (2010c) 
 
 
 
Petrie et al., (2010c) 
 
 
 
Petrie et al., (2010b) 
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maintaining all the other factors at a fixed level. This method is extremely laborious 
and time-consuming, especially for large number of variables. Moreover, it does not 
guarantee the determination of optimal conditions, and is unable to detect the frequent 
interactions occurring between two or more factors (Choudhari and Singhal, 2008). 
These limitations of a single factor optimization process can be overcome by using 
statistical methods. RSM, the statistical based approaches, is a collection of statistical 
techniques for designing experiments, building models, evaluating the effects of 
factors and analyzing optimum conditions of factors for desirable responses (Kalil et 
al., 2000).  
The main advantage of RSM is the reduced number of experimental 
runs needed to evaluate multiple factors and their interactions. Also, study of the 
individual and interactive effects of these factors will be helpful in efforts to find the 
target value. Hence, RSM provides an effective tool for investigating the aspects 
affecting desired response if there are many factors and interactions in the experiment 
(Yin et al., 2010). In addition, RSM has been successfully utilized to optimize 
compositions of fermentation media for production of LC-PUFAs by microorganisms 
(Table 2.8). 
 
2.10 Factors affecting for LC-PUFAs production 
  2.10.1 Carbon and nitrogen sources 
A variety of carbon sources including mono-, di- and polysaccharides 
such as glucose, fructose, sucrose, starch, acetate, ethanol and vegetable oils including 
linseed, corn and canola oils have been reported to affect LC-PUFAs production in 
various kinds of microorganisms (Table 2.9). These carbon sources are generally 
metabolized via the Embden–Meyerhoff or Krebs cycle pathways to generate acetyl-
CoA used for fatty acids synthesis and provide additional reducing power, NADPH, 
for the various desaturation enzyme needed to PUFAs production.  
For instances, Jin et al. (2008) studied the influence of ethanol 
concentration on ARA production and found that ethanol could be converted directly 
to acetyl-CoA used for the synthesis of fatty acids and might generate additional 
reducing power, NADPH, for the ∆5-desaturases needed to produce ARA in M. 
alpina. Zhu et al. (2003) studied the influence of maize starch hydrolysate
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Table 2.8 Optimized culture conditions for LC-PUFA production in various microorganisms by RSM. 
 
Microorganism Optimized variable LC-PUFA LC-PUFA 
production 
(mg/l) 
Reference 
Aureispira 
maritima 
TISTR1715 
 
Mortierella 
alpina ME-1 
 
 
 
M. alpina 
 
 
 
Nitzschia laevis 
 
 
Schizochytrium 
sp. S31 
 
 
 
S. limacinum 
OUC88 
 
 
 
 
S. limacinum 
SR21 
Tryptone (9 g/l), pH (7.9), 
agitation speed (170 rpm), 
temperature (17.8oC) 
 
Fermentation time (5.6 days), 
temperature (13.7oC),  
ethanol (42.44 g/l), KNO3  
(2.62 g/l) 
 
Glucose (10.0 g/l), corn solids 
(5.0 g/l), KH2PO4  (1.0 g/l), 
KNO3 (1.0 g/l) 
 
NaCl (14 g/l), CaCl2 (0.1 g/l), pH 
(8.5), temperature (18oC) 
 
Glucose (27.98 g/l), yeast 
extraction (4.52 g/l),  
NaCl (24.82 g/l), pH (6.96), 
temperature (30oC) 
 
Temperature (23oC), aeration rate 
(1.48 l/min/l),  
agitation speed (250 rpm), 
inoculum age (mid- 
exponential phase) 
 
PI (30 ml/l), NH4Cl (0.04 g/l), 
ammonium acetate  
(1.0 g/l), temperature (19.2oC) 
ARA 
 
 
 
ARA 
 
 
 
 
ARA 
 
 
 
EPA 
 
 
DHA 
 
 
 
 
DHA 
 
 
 
 
 
DHA 
43.43 
 
 
 
1,902 
 
 
 
 
1,390 
 
 
 
280 
 
 
516 
 
 
 
 
4,700 
 
 
 
 
 
4,910 
Saelao et al., 
(2011) 
 
 
Jin et al., 
(2009) 
 
 
 
Nisha et al., 
(2011) 
 
 
Wen and Chen, 
(2001a) 
 
Wu and Li, 
(2003) 
 
 
 
Song et al., 
(2007) 
 
 
 
 
Chi et al., 
(2007) 
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Table 2.9 Effects of carbon sources and concentration on LC-PUFA production in various microorganisms. 
 
Organism Carbon source Carbon 
concentration 
(g/l) 
LC-PUFA LC-PUFA 
production 
(mg/l) 
Reference 
Aurantiochytrium limacinum SR21 
A. mangrovei KF6 
A. mangrovei SK2 
A. mangrovei MP2 
Mortierella alpina ATCC 16266 
M.  alpine 
 
M. alpina ATCC32222 
 
M. alpina NRRL 6302 
M. alpina CBS528.72 
 
Pythium acanthicum ATCC 18660 
Schizochytrium sp.S31 
S. limacinum SR21 
Thraustochytrium  roseum ATCC 2821 
Thraustochytrium sp. ONC-T18 
Glucose 
Glucose 
Glucose 
Glucose 
Glycerol 
Glucose (maize starch 
hydrolysate) 
Glucose 
Starch 
Glycerol 
Rhamnose 
 
Glycerol 
Glucose 
Biodiesel-waste glycerol 
Starch 
Soy 
90 
60 
75 
90 
20 
100 
 
60 
100 
60 
20 
 
20 
40 
75 
25 
100 
DHA 
DHA 
DHA 
DHA 
ARA 
ARA 
 
ARA 
ARA 
ARA 
ARA 
 
ω-3 DPA 
DHA (in lipid) 
DHA 
DHA 
DHA 
4,200 
3,100 
4,700 
800 
910 
1,470 
 
2,424.7 
2,636.9 
24.83 (%TFA) 
40.41 (%TFA) 
 
69.5 
13.64 (%w/w) 
3,005 
650 
4,030 
Yokochi et al., (1998) 
Fan et al., (2001) 
Unagul et al., (2005) 
Wong et al., (2008) 
Bajpai et al., (1991a) 
Zhu et al., (2003) 
 
Jang et al., (2005) 
 
Hou, (2008) 
Nischa and Venkateswaran, 
(2011) 
Singh and Ward, (1998) 
Wu et al., (2005b) 
Chi et al., (2007) 
Li and Ward, (1994) 
Burja et al., (2006) 
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concentration on ARA production in the culture of M. alpina and found that a high 
initial glucose concentration of starch hydrolysate of 100 g/l led to a high ARA 
accumulation (1.47 g/l). Wu et al. (2005b) indicated that glucose was the most 
effective carbon source for biomass, lipid and DHA production and demonstrated that 
the production of DHA increased with an increase in concentration of glucose from 5-
10 g/l. Jang et al. (2005) revealed that glucose and soluble starch were the best carbon 
sources for ARA production by M. alpina. The production of ARA enhanced with an 
increase of glucose and soluble starch increased from 0 to 60 g/l and from 0 to 100 
g/l, respectively, whereas higher than that ranges diminished ARA production. 
  Simple nitrogen sources such as nitrate and urea promote ARA and 
EPA production in M. alpina (Jin et al., 2009) and Phaeodactylum tricornutum 
(Yongmanitchai and Ward, 1991), respectively (Table 2.10). Potassium nitrate, 
KNO3, is essential for the production of LC-PUFAs because it plays a crucial function 
in maintaining high activity of malic enzyme which plays an important role in the 
provision of NADPH for fatty acid biosynthesis and thus regulates the extent of LC-
PUFAs accumulation in M. alpina, especially ARA (Wynn et al., 1999). The 
concentration of nitrogen source must be controlled within a relative low level 
because a high concentration of nitrogen source leads the flux of carbon to the citric 
acid cycle with little carbon used for synthesis of fatty acids (Wynn et al., 2001). Jang 
et al. (2005) indicated that KNO3 was the best nitrogen source for ARA production by 
M. alpina. In addition, complex nitrogen sources such as yeast extract, tryptone and 
corn steep liquor also performed the beneficial effects for LC-PUFA production by 
individual microorganisms (Table 2.10). Such complex nitrogen sources provide 
amino acids, vitamins and growth factors (Aasen et al., 2000; Wen and Chen, 2001b). 
Tryptone is widely used as a complex nitrogen source in various cell cultures. It has 
been reported that the PUFA content of the diatom Nitzschia laevis increased when 
concentration of tryptone was doubled from 0.5 to 1.0 g/l (Wen and Chen, 2001b). 
Glutamate was demonstrated to have a role in activating acetyl-CoA 
carboxylase (ACC; EC 6.4.1.2). ACC catalyzes the formation of malonyl-CoA, an 
essential substrate for fatty acid synthase and for fatty acyl chain elongation systems 
(Kowluru et al., 2001). Furthermore, glutamate can be utilized for fatty acid synthesis, 
either directly through the generation of keto acids or acetyl-CoA (Albers et al.,
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Table 2.10 Effects of nitrogen sources and concentration on LC-PUFA production in various microorganisms. 
 
Organism Nitrogen source Nitrogen 
concentration 
(g/l) 
LC-
PUFA 
LC-PUFA 
production 
(mg/l) 
Reference 
Aurantiochytrium limacinum SR21 
A. mangrovei KF6 
A. mangrovei SK2 
A. mangrovei MP2 
Mortierella alpina ATCC32222 
 
M. alpina ZQ9998 
M. alpina M18 
M.  alpina ATCC32222  
M. alpina CBS528.72 
 
Phaeodactylum tricornutum 
 
Pythium acanthicum ATCC 18660 
Schizochytrium limacinum SR21 
Schizochytrium sp.S31 
Thraustochytrium sp. ONC-T18 
Corn steep liquor 
Yeast extract 
Yeast extract 
Yeast extract 
KNO3 : yeast extract 
(2:1, w/w) 
Glutamate 
Glutamate 
KNO3 : yeast extract 
Yeast extract 
 
Urea 
 
Glutamate 
Corn steep liquor 
Yeast extract 
Yeast extract 
20 
10 
10 
10 
1.0 % 
7.5% 
0.8 
0.8 
(2:1, w/w) 
10.0 
 
1.4 
 
2.0 
1.0 
4.0 
2.0 
DHA 
DHA 
DHA 
DHA 
ARA 
EPA 
ARA 
ARA 
ARA 
ARA 
 
EPA 
 
ω-3 DPA 
DHA 
DHA 
DHA 
4,200 
3,100 
4,700 
800 
51.62 g/g substrate carbon 
16.88 g/g substrate carbon 
1,400 
1,410 
826.3 
35.28 (%TFA) 
 
117.5 
 
43.1 
1,700 
328 
4,470 
Yokochi et al., (1998) 
Fan et al., (2001) 
Unagul et al., (2005) 
Wong et al., (2008) 
Jang et al., (2000) 
 
Lan et al., (2002) 
Yu et al., (2003) 
Jang et al., (2005) 
Nischa and Venkateswaran, 
(2011) 
Yongmanitchai and Ward, 
(1991) 
Singh and Ward, (1998) 
Yokochi et al., (1998) 
Wu et al., (2005b) 
Burja et al., (2006) 
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1996). Yu et al. (2003) studied the influence of glutamate concentration on total lipids 
and ARA production and found that supplementation of less than 0.8 g/l glutamate 
could increase total lipids and ARA production. However, supplementation of greater 
than 0.8 g/l glutamate led to a decrease in the total lipids in biomass and ARA 
production compared with the response to 0.8 g/l glutamate. Similarly, Singh and 
Ward (1998) suggested that glutamate was the best nitrogen sources for ω-3 DPA 
production by P. acanthicum. Certik et al. (1999) reported that glutamate was one of 
the potentially available nitrogen sources for increasing G6PDH activities and 
enhancing PUFA biosynthesis. However, when glutamate concentration is too high, 
glutamate will be converted to proline accompanied by NADPH consumption 
(Andarwulan and Shetty, 1999), which is necessary for ARA biosynthesis. 
 
2.10.2 Metal ions 
CaCl2 and MgSO4 are known to play important roles in various 
enzyme reactions. For example, in the synthesis of lipids and PUFAs, acetyl-CoA 
carboxylase catalyzing the initial step of fatty acid synthesis requires bivalent ions as 
cofactors (Singh and Ward, 1997). One reason for these phenomena is that acetyl-
CoA carboxylase, which catalyzes the conversion of acetyl-CoA into malonyl-CoA, 
requires bivalent metal ions as the cofactors (Guchhait et al., 1974). In addition, Mg2+ 
ion has affected to malic enzyme and ATP citrate lyase activity influencing on the 
production of acetyl-CoA and NADPH for synthesis of fatty acid (Muhid et al., 
2008). Added minerals may act as cofactors of this enzyme system, which catalyzes 
the initial step of fatty acid synthesis (Higashiyama et al., 1999).  
However, the concentrations of the ions in the medium needs to be at 
appropriate levels for maximizing yields. Chiou et al. (2001) found that ferrous (Fe2+) 
ions increased the production of ARA and EPA in cultures of the bryophyte, M. 
polymorpha, whereas there was no notable change in PUFA production by additional 
Mg2+, Mn2+ and Cu2+. Enhancement of PUFA yield by Fe2+ resulted in an increase of 
intracellular lipid content, rather than selective enhancement of certain fatty acids 
(Chiou et al., 2001). On the other hand, Sajbidor et al. (1992) studied the influence of 
Ca2+, Mg2+, Mn2+ and Fe2+ on ARA production in the culture of Mortierella sp. and 
indicated that a low concentration (2 mg/l) of Mn2+ was beneficial for ARA 
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production, whereas a higher concentration repressed lipid accumulation. However, 
these three metal ions (Ca2+, Mg2+ and Fe2+) still influenced LA production (Sajbidor 
et al., 1992). 
 
2.10.3 Effect of oil supplementation 
Various studies have also indicated that vegetable oil addition was 
beneficial to enhance LC-PUFAs yield (Table 2.11). Vegetable oils generally contain 
high levels of C18-fatty acid, precursors for LC-PUFA biosynthesis. For example, LA 
is the major fatty acid in soybean oil, corn oil, peanut oil and sunflower oil (56–85%), 
ALA is the major fatty acid in linseed oil (58%) (Jang et al., 2005), and OA is rich in 
palm oil (30–45%) (Mhanhmad et al., 2011).  
Utilization of oils by microorganisms is accompanied with production 
of extracellular lipases, which cleave fatty acid residues from glycerol, and the fatty 
acids produced can either be incorporated to lipid structures or degraded to basic 
skeletons serving the biomass synthesis (Esfhani et al., 1981; Akhtar et al., 1983). 
Shinmen et al. (1989) showed that olive oil and soybean oil addition increased the 
accumulation of ARA in Mortierella fungi and supplementation of oils stimulates 
EPA, DHA and total PUFA production in M. alpina (Jang et al., 2005). 
Jareokitmongkol et al. (1993) suggested that 3% of linseed oil amendment produced 1 
g/l of EPA in M. alpina (20% of total fatty acid). 
 
2.10.4 Temperature 
Temperature is thought to be one of the most important environmental 
factors that affect all aspects of the growth and the fatty acid composition of most 
microorganisms (Table 2.12). It also influence the enzymatic reactions, cell 
membrane transport system, and some other cellular characters. A low-temperature 
growth condition will lead to a spontaneous response of strain, which aims at 
maintaining proper membrane lipid fluidity and functions. This reaction will increase 
the proportion of unsaturated fatty acids, especially PUFAs. This evidence may cause 
by the more availability of dissolved oxygen at lower temperatures (Harris and James, 
1969) which lead to enhance fatty acid synthesis by aerobic desaturase and elongase 
enzymes (Singh and Ward, 1997; Higashiyama et al., 1999). Jang et al. (2005) also
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Table 2.11 Effects of oil supplement on LC-PUFA production in various microorganisms. 
  
Organism Oil type Oil 
concentration 
(%w,w) 
LC-PUFA LC-PUFA 
production (mg/l) 
Reference 
Mortierella alpina ATCC32222 
 
 
M. alpina ATCC32222 
 
 
 
Pythium acanthicum ATCC 18660 
Soybean oil 
 
 
Linseed oil 
 
Sunflower oil 
 
Linseed oil 
1.0 
 
 
1.0 
 
1.0 
 
1.0 
ARA 
EPA 
 
ARA 
EPA 
DHA 
 
ω-3 DPA 
57.02 g/g substrate carbon 
29.45 g/g substrate carbon 
 
1923.3 
524.6 
36.3 
 
110.8 
Jang et al., (2000) 
 
 
Jang et al., (2005) 
 
 
 
Singh and Ward, (1998) 
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Table 2.12 Effect of temperature and temperature shift on LC-PUFA production in various microorganisms. 
 
Organism Temperature 
(oC) 
LC-PUFA LC-PUFA 
production (mg/l) 
Reference 
Aurantiochytrium sp. mh0186 
Crypthecodinium cohnii ATCC 
30556 
Mortierella alpina ATCC32222 
 
 
 
M. alpina ATCC32222 
 
M. alpina NRRL 6302 
M. zychae NRRL 2592 
M. alpina CBS528.72 
 
Phaeodactylum tricornutum 
Pythium acanthicum ATCC 18660 
P. ultimum 
 
Schizochytrium sp. HX-308 
15 
Shift from 25oC (48 h) to 15oC (24 h) 
 
Shift from 20oC (5 days) to  
12oC (5 days) 
Shift from 20oC (5 days) to  
12oC (5 days) 
12 
12 
30 
20 
25 
 
Shift from 25oC (6 days) to 10oC (12 h) 
20 
25 
25 
Shift from 30 °C (32 h) to 20 °C 
DHA 
DHA 
 
ARA 
 
 
EPA 
ARA 
EPA 
ARA 
ARA 
ARA 
 
EPA 
ω-3 DPA 
ARA 
EPA 
DHA 
~800 
105.84 
 
49.78 g/g substrate carbon 
 
 
26.93 g/g substrate carbon 
882.4 
34.4 
23.31 (%TFA) 
22.81 (%TFA) 
38.70 (%TFA) 
 
6.6 
40.8 
220 
170 
51.98 (%TFA) 
Taoka et al., (2009) 
Jiang and Chen, (2000a) 
 
Jang et al., (2000) 
 
 
 
Jang et al., (2005) 
 
Hou, (2008) 
 
Nischa and Venkateswaran, 
(2011) 
Jiang and Gao, (2004) 
Singh and Ward, (1998) 
Gandhi and Weet, (1991) 
 
Zeng et al., (2011) 
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reported that ARA and EPA production of M. alpina ATCC 32222 was the highest at 
12oC (Jang et al., 2005). Similarly, both ARA and EPA yields of M. alpina cultures 
were enhanced at low culture temperature (12-15oC) (Jang et al., 2000). 
The two-stage cultivation for PUFA production has been conducted by 
Yuan et al. (2002). The obtained results showed that the higher temperature was 
favorable for an increase in biomass and lipids, but the lower temperature was more 
suitable for the accumulation of ARA in M. alpina I49-N18. A temperature shift 
strategy has also employed to enhance the overall PUFA (including ARA, EPA and 
DHA) production because the optimal temperature for cell growth is often higher than 
that for PUFAs formation (Jiang and Chen, 2000a). 
 
2.10.5 Initial pH of the culture medium 
  The media pH is a significant factor that influences the physiology of a 
microorganism by affecting nutrient solubility and uptake, enzyme activity, cell 
membrane morphology, by-product formation and oxidative- reductive reactions 
(Cromwick et al., 1996), and therefore it is a parameter that clearly manipulates 
PUFA production (Table 2.13). However, the effect of pH on production of PUFAs 
depends on the species of microorganism used.  
For example, the yield of EPA by the diatom P. tricornutum reaches its 
maximum when the pH is 7.6 (Yongmanitchai and Ward, 1991). Jiang and Chen 
(2000b) also found that a neutral pH (7.2) was optimum in terms of degree of fatty 
acid unsaturation, and the proportion of ω-3PUFAs produced by Crypthecodinium 
cohnii. Whereas the percentage of EPA in the total lipids in the culture of another 
diatom, I. galbana, increased with decreasing the pH from pH 8.0 to 6.0 (Molina et 
al., 1992). Yuan et al. (2002) reported that higher pH values (8.0-8.5) were favorable 
for the production of ARA in lipids and in media by M. alpine I49-N18. However, 
Nuutila et al. (1997) reported that lowering the pH to 5.0 caused the ARA 
concentrations to increase, whereas the optimum pH for EPA production was 7.6 in 
the cultivation of the red alga Porphyridium cruentum. 
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Table 2.13 Effect of pH on LC-PUFA production in various microorganisms. 
 
Organism Intitial pH LC-PUFA LC-PUFA production 
(mg/l) 
Reference 
Mortierella alpina ATCC32222 
 
 
M. alpina NRRL 6302 
 
M. zychae NRRL 2592 
 
M. alpina CBS528.72 
 
Phaeodactylum tricornutum 
 
Schizochytrium sp.S31 
6.0 
7.0 
 
6.0 
 
6.0 
 
6.5 
 
7.6 
 
7.0 
ARA 
EPA 
 
ARA 
 
ARA 
 
ARA 
 
EPA 
 
DHA 
54.07 g/g substrate carbon 
18.2 g/g substrate carbon 
 
21.05 (%TFA) 
 
23.38 (%TFA) 
 
34.72 (%TFA) 
 
93.1 
 
314 
Jang et al., (2000) 
 
 
Hou, (2008) 
 
Hou, (2008)  
 
Nischa and Venkateswaran, (2011) 
 
Yongmanitchai and Ward, (1991) 
 
Wu et al., (2005b) 
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2.10.6 Agitation speed and aeration (O2) 
Agitation speed level is always an important factor in aerobic 
biological systems, since when the supply of oxygen is limited, both cell growth and 
product formation can be severely affected (Wang and Zhong, 2007). Higher agitation 
rates result in an increase in oxygen supply for growth, and can lead to an increase in 
the availability of intracellular molecular oxygen. This ensures optimum activities of 
the oxygen-dependent enzymes in PUFA biosynthesis (Gibbs and Seviour, 1996; 
Singh and Ward, 1997; Higashiyama et al., 1999). However, the optimal dissolved 
oxygen concentration may vary with different spices.  
For example, the fungus T. aureum ATCC34304 showed maximum 
biomass production with an agitation speed of 100 rpm, and the highest PUFA content 
in total lipids at 150 rpm, under optimal culture conditions. However, agitation speeds 
higher than 250 rpm physically disrupted the cells, so that the morphology was found 
to be severely changed and the PUFA content was also greatly reduced (Hur et al., 
2002). Higashiyama et al. (1999) also found that a dissolved oxygen (DO) range of 
10-15 ppm was optimum for maximum ARA yield in M. alpina cultures, but high 
levels of oxygen (average DO, 20-50 ppm) decreased ARA production due to cell 
adaptation by β-oxidation of the fatty acid. 
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CHAPTER 3 
 
MATERIALS AND METHODS 
 
3.1 Materials 
 
3.1.1 Marine algae and plant materials and culture conditions 
Pavlova sp. CCMP459 was purchased from Provasoli-Guillard 
National Center for Culture of Marine Phytoplankton (CCMP, West Boothbay 
Harbor, ME, USA). The Gransden strain of Physcomitrella patens (Ashton and Cove, 
1977) supplied by Prof. Ralph S. Quatrano (Washington University, St. Louis, USA) 
was used throughout these studies. Protonemata (14-day-old) were grown in liquid 
BCD basal medium to which di-ammonium tartrate was added to 5 mM and cultured 
at 25oC under continuous light provided by fluorescent tubes (Knight et al., 2002) 
unless indicated otherwise. 
 
3.1.2 Materials  
Materials used for cloning, expression of Pavlova sp. ∆5-elongase and 
fatty acid analysis were purchased from the following companies. 
 
Materials Company 
- Biodyne® B (0.4 µm) 
- 1,000 µl Blue Traditional Shaped Tip 
- 5 ml Castor® Stripette® 
- 10 ml Castor® Stripette® 
- 10 µl Extended Length Tip (Neptune) 
- 0.2 ml Flat Cap PCR Tubes 
- GC vial (1.5 ml)  
- Glass Insert (0.1 ml) 
- 0.25 mm x 30 m x 0.25 µm HP-INNOWax 
capillary column 
Pall Life Sciences, Mexico 
Biotix, Mexico 
Corning, USA 
Corning, USA 
Biotix, Mexico 
Axygen, Mexico 
Agilent Technologies, USA 
Agilent Technologies, USA 
Agilent Technologies, USA 
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- 1.5 ml Microcentrifuge Tube 
- Omni TipTM Plastic Probes 
- Pipet Aid (ROTA-Filler 3000®) 
- 14 ml Polypropylene Round-Bottom Tube 
- 15 ml Screw Cap Conical Bottom Centrifuge Tubes 
- 50 ml Screw Cap Conical Bottom Centrifuge Tubes 
- Sterilized-Disposable Plastic Petri-dishes  
(90x15 mm) 
- 0.2 µm Syringe filter 
 
- 200 µl Universal Tip 
Biomed, Thailand 
Omni International, USA 
Heathrow Scienctific, China 
BD Biosciences, USA 
Corning, USA 
Corning, USA 
Biomed, Thailand 
 
Sartorius Stedim Biotech, 
Germany 
Biotix, Mexico 
 
3.1.3 Chemicals 
 3.1.3.1 Chemicals used for cloning and expression of Pavlova sp. ∆5-
elongase were purchased from the following companies. 
 
Chemicals Company 
- Agarose 
- Ammonium tartrate 
- Ampicillin 
- Anti-digoxigenin-AP Fab Fragments 
 
- Blocking reagent 
 
-5-Bromo-4-chloro-3-indolyl-beta-D-
galactopyranoside (X-Gal) 
- Casein Enzyme Hydrolysate, Type-1 
- Chemi-luminescent substrate (CSPD) 
 
- DIG Easy Hyb 
 
Bio Basic, Canada 
Fluka, Germany 
Bio Basic, Canada 
Roche Applied Sciences, 
Germany 
Roche Applied Sciences, 
Germany 
Sigma-Aldrich, USA 
 
Himedia, India 
Roche Applied Sciences, 
Germany 
Roche Applied Sciences, 
Germany 
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- DL-maleic acid 
- DNA Molecular Weight Marker II DIG labeled  
0.12-23.1 kbp 
- Ethanol, AR grade 
- Ethylenediaminetetraacetic acid tetrasodium 
salt dihydrate 
- Geneaid Plasmid Maxi Kit 
- Glutamic acid 
- High-Speed Plasmid Mini Kit 
- Hygromycin B 
- Isopropyl thiogalactoside (IPTG) 
- Kanamycin 
- 1 kb DNA Ladder 
- Lithium chloride 
- Manganess (II) chloride 
- Mannitol 
- MES monohydrate 
- Nickel chloride 
- NucleonTM PhytoPureTM Genomic DNA 
Extraction Kit 
- Orange G (molecular biology tested) 
- PCR Dig Probe Synthesis Kit 
 
- Polyethylene glycol 6000 
- Potassium nitrate 
- Potassium phosphate 
- Propan-2-ol, AR grade 
- QIAquick Gel Extraction Kit 
- RNeasy Plant Mini Kit 
- Seakem® LE agarose gel 
 
Bio Basic, Canada 
Roche Applied Sciences, 
Germany 
RCI Labscan, Thailand 
Fluka, Germany 
 
Geneaid Biotech, Taiwan 
Univar, New Zealand 
Geneaid Biotech, Taiwan 
Sigma-Aldrich, Germany 
Sigma-Aldrich, USA 
Bio Basic, Canada 
Promega, Germany 
Ajax Finechem, New Zealand 
Univar, New Zealand 
Univar, New Zealand 
Fluka, Germany 
Univar, New Zealand 
GE Healthcare, USA 
 
Sigma-Aldrich, Germany 
Roche Applied Sciences, 
Germany 
Fluka, Germany 
Univar, New Zealand 
J.T. Baker, USA 
RCI Labscan, Thailand 
Qiagen, USA 
Qiagen, USA 
Cambrex Bio Science Rockland, 
USA 
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- Sodium chloride 
- Sodium dodecyl sulphate 
- Spectinomycin 
- SYBR® Safe DNA gel stain 
- Tris-hydrochloride 
-Tris (hydroxymethyl) aminomethane 
(molecular biology grade) 
- Tri-sodium citrate 
- Yeast extract 
RCI Labscan, Thailand 
Ajax Finechem, New Zealand 
Bio Basic, Canada 
Invitrogen, USA 
Bio Basic, Canada 
Research Organics, USA 
 
Ajax Finechem, New Zealand 
Himedia, India 
 
3.1.3.2 Chemicals used for fatty acid analysis were purchased from the 
following companies. 
 
Chemicals Company 
- Fatty acid standard 
- Heptane, AR grade 
- Methanol, AR grade 
- Sulfuric acid, AR grade 
Nu-Check-Prep, USA 
Lab Scan, Thailand 
Lab Scan, Thailand 
Lab Scan, Thailand 
 
3.1.4 Bacterial strains 
  Two strains of E. coli were used in this study were purchased from the 
Invitrogen. 
 
Strain Genotype 
E. coli DB3.1 
 
 
E. coli TOP10 
F- gyrA462 endA1 D(sr1-recA) mcrB mrr hsdS20(rB-, mB-) 
supE44 ara-14 galK2 lacY1 proA2 rpsL20(Smr) xyl-5 λ- leu 
mtl-1 
F- mcrA ∆(mrr-hsdRMS-mcrBC) Φ80lacZ∆M15 ∆lacX74 
recA1 araD139 ∆(ara-leu)7697 galU galK rpsL (StrR) endA1 
nupG 
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3.1.5 Enzymes 
  Restriction enzymes, polymerases and DNA modifying enzymes were 
purchased from the following companies. 
 
Enzyme Company 
- ApaI 
- Driselase from Basidiomycetes sp. 
- EcoRI 
- EcoRV 
- Gateway® LR ClonaseTM II Enzyme Mix 
- HindIII  
- NcoI 
- Taq DNA Polymerase 
- ThermoScriptTM RT-PCR System 
TaKaRa Bio, Japan 
Sigma-Aldrich, Japan 
TaKaRa Bio, Japan 
TaKaRa Bio, Japan 
Invitrogen, USA 
TaKaRa Bio, Japan 
TaKaRa Bio, Japan 
Invitrogen, USA 
Invitrogen, USA 
 
3.1.6 Plasmid vectors 
  Cloning vector (pCR®2.1-TOPO®), gateway entry vector 
(pCR®8/GW/TOPO) were purchased from Invitrogen (Carlsbad, CA, USA) and plant 
gateway destination vectors (pMDC32 and pMDC43) were purchased from 
Arabidopsis Biological Resource Center (ABRC) (Column, OH, USA). The maps of 
the vectors pCR®2.1-TOPO®, pCR®8/GW/TOPO, pMDC32 and pMDC43 are shown 
in Figures 3.1, 3.2, 3.3 and 3.4, respectively. 
 
 
Figure 3.1 Map of cloning vector pCR®2.1-TOPO® (Invitrogen). 
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Figure 3.2 Map of gateway cloning vector pCR8®/GW/TOPO® (Invitrogen). 
 
 
Figure 3.3 Map of gateway plant destination vector pMDC32 (ABRC). 
 
 
Figure 3.4 Map of gateway plant destination vector pMDC43 (ABRC). 
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3.1.7 Apparatuses used for cloning, expression of Pavlova sp. ∆5-elongase and 
fatty acid analysis 
 
Apparatus Company 
- Agilent 6890N Gas chromatograph (GC) 
- Bioharzard Safety Cabinet Class II (Safe 2010) 
- Freezer (-20oC) 
- Gas chromatograph-Mass spectrometry (GC-
MS) 
           - GC: Hewlett Packard 5890 Series II 
           - MS: Hewlett Packard 5972A 
- Gel documentation (Bio-Rad Gel Doc 1000) 
- GyroSpin Centrifuge 
- Hermle Z323K universal refrigerated centrifuge 
 
- Hot air oven 
- New Brunswick Scientific Innova 2100 Platform 
Shaker 
- New Brunswick Scientific Innova 4230 
Refrigerated Benchtop Incubator Shaker 
- Omni THQ - Digital Tissue Homogenizer 
- pH meter (420A) 
- Refrigerator 
- SL SHEL LAB Laboratory Incubators 
- TaKaRa PCR Thermal Cycler Dice TP600 
- Thermomixer Comfort 
- Ultra Low Temperature Freezer (-86oC Freezer) 
- UV-spectrophotometer Gensys 6 
- Water bath 
Agilent technologies, USA 
Thermo electron, USA 
Sanyo, Japan 
 
 
Hewlett Packard, USA 
Hewlett Packard, USA 
Bio-Rad, USA 
Gyrozen, Korea 
Hermle Labortechnik, 
Germany 
Memmert, Germany 
New Brunswick Scientific, 
USA 
New Brunswick Scientific, 
USA 
Omni International, USA 
Orion Research, USA 
Toshiba, Japan 
Sheldon Manufacturing, USA 
TaKaRa Bio, Japan 
Lab Mark, Czech Republic 
Shenyang Faith Trading, China 
Thermo Scientific, USA 
Memmert, Germany 
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3.2 Methods 
 
3.2.1 Cloning of Pavlova sp. ∆5-elongase gene 
 
3.2.1.1 RNA extraction 
Approximately 20 mg fresh weight of Pavlova sp. CCMP 459 was 
ground to a fine powder under liquid nitrogen using a pre-cooled mortar and pestle. 
Total RNA was extracted from Pavlova sp. CCMP 459 using the RNeasy Plant Mini 
Kit (Qiagen) and determine the total RNA concentration using UV-spectrophotometer 
(Table 3.1). 
 
Table 3.1 Total RNA extraction (RNeasy Plant Mini Kit, Qiagen). 
 
Step Action 
1. Breaking the cell wall - Approximately 20 mg fresh weight of Pavlova sp.  
- Grind to a fine powder using liq. N2 in a mortar 
and pestle 
- Transfer the powder to RNase-free, liq.N2 in  
1.5 ml microcentrifuge tube 
2. Cell lysis - Add 450 µl of buffer RTL 
- Mix vigorously 
- Incubate at 56oC for 30 min 
3. Centrifugation - Pipet the lysate onto a QIA shredder spin column 
placed in 2 ml collection tube 
- Centrifuge at 12,500 rpm 
- Transfer the supernatant of the flow-through to  
a new microcentrifuge tube 
4. Wash - Add 0.5 volumn of 100% ethanol 
- Mix immediately 
- Apply all sample to an RNeasy mini column 
placed in a 2 ml microcentrifuge tube 
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Table 3.1 Total RNA extraction (RNeasy Plant Mini Kit, Qiagen) (continued). 
 
Step Action 
4. Wash (continued) - Centrifuge at 12,500 rpm for 30 sec 
- Discard the flow-through liquid 
5. Wash - Add 700 µl of buffer RW1 to the RNeasy column 
- Centrifuge at 12,500 rpm for 30 sec 
- Discard the flow-through liquid 
- Transfer the RNeasy column into a new 2 ml 
microcentrifuge tube  
6. Wash - Add 700 µl of buffer RPE to the RNeasy column  
- Centrifuge at 12,500 rpm for 30 sec 
- Discard the flow-through liquid 
7. Wash - Add another 500 µl of buffer RPE to  
the RNeasy column  
- Centrifuge at 12,500 rpm for 5 min 
- Discard the flow-through liquid 
- Transfer the RNeasy column into a new 1.5 ml 
collection tube 
8. Elution - Add 50 µl of RNase-free water directly onto  
the RNeasy silica gel membrane 
- Centrifuge at 12,500 rpm for 2 min 
- Collect the flow-through liquid 
9. Determination - Determine the total RNA concentration using  
UV-spectrophotometer 
 
3.2.1.2 cDNA synthesis  
One µl of Oligo (dT)14 primer (RACE 32: 5’-GAC TCG AGT CGA 
CAT CGA TTT TTT TTT TTT TT-3’) (Frohman et al., 1988) and 2 µl of 10 mM 
dNTPs were added to 5 µg of total RNA in a 12 µl volume reaction, incubated at 
65oC for 5 min and placed on ice. The cDNA synthesis mix containing 4 µl of 5x first 
strand buffer, 1 µl of 0.1 M DTT and 15 units/µl ThermoScriptTM III Reverse 
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Transcriptase (Invitrogen) was then added to the previous reaction on ice. After 
incubation at 4oC for 10 min, followed by 60 min at 50oC and finally, the reaction 
was terminated by incubating at 75oC for 5 min. The cDNA was subsequently used as 
a template for PCR amplification with primers. 
 
3.2.1.3 DNA cloning 
Single strand cDNA of Pavlova sp. CCMP459 was used as a template 
for PCR amplification with specific primers. The forward and reverse primers were 
PsELO5-For, 5’-ATG ATG TTG GCC GCA G-3’ (underlined sequence is a start 
codon) and PsELO5-Rev, 5’-TTA CTC CGC CTT GAC CG-3’ (underlined sequence 
is a stop codon), respectively (Pereira et al., 2004b).  
The PCR was carried out in a total volume of 50 µl containing 2 µl of 
10 µM each primers, 5 µl of 10x PCR buffer, 1 µl of 10 mM dNTPs, 1 µl of cDNA as 
a template, 1.5 µl of 50 mM MgCl2, and 0.5 µl of 5 U/µl Taq DNA polymerase 
(Invitrogen). After initial denaturation at 94oC for 4 min, amplification was 
performed in 35 cycles of 1 min at 94oC, 0.5 min at 49oC and 2.5 min at 72oC, 
followed by a final extension at 72oC for another 10 min. The amplified products 
were separated on 1.0% (w/v) agarose gels and purified by QIAquick Gel Extraction 
(Table 3.2).  
Aliquot of 1 µl was directly cloned into pCR® 2.1-TOPO® (Invitrogen) 
(Figure 3.1) in a total volume of 6 µl at 4oC overnight. Three microliters of the 
ligation reaction were then transformed into One Shot® TOP10 Chemically competent 
E. coli cells (Invitrogen) and cultured on solid Luria-Bertani (LB) medium containing 
100 µg/ml ampicillin, surface spread by 50 µl of 100 mM IPTG and 50 mg/ml X-Gal. 
Plasmids DNA were purified from transformed E. coli cultures by High-Speed 
Plasmid Mini Kit (Geneaid) (Table 3.3).  
The resulting plasmids were verified by digestion with EcoRI for 60 
min at 37oC and analyzed by 1.0% agarose gel electrophoresis. Plasmid DNA was 
purified and sequenced in both directions with M13 forward and reverse primers, 
resulting in the plasmid named pCR®2.1-TOPO®-PsELO5. 
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Table 3.2 DNA gel purification (QIAquick Gel Extraction, Qiagen). 
 
Step Action 
1. Excise - Excise the DNA fragment form the agarose gel 
- Weigh the gel slice in a 1.5 ml microcentrifuge 
tube  
2. Dissolve gel - Add 3 volumes of buffer QG to 1 volume of gel 
- Incubate at 50oC for 15 min and mix 
3. Centrifugation - Pipet the sample onto the QIAquick column 
- Centrifuge at 12,500 rpm for 1 min 
- Discard the flow-through 
4. Binding DNA - Add 500 µl of buffer QG to QIAquick column 
- Centrifuge at 12,500 rpm for 1 min 
- Discard the flow-through 
5. Wash the DNA pellet - Add 750 µl of Buffer PE to QIAquick column 
- Stand for 2 min 
- Centrifuge at 12,500 rpm for 1 min twice 
- Discard the flow-through 
6. Elution - Place QIAquick column to a clean 1.5 ml 
microcentrifuge tube 
- Add 32 µl of Buffer EB to QIAquick membrane 
- Centrifuge at 12,500 rpm for 1 min twice 
- Collect the purified DNA 
- Store at -20oC until used    
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Table 3.3 Plasmid DNA isolation (High-Speed Plasmid Mini Kit, Geneaid). 
 
Step Action 
1. Harvesting  - Harvest 5 ml of bacterial culture by centrifugation 
at 12,500 rpm for 6 min 
- Pour off supernatant 
2. Cell lysis  - Add 200 µl of Cell Resuspension Solution 
containing 50 µg/ml RNase 
- Mix with vortex 
- Add 200 µl of Cell Lysis Solution 
- Inverting mix 
3. Cell debris precipitation - Add 300 µl of PD3 
- Inverting mix immediately 
- Centrifuge at 12,500 rpm for 15 min 
4. Binding DNA  - Decant the clear lysate into the Spin column 
placed in a 2 ml collection tube 
- Centrifuge at 12,500 rpm for 1 min 
- Discard the flow-through 
5. Wash the DNA pellet - Add 400 µl of PW  
- Centrifuge at 12,500 rpm for 1 min 
- Discard the flow-through  
6. Wash the DNA pellet  - Add 600 µl of Wash Buffer  
- Centrifuge at 12,500 rpm for 1 min twice 
- Discard the flow-through 
7. Elution - transfer the Spin column to a new 1.5 ml 
microcentrifuge tube 
- Add 50 µl of TE buffer 
- Stand for 2 min 
- Centrifuge at 12,500 rpm for 2 min 
- Collect the plasmid DNA  
- Store at -20oC until used 
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3.2.2 Functional analysis of Pavlova sp. ∆5-elongase in P. patens 
 
3.2.2.1 Construction of entry clone 
The primers PsELO5-For and PsELO5-Rev were used for PCR 
amplification of the pCR®2.1-TOPO®-PsELO5 with Taq DNA polymerase 
(Invitrogen). PCR was carried out in a total volume of 50 µl containing 2 µl of 10 µM 
of each primer, 5 µl of 10x PCR buffer, 1 µl of 10 mM dNTPs, 1.5 µl of 50 mM 
MgCl2, 1 µl of 1/50 diluted pCR®2.1-TOPO®-PsELO5 as a template, and 0.5 µl of 5 
U/µl Taq DNA polymerase (Invitrogen). The PCR conditions were conducted as 
following; initial denaturation for 4 min at 94oC, followed by 28 cycles of 1 min at 
94oC, 0.5 min at 49oC, 2.5 min at 72oC, followed by a final extension at 72oC for 
another 10 min (Table 3.4).  
One microliter of amplification product was incorporated directly into 
1 µl of entry vector, pCR® 8/GW/TOPO® vector (Invitrogen) (Figure 3.2) in a total 6 
µl solution containing 1 µl of salt solution. The mixture was incubated at room 
temperature for 60 min and transformed into One Shot® TOP10 Chemically 
competent E. coli cells (Invitrogen). The transformants were cultured on LB medium 
containing 100 µg/ml spectinomycin. Plasmids DNA were purified from transformed 
E. coli cultures by High-Speed Plasmid Mini Kit (Geneaid) (Table 3.3). The resulting 
plasmids were verified by digestion with EcoRI for 60 min and analyzed by 1.0% 
agarose gel electrophoresis.  
The corresponding plasmid was sequenced with M13 forward and 
reverse primers, yielding the plasmid attL1-PsELO5-attL2. The obtained plasmid 
containing PsELO5 sequence flanked by attL recombination sequences was then 
recombined with attR sites of destination vectors using the Gateway® LR ClonaseTM 
II Enzyme Mix (Invitrogen). 
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Table 3.4 Construction of pCR® 8/GW/TOPO® vector containing Pavlova sp. ∆5-
elongase gene (the plasmid attL1-PsELO5-attL2). 
   
Step Action 
1. PCR mixtures - 0.5 µl of Taq DNA polymerase (Invitrogen) 
- 5.0 µl of 10X PCR buffer 
- 4.0 µl of 2.5 mM dNTPs 
- 1.5 µl of 50 mM MgCl2  
- 2.0 µl of 10 µM Primer PsELO5-For  
- 2.0 µl of 10 µM Primer PsELO5-Rev 
- 35  µl of sterile water 
2. PCR conditions  - Pre-denaturation at 94oC for 4 min 
- Denaturation at 94oC for 1 min 
- Anneling at 49oC for 0.5 min 
- Extension at 72oC for 2.5 min 
- Final extension at 72oC for 10 min 
- 1 cycle 
 
         - 28 cycles 
 
- 1 cycle 
3. DNA purification - Separate on 1.0% agarose gel electrophoresis 
- Gel purify by QIA Gel Extraction Kit (See Table 3.2)  
4. Ligation mixture   - 1.0 µl of pCR® 8/GW/TOPO® vector   
- 1.0 µl of PCR product 
- 1.0 µl of salt solution 
- 3.0 µl of sterile water  
- Incubate at 4oC, overnight  
5. Transformation - Add 3 µl of mixed into 50 µl of E. coli competent cells 
- Keep on ice for 30 min and heat at 42oC for 1 min 
- Keep on ice for 5 min and add 300 µl of SOC medium 
- Incubate with shaking incubator at 37oC for 60 min 
- Spread plates on LB medium containing 100 µg/ml 
spectinomycin      
6. DNA extraction - Plasmid isolation by High-Speed Plasmid Mini Kit 
(Geneaid) (See Table 3.3) 
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3.2.2.2 Construction of P. patens expression vector 
This reaction separately transferred 150 ng (2 µl) of PsELO5 coding 
sequence of the plasmid attL1-PsELO5-attL2 into 100 ng (3 µl) of desired destination 
vector, pMDC32 (a tandemly duplicated cauliflower mosaic virus 35S (CaMV35S) 
promoter) (Figure 3.3) or pMDC43 (a tandemly duplicated CaMV35S promoter 
together with green fluorescence protein (GFP6) region) (Figure 3.4) (ABRC) 
(Columbus, OH, USA) (Curtis and Grossniklaus, 2003) in a total volume of 10 µl 
solution containing 3 µl of TE buffer (pH 8.0), and 2 µl of LR ClonaseTM II Enzyme 
Mix (Invitrogen) at 4oC for 2 days (Table 3.5).  
The mixtures are further incubated with 1 µl of Proteinase K at 37 oC 
for 15 min. An aliquot of 3 µl was introduced into One Shot® TOP10 Chemically 
Competent E. coli cells (Invitrogen). The transformants were cultured on LB medium 
containing 50 µg/ml kanamycin. Plasmids DNA were further purified from 
transformed E. coli cultures by High-Speed Plasmid Mini Kid (Geneaid) (Table 3.3). 
The resulting plasmids were verified by digestion with EcoRI at 37oC for 60 min and 
analyzed by 1.0% agarose gel electrophoresis. This resulted in the generation of 
recombinant plasmids, pMDC32-PsELO5 carrying a gene PsELO5 and pMDC43-
PsELO5 carrying a gene PsELO5 fused to C-terminus of GFP6, driven by a tandemly 
duplicated CaMV35S promoter and nos terminator, and containing hygromycin 
resistance (Hygr) gene as a selection marker. 
 
Table 3.5 Construction of P. patens expression vector. 
 
Step Action 
1. Recombination - 2.0 µl of pMDC32 or pMDC43 (150 ng) (ABRC) 
- 3.0 µl of pCR® 8/GW/TOPO® vector containing 
Pavlova sp. ∆5-elongase gene (the plasmid attL1-
PsELO5-attL2) 
- 2.0 µl of TE buffer (pH 8.0) 
- 2.0 µl of LR ClonaseTM Enzyme Mix (Invitrogen) 
- Incubate at 4oC, overnight 
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Table 3.5 Construction of P. patens expression vector (continued). 
 
Step Action 
2. Digestion - Add 1 µl of Proteinase K (Invitrogen) 
- Incubate at 37oC for 15 min  
3. Transformation - Add 5.0 µl of recombination reaction into E. coli 
competent cells (See Table 3.4)    
4. DNA extraction  - Plasmid isolation by High-Speed Plasmid Mini Kit 
(Geneaid) (See Table 3.3) 
 
3.2.2.3 Large scale plasmid DNA purification 
An aliquot of 0.5 µl of recombinant plasmids, pMDC32-PsELO5 or 
pMDC43-PsELO5, was introduced into One Shot® TOP10 Chemically Competent E. 
coli cells (Invitrogen) (Table 3.4). The transformants were cultured on solid LB 
medium containing 50 µg/ml kanamycin and a single colony was then transferred into 
500 ml Erlenmeyer flasks containing 250 ml of liquid LB medium containing 50 
µg/ml kanamycin. Plasmids DNA were further purified from transformed E. coli 
cultures by Geneaid Plasmid Maxi Kit (Geneaid) (Table 3.6). The resulting plasmids 
were verified by digestion with EcoRI for 60 min at 37oC and analyzed by 1.0% 
agarose gel electrophoresis and determined the DNA concentration using UV-
spectrophotometry. 
 
Table 3.6 Large scale plasmid DNA purification (Geneaid Plasmid Maxi Kit, 
Geneaid). 
 
Step Action 
1. Cell harvesting - Transfer 50 ml of cells to a 50 ml centrifuge tube 
- Centrifuge at 13,000 rpm for 15 minutes 
- Discard the supernatant completely 
- Repeat as required for samples >50 ml using the 
same centrifuge tube 
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Table 3.6 Large scale plasmid DNA purification (Geneaid Plasmid Maxi Kit, 
Geneaid) (continued). 
 
Step Action 
2. Re-suspension - Add 10 ml of PM1 Buffer (RNase A added) to re-
suspend the cell pellet completely by vortex or pipette 
3. Cell lysis - Add 10 ml of PM2 Buffer and mix gently by 
inverting the tube 10 times (be sure and mix 
completely) 
- Do not vortex, to avoid shearing the genomic DNA 
- Let stand at room temperature for at least 2 minutes 
to ensure the lysate is clear 
4. Neutralization - Add 10 ml of PM3 Buffer 
- Immediately shake vigorously for 10 seconds 
- Do not vortex 
- Centrifuge at 13,000 rpm for 30 minutes at 4oC 
5. DNA binding - Transfer the supernatant to the equilibrated Plasmid 
Maxi Column and allow the column to empty 
completely by gravity flow 
- Discard the flow-through and place the Plasmid 
Maxi Column back in the 50 ml centrifuge tube 
6. Wash - Wash the Plasmid Maxi Column by adding 30 ml of 
PW Buffer 
- Allow the column to empty completely by gravity 
flow then discard the filtrate 
7. DNA elution - Place the Plasmid Maxi Column in a clean 50 ml 
centrifuge tube 
- Add 12 ml of PEL Buffer to elute the DNA by 
gravity flow 
- Discard the Plasmid Maxi Column once it has 
emptied completely 
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Table 3.6 Large scale plasmid DNA purification (Geneaid Plasmid Maxi Kit, 
Geneaid) (continued). 
 
Step Action 
8. DNA precipitation - Add 9 ml (0.75 volumes) of isopropanol to the 
eluted DNA from Step 7 
- Mix the tube completely then centrifuge at  
13,000 rpm for 60 minutes at  4ºC 
- Carefully remove the supernatant and wash the 
DNA pellet with 5 ml of 75% ethanol 
- Centrifuge at 13,000 rpm for 30 minutes at 4ºC. 
- Carefully remove the supernatant 
- Air-dry the DNA pellet for 10 minutes 
- Dissolve the DNA pellet in 0.5 ml (or suitable 
volume) of TE 
9. Determination - Determine the DNA concentration using  
UV-spectrophotometry 
 
3.2.2.4 Protoplast transformation and regeneration 
 
3.2.2.4.1 Protoplast isolation 
Protoplasts were isolated from 5 plates (1 g fresh weight) of 14-
day-old protonemal wild type P. patens cultures by digestion with 20 ml of 0.5% 
Driselase enzyme suspension dissolved in 8% D-mannitol for 45 min. The digested 
moss material was successively passed through sieve with a pore size of 100 µm, 
centrifuged at 250g and washed in 20 ml of 8% D-mannitol twice. Subsequently, the 
protoplast pellets were resuspended in 10 ml of calcium protoplast wash (CaPW) 
solution and estimated the protoplast density using a haemocytometer (Grimsley et 
al., 1977) (Table 3.7). 
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Table 3.7 Protoplast isolation. 
 
Step Action 
1. Cell Harvesting and 
digestion 
- Approximately 1g fresh weight of 14-day-old 
protonemata wild type P. patens tissue 
- Digested with 20 ml of 0.5% Driselase (Sigma)  
for 45 min   
2. Centrifugation  - Digested moss material is successively passed 
through sieve with a pore size of 100 µm 
- Centrifuge at 250g for 5 min 
- Discard the supernatant  
3. Wash - Add 20 ml of 8% mannitol twice  
- Centrifuge at 250g for 5 min 
- Remove the supernatant 
- Yielding isolated moss protoplasts pellet 
4. Resuspend  - Resuspend the protoplast pellet in 10 ml of CaPW 
5. Estimate - Estimate the protoplast density using  
a haemocytometer 
 
3.2.2.4.2 Polyethylene-glycol (PEG)-mediated transformation 
of protoplasts and P. patens regeneration 
Three hundred microliters of the expression construct, pMDC32-
PsELO5 and pMDC43-PsELO5 from section 3.2.2.3 were separately digested with 
HindIII in a total volume of 400 µl at 37oC for 5 hr. The linear DNA was then 
subsequently precipitated. Fiveteen micrograms of the linear plasmids were 
separately transformed into 5x105 protoplasts of the wild type P. patens by PEG-
method (Schaefer et al., 1991 with modification) (Table 3.10).  
Transformation experiments were performed by polyethylene 
glycol (PEG) 6,000 with 300 µl of D-mannitol/MgCl2/MES (MMM) solution (See 
Appendix A) of a WT protoplast suspension (5x105 protoplasts) added to 15 µg linear 
plasmids. After transformation, the transformed protoplasts were resuspended in the 1 
ml of sterile 8% D-mannitol and added with 7 ml of molten PRMT (protoplast 
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regeneration medium-top) medium (See Appendix A), 2 ml of mixtures were plated 
onto each 90x15 mm Petri dishes containing solidified protoplast regeneration 
medium-bottom (PRMB) medium (See Appendix A) and cultured at 25oC under 
continuous light provided by fluorescent tubes. The medium was covered with a 
sterile cellophane sheet which facilitates the transfer of the regenerating plant at 
subsequent stages.  
After regeneration of protoplasts on PRMB/PRMT medium for 
14 days, the cellophanes with the culture were transferred to the solid BCD medium 
(Knight et al., 2002) containing hygromycin B (25 µg/ml) and cultured for 14 days, 
followed by 14 days release period on medium without antibiotic and retransferred to 
selective medium for a further 14 days. Transformed plants that survived this 
selection regime were defined as stable transformants. 
 
Table 3.8 Protoplast transformation and regeneration. 
 
Step Action 
1. Protoplast 
harvesting 
- Aliquot 5x105 protoplasts into the sterile tube 
- Centrifuge at 250g for 5 min and discard the supernatant 
- The protoplast pellet 
2. Resuspend - Add 300 µl of MMM solution and add 15 µg of 
expression vector DNA into the protoplast suspension  
3. Transformation Time in minutes 
0 
5 
10 
20 
25 
30 
35 
40 
 
- Add 300 µl of PEG solution 
- Heat at 45oC for 5 min 
- Keep on ice for 10 min 
- Add 1 ml of CaPW and mix gently 
- Add 2 ml of CaPW and mix gently 
- Add 4 ml of CaPW and mix gently 
- Add 4 ml of CaPW and mix gently 
- Centrifuge at 250g for 5 min 
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Table 3.8 Protoplast transformation and regeneration (continued). 
 
Step Action 
4. Resuspend and 
dispense 
- Resuspend the protoplast pellet in 1 ml of  
sterile 8% mannitol 
- Add 7 ml of molten PRMT medium 
- Dispense onto 90x15 mm plates of PRMB overlayed with 
cellophane (2 ml/plate) 
- Incubate at 25oC under continuous light for 14 days 
 
3.2.3 Fatty acid analysis of P. patens by GC-MS 
 Total fatty acids from 14-day-old protonemata of moss were analyzed 
by GC and fatty acid methyl esters (FAMEs) prepared according to Kaewsuwan et 
al., (2006). Briefly, total fatty acids of moss tissues from wild type and individual 
transgenic P. patens plants were transmethylated with 2.5% sulfuric acid dissolved in 
methanol at 85°C for 30 min, a total of 1 ml of water and 1 ml of heptane were added 
to the extracts and well mixed. The top organic layers with the FAMEs were collected 
and dried under nitrogen gas.  
GC analysis of FAMEs was conducted using an Agilent 6890N (USA) 
equipped with an HP-INNOWax capillary column (0.25 mm x 30 m x 0.25 µm), a 
flame ionization detector, using helium as the carrier gas. An aliquot (2 µl) of each 
sample extract was injected onto the GC column using the injector in the split mode. 
The initial column temperature was 185oC (0.5 min) and was increased at a rate of 
3.5oC/min to 235oC (14.3 min), and then maintained at 235oCfor 1.0 min. Fatty acids 
were identified by comparison with the retention times of standards and were 
expressed as mg/l.  
The amounts of fatty acids were estimated from the peak areas 
extrapolated with the calibration curves of known fatty acid standards. The 
corresponding fatty acids were further verified with the same condition by GC–MS 
using the HP 5972A Series operating at an ionization voltage of 70 eV with a scan 
range of 50-500 Da. 
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3.2.4 Molecular analysis by PCR and Southern blotting 
 
3.2.4.1 Genomic DNA extraction for PCR analysis 
Approximately 50 mg fresh weight of 14-day-old protonemal wild type 
and stable transgenic P. patens were frozen using liquid nitrogen and pulverized in a 
microcentrifuge tube. The powdered tissues were blended with 250 µl of shortly 
extraction buffer (See Appendix A) twice, incubated on ice for 5 min, and centrifuged 
at 13,000 rpm for 5 min. A volume of 350 µl of supernatant was mixed with 350 µl of 
isopropanol and centrifuged at 13,000 rpm for an additional 15 min. Genomic DNA 
pellet was washed with 250 µl of 70% ethanol, followed by resuspending dried 
genomic DNA with 400 µl TE buffer before PCR analysis (Table 3.9).  
 
Table 3.9 Genomic DNA extraction for PCR analysis. 
 
Step Action 
1. Breaking of the cell wall  - Approximately 50 mg fresh weight of wild type 
and stable transgenic P. patens.  
- Grind to a fine powder using liq. N2 in a mortar 
and pestle 
- Transfer the powder to RNase-free, liq.N2 in  
1.5 ml microcentrifuge tube 
2. Cell lysis - Add 500 µl of shortly extraction buffer 
- Mix vigorously 
- Centrifuge at 13,000 rpm for 10 min 
3. DNA precipitation - Add 350 µl of isopropanol to 350 µl of supernatant 
- Mix with vortex  
- Centrifuge at 13,000 rpm for 15 min 
- Discard the supernatant 
- Yielding the DNA pellet  
4. DNA washing - Add 250 µl of 70% ethanol and mix vigorously 
- Centrifuge at 13,000 rpm for 15 min  
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Table 3.9 Genomic DNA extraction for PCR analysis (continued). 
 
Step Action 
5 DNA drying - Dry the DNA by speed vacuum for 10 min 
6. DNA dissolving - Resuspend the genomic DNA with 400 µl of  
TE buffer 
- Keep at 4oC, overnight   
7. Storage - Store at -20oC, overnight until used  
 
3.2.4.2 PCR analysis 
DNA integration event of PsELO5 was verified by PCR experiments 
with specific primers, PsELO5-For, 5’-ATG ATG TTG GCC GCA G-3’ and 
PsELO5-Rev, 5’-TTA CTC CGC CTT GAC CG-3’ corresponded to the start and stop 
regions of PsELO5 (Pereira et al., 2004b). The hygromycin resistance (Hygr) gene 
was also confirmed by PCR with primers, Hygro-For, 5'-ATG AAA AAG CCT GAA 
CTA CCG-3' and Hygro-Rev, 5'-CTA TTT CTT TGC CCT CGG A-3' derived from 
5’- and 3’- Hygr coding region.  
The PCRs were carried out in a total volume of 50 µl containing 2 µl 
of 10 µM each primers, 5 µl of 10x PCR buffer, 1 µl of 10 mM dNTPs, 1 µl of 1/50 
genomic DNA as a template, 1.5 µl of 50 mM MgCl2, and 0.5 µl of 5 U/µl Taq DNA 
Polymerase (Invitrogen). After initial denaturation at 94oC for 4 min, amplification 
was performed in 35 cycles of 1 min at 94oC, 0.5 min at 49oC and 2.5 min at 72oC, 
followed by a final extension at 72oC for another 10 min and amplification product 
was analyzed on 1.0% agarose gel electrophoresis. 
 
3.2.4.3 Genomic DNA extraction for Southern blotting 
Genomic DNA was extracted from approximately 1 g fresh weight of 
14-day-old protonemal wild type and stable transgenic P. patens tissues using the 
NucleonTM PhytoPureTM Genomic DNA Extraction Kit (Amersham Biosciences) 
(Table 3.10). DNA was recovered by ethanol precipitation and dissolved in 250 µl of 
TE buffer. 
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Table 3.10 Genomic DNA extraction (NucleonTM PhytoPureTM Genomic DNA 
Extraction Kit, Amersham Biosciences). 
 
Step Action 
1. Breaking of the cell 
wall  
- Approximately 1g fresh weight of 14-day-old 
protonemata P. patens  
- Grind to a fine powder using liq. N2 in a mortar and 
pestle 
- Transfer the powder to RNase-free, liq.N2 in  
1.5 ml microcentrifuge tube 
2. Cell lysis  - Add 4.6 ml of Reagent 1 containing 20 µg/ml RNase 
and mix thoroughly with vortex mixer 
- Add 1.5 ml of Reagent 2 
- Invert several times to gel homogeneous mixture 
- Incubate at 56oC in water bath for 10 min 
- Place sample on ice for 20 min 
3. DNA extraction - Remove sample from ice 
- Add 2 ml of CHCl3 (-20oC) and mix gently 
- Add 200 µl of Nucleon PhytoPure DNA extraction 
resin suspension 
- Centrifuge at 13,000 rpm for 30 min 
- Transfer the upper DNA containing phase into  
a fresh tube (~ 7 ml) 
4. DNA precipitation  - Add an equal volume of cold isopropanol (~ 7 ml) 
- Gently invert the tube until DNA precipitates 
- Centrifuge at 13,000 rpm for 30 min  
5. DNA washing  - Add 10 ml of cold 70% ethanol 
- Centrifuge at 13,000 rpm for 30 min 
- Discard the supernatant  
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Table 3.10 Genomic DNA extraction (NucleonTM PhytoPureTM Genomic DNA 
Extraction Kit, Amersham Biosciences) (continued). 
 
Step Action 
6. DNA dry and 
dissolving 
- Dry the DNA pellet by speed vacuum for 30 min 
- Add 250 µl of sterile TE buffer and keep at 4oC, 
overnight  
7. Determination  - Determine the DNA concentration by  
UV-spectrophotometry  
 
3.2.4.4 Southern blotting 
One microgram aliquots of genomic DNA from wild type and stable 
transgenic lines (C6, N15 and N64) were completely digested with EcoRV, EcoRI or 
NcoI for 6 h, separated on a 0.6% (w/v) Seakem LE agarose gel (Cambrex Bio 
Science Rockland, Rockland, ME, USA). The DNA was then transferred to a 
Biodyne B positively charged 0.45 nylon membrane (Pall Life Sciences, Ann Arbor, 
MI, USA) in 10x saline sodium citrate (SSC) for 4 h. To improve transfer of the 
larger DNA fragments, the gel was soaked in 0.25 M HCl for 10 min to partially 
depurinate the DNA, followed by denaturation with 0.5 M NaOH/1.5 M HCl for 15 
min and neutralization with 0.5 M Tris base/1.5 M NaCl pH 7.0 for an additional 15 
min. After prehybridization with DIG Easy Hyb (Roche Applied Science, USA) at 
40oC for 45 min, the membrane filter was separately probed with specific fragments 
amplified from the expression constructs used for transformation which were 
corresponded to PsELO5 and Hygr coding region. The probes were labeled with PCR 
DIG Probe Synthesis Kit (Roche Applied Science, USA) and the hybridization was 
performed overnight at 40oC in DIG Easy Hyb (Roche Applied Science, USA). The 
membrane was washed twice with 2x SSC, 0.1% sodium dodecyl sulfate (SDS) at 
room temperature for 5 min and then wash twice with 0.1x SSC, 0.1% SDS at 65oC 
for 30 min. Detection was accomplished with a chemi-luminescent substrate (CSPD, 
Roche Applied Science, USA) and exposed to CL-XPosure Film (Thermo Scientific 
Inc., Rockford, IL, USA). 
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3.2.5 Optimization of biomass and ADA production in transgenic P. patens 
culture 
  
3.2.5.1 Starter culture preparation and cultivation conditions 
Protonemata tissues (14-day-old, 1 g) of transgenic P. patens C6 were 
blended with 100 ml of modified liquid BCD basal medium with a homogenizer 
(OMNI THQ, USA) at a speed of 30,000 rpm for 1 min yielding 1.0% (w/v) starter 
inoculum. Then 10 ml of cell suspension was inoculated in 250 ml Erlenmeyer flasks 
containing 90 ml of modified liquid BCD basal medium and further cultivated on an 
orbital shaker (New Brunswick Scientific Innova 2100, USA) at 125 rpm with 
continuous light conditions provided by fluorescent tubes (126 µmol/m2/s1) at 25oC 
for 14 days.  
The obtained protonemata tissues (14-day-old, 4 g) were transferred 
into 250 ml Erlenmeyer flasks containing 100 ml of liquid BCD basal medium 
formulated by central composite design (CCD) and further cultivated on an orbital 
shaker (New Brunswick Scientific Innova 2100, USA) at 125 rpm with a continuous 
light condition provided by fluorescent tubes (126 µmol/m2/s1) at 25oC for 14 days.  
 
3.2.5.2 Optimization of culture medium for biomass and ADA 
production using RSM 
The optimization of medium constituents to improve biomass and 
ADA production in transgenic P. patens C6 was carried out based on BCD medium 
(Knight et al., 2002) using RSM (Rao et al., 2000). The effects of sucrose (A), 
potassium nitrate (B) and glutamate (C) were studied by CCD method with five 
settings (2, 1, 0, +1, +2) of each three factor levels (Table 3.11). Sucrose could be 
converted directly to acetyl-CoA used for fatty acids synthesis and provided 
additional reducing power, NADPH, for the various desaturation enzymes needed to 
produce ARA (Jin et al., 2008; Jin et al., 2009), which is precursor of ADA 
biosynthesis. Potassium nitrate is essential for the production of LC-PUFAs because 
it plays a crucial function in maintaining high activity of malic enzyme which plays 
an important role in the provision of NADPH for fatty acid biosynthesis and thus 
regulates the extent of LC-PUFAs accumulation in M. alpina, especially ARA (Wynn 
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et al., 1999) and glutamate was demonstrated to have a role in activating acetyl-CoA 
carboxylase (ACC; EC 6.4.1.2). ACC catalyzes the formation of malonyl-CoA, an 
essential substrate for fatty-acid synthase and for fatty acyl chain elongation systems 
(Kowluru et al., 2001).  
The relationship of the independent variables and the responses 
(biomass or ADA production) was calculated by the second-order polynomial 
equation: 
 
 Yi = β0 + β1A + β2B + β3C + β11A2 + β22B2 + β33C2 + β12AB + β13AC + β23BC         (1) 
 
where Yi is the predicted response, A, B, C, D, and E are the independent variables, 
β1, β2 and β3 are the linear effects, β11, β22 and β33 are the squared effects, and β12, β13 
and β23 are the interaction terms. 
The analysis of variance (ANOVA) for the experimental data and the 
model coefficients were calculated using the software, Design-Expert® v.7.1.5. (Stat 
Ease Inc., MN). In addition, two-dimension contour plots were constructed for visual 
observation of the trend of maximum responses and the interactive effects of the 
significant variables on the responses.  
 
Table 3.11 Levels of variables used in the central composite experimental design used 
for studying the effects of sucrose (A), potassium nitrate (B) and glutamate (C) 
concentrations on biomass and ADA production by transgenic P. patens C6. 
 
Runs Sucrose concentration 
(A) (g/l) 
Potassium nitrate 
concentration 
(B) (g/l) 
Glutamate concentration 
(C) (g/l) 
1 
2 
3 
4 
5 
40 (-1) 
80 (1) 
40 (-1) 
80 (1) 
40 (-1) 
0.6 (-1) 
0.6 (-1) 
1.0 (1) 
1.0 (1) 
0.6 (-1) 
1.0 (-1) 
1.0 (-1) 
1.0 (-1) 
1.0 (-1) 
2.0 (1) 
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Table 3.11 Levels of variables used in the central composite experimental design used 
for studying the effects of sucrose (A), potassium nitrate (B) and glutamate (C) 
concentrations on biomass and ADA production by transgenic P. patens C6 
(continued). 
 
Runs Sucrose concentration 
(A) (g/l) 
Potassium nitrate 
concentration 
(B) (g/l) 
Glutamate concentration 
(C) (g/l) 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
80 (1) 
40 (-1) 
80 (1) 
20 (-2) 
100 (2) 
60 (0) 
60 (0) 
60 (0) 
60 (0) 
60 (0) 
60 (0) 
60 (0) 
60 (0) 
60 (0) 
60 (0) 
0.6 (-1) 
1.0 (1) 
1.0 (1) 
0.8 (0) 
0.8 (0) 
0.4 (-2) 
1.2 (2) 
0.8 (0) 
0.8 (0) 
0.8 (0) 
0.8 (0) 
0.8 (0) 
0.8 (0) 
0.8 (0) 
0.8 (0) 
2.0 (1) 
2.0 (1) 
2.0 (1) 
1.5 (0) 
1.5 (0) 
1.5 (0) 
1.5 (0) 
0.5 (-2) 
2.5 (2) 
1.5 (0) 
1.5 (0) 
1.5 (0) 
1.5 (0) 
1.5 (0) 
1.5 (0) 
 
3.2.5.3 Experimental validation of the optimized conditions 
Two selected experiments were conducted in 250 ml shake-flasks 
containing the total volume of 100 ml final production liquid medium with 4 g of 14-
day old protonemata as described above to verify the validity of the optimal 
conditions for maximum biomass and ADA production. Each of these experiments 
was carried out in triplicate and the data calculated as mean ± S.E. (n=3). 
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3.2.5.4 Effects of EPA and oil supplementation on biomass, ADA 
and ω-3 DPA production in transgenic P. patens culture 
Oil supplementation was applied to improve C22-PUFA production in 
transgenic P. patens C6 based on the optimized liquid BCD medium from section 
3.2.5.3. The basal medium supplemented with 0.1 mM EPA or 0.2% (v/v) each of oils 
including linseed oil, soybean oil, sunflower oil, corn oil and palm oil was used for oil 
amendment test. Tween 80 at 0.25% (w/v) was used as an emulsifier. 
  The cultivation of the transgenic P. patens C6 was performed by 
inoculation of 14 day-old protonemata (4% w/v) in 250 mL sterile shake-flasks 
containing the total volume of 100 ml optimized liquid BCD with oil 
supplementation. The liquid BCD basal medium was used as the control experiment. 
After 14 days of cultivation in a growth room at 25oC in an orbital shaker set at 125 
rpm under continuous light provided by fluorescent tubes (126 µmol/m2/s1), DCW 
and production of PUFAs in the cells were estimated in triplicate. 
 
3.2.5.5 Dry cell weight determination (Biomass production) 
After 14 days of culture, the cells were separated from the media by 
filtration through a sieve and then washed three times with a large amount of distilled 
water to remove residual medium. The cells were filtered again under vacuum 
condition, subsequently frozen at -20°C and freeze-dried for 3-4 days. Finally, the 
biomass production was calculated in term of dry cell weight and expressed as g/l of 
DCW. Each treatment was conducted in triplicate.  
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CHAPTER 4  
 
RESULTS AND DISCUSSION 
 
4.1 Cloning of ∆5-elongase gene from Pavlova sp. 
 The P. patens produces several PUFAs, especially ARA and EPA 
(Grimsley et al., 1981; Kaewsuwan et al., 2006) which are C20-PUFAs required for 
the synthesis of the C22-PUFAs, ADA and ω-3 DPA, respectively by a ∆5-elongase 
(Pereira et al., 2004b). However, P. patens lacks this C22 PUFA synthesizing enzyme, 
whereas the algae accumulates large amounts of DHA in the cells (Medina et al., 
1998; Meireles et al., 2003; Zhou et al., 2007). Accumulation of C22-PUFA in the 
algae indicates high activities of very long-chain PUFA synthesizing enzymes. 
Previously gene encoding for ∆5-elongase was isolated from the marine microalgae 
Pavlova sp. CCMP459 (Pereira et al., 2004b). This expressed enzyme displayed 
unique substrate specificity for both ω-6 and ω-3 C20 PUFA substrates, with no 
activity toward any C18 or C22 PUFA substrates (Pereira et al., 2004b). This study is 
therefore interested in the production of C22-PUFA substrates in P. patens for further 
ω-6 DPA and DHA productions.  
To identify a gene coding for the ∆5-elongation enzyme involved in the 
final step of ADA and ω-3 DPA biosynthesis, which are the precursors of ω-6 DPA 
and DHA, respectively, cDNA reverse-transcribed from Pavlova sp. mRNA was PCR 
amplified with PsELO5-forward and PsELO5-reverse primers based on NCBI 
sequence data (accession number AY630573) (Pereira et al., 2004b) and Taq DNA 
polymerase (Invitrogen) which performs a nontemplate-dependent terminal 
transferase activity by adding a single deoxyadenosine (A) to the 3´ ends of PCR 
products. An amplification product contained the expected length (approximately 836 
bp indicated by arrow) (Figure 4.1 and 4.2b) was cloned into pCR®2.1-TOPO® vector 
(Invitrogen) containing a single overhanging 3´ deoxythymidine (T) residues (Figure 
4.2a). Topoisomerase I from Vaccinia virus binds to duplex DNA at specific sites and 
cleaves the phosphodiester backbone after 5′-CCCTT in one strand (Shuman, 1991) 
(Figure 4.2c). The energy from the broken phosphodiester backbone is conserved by 
formation of a covalent bond between the 3′ phosphate of the cleaved strand and
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a tyrosyl residue (Tyr-274) of topoisomerase I. The phospho-tyrosyl bond between 
the DNA and enzyme can subsequently be attacked by the 5′ hydroxyl of the original 
cleaved strand, reversing the reaction and releasing topoisomerase (Shuman, 1994) 
(Figure 4.2c), yielding plasmid named pCR®2.1-TOPO®-PsELO5 (approximately 
3,931 bp) (Figure 4.2d).  
The resulting plasmids were verified by digestion with EcoRI (Figure 
4.2e). After screening the five plasmid DNA (P1-P5), two (P1 and P2) of those 
plasmids were released the approximately 852 bp sized gene of interest (B) from the 
approximately 3,913 bp sized of vector (A) (Figure 4.2f) and clone P2 was selected 
for sequencing with M13 forward and reverse primers. 
  
 
 
Figure 4.1 PCR amplification products from Pavlova sp. cDNA with PsELO5-For and 
PsELO5 Rev primers and analyzed on 1.0% agarose gel electrophoresis. The DNA 
sizes in kbp are indicated on the left. The arrow indicates the expected DNA size. 
M  : 1 kbp DNA Ladder (Promega) 
PCR : PCR amplification product 
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Figure 4.2 Construction of the plasmid pCR®2.1-TOPO®-PsELO5. (a) pCR®2.1-TOPO® vector 
(Invitrogen). (b) PCR products. (c) Topoisomerase reaction. (d) Recombinant plasmid pCR®2.1-
TOPO®-PsELO5. (e and f) Plasmid DNA isolated from E. coli cultures and digested with EcoRI. The 
DNA sizes in kbp are indicated on the right.  
M : 1 kbp DNA Ladder (Promega)  
P1-5 : Plasmid DNA from clone No. 1-5 
A : Approximately 3,913 bp sized pCR2.1®-TOPO vector (Invitrogen) 
B : Approximately 852 bp sized of Pavlova sp. ∆5-elongase 
* : Selected plasmid DNA for sequencing 
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The open reading frame (ORF) of the clone PsELO5 cDNA (clone P2) 
is 834 bp from an ATG start to a TAA stop codons and codes for 277 amino acids 
with 100% identity to a cloned Pavlova sp. ∆5-elongase (accession number 
AY630573) from previously reported (Pereira et al., 2004b) (Figure 4.3). This amino 
acid polypeptide contained a C-terminal lysine-rich motif, typical characteristic for 
the endoplasmic reticulum (ER) targeting (Jackson et al., 1990) as well as four 
conserved motifs including KxxExxDT (Box 1), QxxFLHxYHH (Box 2) the extended 
histidine-rich box which is suggested to be functionally important for PUFA 
elongation (Qi et al., 2002), NxxxHxxMYxYY (Box 3), and TxxQxxQ (Box 4), 
which are commonly of PUFA elongases (Meyer et al. 2004; Jakobsson et al. 2006) 
(Figure 4.3). However, these conserved motifs were not found in other classes of plant 
microsomal elongases, β-ketoacyl CoA synthases, and fatty acid elongases (FAE) 
involved in extraplastidial elongation of saturated and monounsaturated fatty acids. 
The secondary structure analysis revealed that PsELO5 is highly hydrophobic and 
predicted to contain six transmembrane domains (Pereira et al., 2004b) (Figure 4.4). 
 
4.2 Functional analysis of Pavlova sp. ∆5-elongase in P. patens 
 
4.2.1 Construction of entry clone 
In this approach, PCR was used to amplify the PsELO5 sequence from 
plasmid pCR®2.1-TOPO®-PsELO5 (Figure 4.2d) with two specific primers, PsELO5-
For and PsELO5-Rev and Taq DNA polymerase (Invitrogen) which performs a non-
template-dependent terminal transferase activity by adding a single deoxyadenosine 
(A) to the 3′ ends of PCR products.  
An amplification product containing an approximately 836 bp size of 
Pavlova sp. ∆5-elongase (Figure 4.5b) was directly ligated into pCR8®/GW/TOPO® 
entry vector (Invitrogen) containing a single overhanging 3′ deoxythymidine (T) 
residues (Figure 4.5a). Topoisomerase I from Vaccinia virus binds to duplex DNA at 
specific sites (CCCTT) and cleaves the phosphodiester backbone in one strand 
(Figure 4.5c) (Shuman, 1991). The energy from the broken phosphodiester backbone 
is conserved by formation of a covalent bond between the 3′ phosphate of the cleaved 
strand and a tyrosyl residue (Tyr-274) of topoisomerase I. The phospho-tyrosyl bond
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Figure 4.3 Nucleotide and amino acid polypeptide sequences of Pavlova sp. ∆5-elongase characterized in the present study. The alignment was obtained using the 
Clustal X program. Conserved amino acid motifs are shown in a red box and the restriction enzyme ApaI site is shown in a blue box.  
PvELO5 : A cloned Pavlova sp. ∆5-elongase (accession number AY630573) from previously reported (Pereira et al., 2004b) 
PsELO5 : A clone Pavlova sp. ∆5-elongase (In the present study) 
* : The dilysine residues at -3 and -6 positioned from the C-terminus gave this gene probable localized in the endoplasmic reticulum (ER)
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Figure 4.4 Analysis of Pavlova sp. ∆5-elongase using the TMHMM Server v. 2.0 predicts the existence of six transmembrane segments. Using that data the 
TMRPres2D tool generated two-dimensional rendering of Pavlova sp. ∆5-elongase. The TMHMM analysis predicts that N- and C-terminus are located on the inside 
of the cytoplasmic membrane. Conserved amino acid motifs are shown in the yellow box. 
Box 1 (KYVELLDT) 
Box 2 (QVSFLHVYHH) 
Box 3 (NSIIHVMMYSYY) 
Box 4 (TQAQLVQ) 
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Figure 4.5 Construction of the plasmid pCR®8/GW/TOPO®-PsELO5. (a) pCR®8/GW/TOPO® vector 
(Invitrogen). (b) PCR products. (c) Topoisomerase reaction. (d) Recombinant plasmid 
pCR®8/GW/TOPO®-PsELO5. (e and f) Plasmid DNA isolated from E. coli cultures and digested with 
ApaI. The DNA sizes in kbp are indicated on the right.  
 M : 1 kbp DNA Ladder (Promega) 
 G1-2 : Plasmid DNA from clone No. 1 and 2 
 G1 : Approximately 3,020 and 631 bp sized DNA 
 G2 : Approximately 3,229 and 422 bp sized DNA 
 * : The reverse orientation of PsELO5 in pCR®8/GW/TOPO® vector 
 ** : The forward orientation of PsELO5 in pCR®8/GW/TOPO® vector 
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between the DNA and enzyme can subsequently be attacked by the 5′ hydroxyl of the 
original cleaved strand, reversing the reaction and releasing topoisomerase (Figure 
4.5c) (Shuman, 1994), resulting in plasmid named pCR®8/GW/TOPO®-PsELO5 
(approximately 3,651 bp) (Figure 4.5d). To prevent the reverse orientation of PsELO5 
in pCR®8/GW/TOPO® vector in the subsequent step, restriction enzyme was used for 
verification: ApaI digested single site at 318 and 568 bp-positions of PsELO5 cDNA 
and pCR®8/GW/TOPO® vector, respectively (Figure 4.5e). The forward orientation of 
PsELO5 cDNA in pCR®8/GW/TOPO® vector was demonstrated in the plasmid clone 
G2 since it showed the approximately 3,229 and 422 bp sized DNA, whereas the 
plasmid from G1 contained the reverse orientation of PsELO5 cDNA in 
pCR®8/GW/TOPO® vector because it provided two distinguish DNA bands at 
approximately 3,020 and 631 bp (Figure 4.5f). Therefore clone G2 was selected for 
sequencing with GW1 and GW2 primers, yielding the plasmid attL1-PsELO5-attL2.  
 
4.2.2 Construction of P. patens expression vector 
Gateway-compatible plant destination vector was used for protein 
over-expression of PsELO5 in P. patens. The resulting recombinant plasmid G2 has 
PsELO5 gene flanked by attL recombination sequence and it then was consequently 
recombined with attR sites of a desired destination vectors, pMDC32 (Figure 4.6a) 
and pMDC43 (Figure 4.7a), yielding the recombinant plasmids pMDC32-PsELO5 
(approximately 10,932 bp) (Figure 4.6b) and pMDC43-PsELO5 (approximately 
11,666 bp) (Figure 4.7b). Both resulting plasmids were verified by digestion with 
EcoRI (Figure 4.6c and 4.7c). After screening the two plasmids pMDC32-PsELO5 
(K1-2) (Figure 4.6d), both were released the approximately 852 bp sized gene of 
interest (B) from the approximately 9,736 and 344 bp sized of vector (A1 and A2) 
(Figure 4.6d). Similarly, the seven plasmids pMDC43-PsELO5 (R1-R7) were released 
the approximately 852 bp sized gene of interest (B) from the approximately 10,470 
and 344 bp sized of vector (A1 and A2) (Figure 4.7d). Therefore clone K1 and R5 
were selected for large scale plasmid DNA purification since clone K1 indicated that 
the expression construct contained a Pavlova sp. ∆5-elongase driven by a tandemly 
duplicated CaMV 35S promoter (K1), while clone R5 contained a Pavlova sp. ∆5-
elongase driven by a tandemly duplicated CaMV35S promoter together with GFP and
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Figure 4.6 Construction of P. patens over-expression vector, pMDC32-PsELO5. (a) Recombination 
reaction. (b) Recombination plasmid pMDC32-PsELO5. (c and d) The plasmid DNA isolated from E. 
coli cultures and digested with EcoRI. The DNA sizes in kbp are indicated on the left.  
M : 1 kbp DNA Ladder (Promega)  
K1-2 : Plasmid DNA from clone No. 1 and 2  
A1 and A2 : Approximately 9,736 and 344 bp sized pMDC32 vector  
B : Approximately 852 bp sized gene of Pavlova sp. ∆5-elongase  
* : Selected plasmid DNA for large scale plasmid DNA purification 
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Figure 4.7 Construction of P. patens over-expression vector, pMDC43-PsELO5. (a) Recombination 
reaction. (b) Recombination plasmid pMDC43-PsELO5. (c and d) The plasmid DNA isolated from E. 
coli cultures and digested with EcoRI. The DNA sizes in kbp are indicated on the left.  
M : 1 kbp DNA Ladder (Promega)  
R1-7 : Plasmid DNA from clone No. 1, 2, 3, 4, 5, 6 and 7  
A1 and A2 : Approximately 10,470 and 344 bp sized pMDC43 vector  
B : Approximately 852 bp sized gene of Pavlova sp. ∆5-elongase  
*  : Selected plasmid DNA for large scale plasmid DNA purification  
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nos terminator with hygromycin resistance selection cassette which used to transform 
into the moss protoplasts (Figure 4.6d and 4.7d).  
 
4.2.3 Protoplast transformation and regeneration  
After protoplast transformation with pMDC32-PsELO5 or pMDC43-
PsELO5, transformed plants that still survived on the BCD medium containing 
hygromycin B were defined as stable transformants, while wild type cannot grow on 
selection medium (Figure 4.8 and 4.9). Protoplasts transformed with linear plasmids, 
pMDC32-PsELO5 and pMDC43-PsELO5 gave 36 and 47% stable transformants 
from 250 and 180 picked regenerants, respectively, on the selective medium. All 
transformants were morphologically indistinguishable from the wild type plant. They 
gave rise to normal filamentous growth and gametophore formation (Figure 4.8c and 
4.9c). 
 
4.2.4 Fatty acid analysis of P. patens by GC and GC-MS 
To produce ADA and ω-3 DPA in P. patens, it is necessary to express 
the ∆5-elongase gene (Figure 4.10). Generally, various promoters are used to facilitate 
gene expression in plants. The CaMV 35S promoter is highly active in most of the 
transgenic plants. However, a tandemly duplicated CaMV 35S promoter showed a six 
fold higher expression level of activity in P. patens than the normal CaMV 35S 
promoter (Horstmann et al., 2004). In this study, P. patens was transformed with the 
two recombinant plasmids, pMDC32-PsELO5 that contains PsELO5 cDNA (Pereira 
et al., 2004b) or pMDC43-PsELO5 carrying a gene PsELO5 fused to C-terminus of 
GFP6, driven by a tandemly duplicated CaMV 35S promoter and nos terminator, and 
contained the Hygr gene as a selection marker. One hundred and seventy-seven stable 
hygromycin-resistant transgenic lines (92 and 85 lines for P. patens transformed with 
pMDC32-PsELO5 and pMDC43-PsELO5, respectively) were screened by co-
migration and spiking with known fatty acid standards and by the mass spectrometry 
(MS) fragmentation patterns. GC analysis of FAMEs of all transgenic lines showed 
that they contained only one additional fatty acid peak (retention time, RT = 14.7 
min) compared to the wild type (Figure 4.11 and 4.12). This was identical to that of 
the methyl ester of authentic ADA and this compound, when investigated by
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Figure 4.8 Regeneration of transgenic P. patens transformed by pMDC32-PsELO5 on 
the selective BCD medium containing hygromycin B (25 µg/ml). 
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Figure 4.9 Regeneration of transgenic P. patens transformed by pMDC43-PsELO5 on 
the selective BCD medium containing hygromycin B (25 µg/ml). 
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GC-MS, displayed a molecular ion of 346 m/z, which is the expected molecular ion 
for methyl ester of ADA as well as the fragmentation patterns identical to that of the 
authentic ADA methyl ester (Figure 4.13). It was therefore considered to be ADA, an 
ω-6 elongation product of the PsELO5. Further estimation of ADA quantity from the 
calibration ADA standard revealed that the four pMDC43-PsELO5 transgenics with 
the highest ADA production lines (N15, N64, N70 and N77) obviously produced 
22.6-46.4 times higher levels of ADA compared to the six transgenic line (C1, C2, 
C3, C4, C5 and C6) containing the pMDC32-PsELO5 construct (Table 4.1), while no 
ADA was detected in the control wild type (Figure 4.11 and 4.12; Table 4.1).   
However, an ω-3 DPA was not observed from any transgenic lines 
cultivated in BCD media (Figure 4.11 and 4.12; Table 4.1). This might due to vary 
low amount of substrate EPA naturally present in P. patens. However, it has been 
reported that lower temperature could activate EPA production. This evidenced may 
cause by the more availability of dissolved oxygen at lower temperatures (Harris and 
James, 1969) which lead to enhance fatty acid synthesis by aerobic desaturase and 
elongase enzymes (Higashiyama et al., 1999). Jang et al. (2005) reported that EPA 
production of Mortierella alpina ATCC 32222 was the highest at 12oC (Jang et al., 
2005). Similarly, the EPA yield of M. alpina cultures was enhanced at low culture 
temperature (12-15oC) (Jang et al., 2000). Moreover, the improvement of EPA 
production in microalgae by temperature shifting has been reported (Jiang and Gao, 
2004). Jiang and Gao (2004) showed that EPA yield in the Phaeodactylum 
tricornutum increased up to 6.6 mg/l after application of a two-stage culture with 
temperature shifting from 25oC for 6 days to 15oC for 12 h, being raised by 120% 
compared with the control. In addition, P. patens contains high proportions of ARA 
(Grimsley et al., 1981; Kaewsuwan et al., 2006). ARA plays an important role as a 
precursor for EPA production, which involve the enzyme ∆17-desaturase. Previously a 
novel gene from an EPA-rich fungus (Saprolegnia diclina), namely sdd17, had been 
identified (Pereira et al., 2004a). This gene encodes an ω-3 desaturase that is mainly 
involved in EPA production from its ω-6 C20 PUFA substrate (ARA), specifically by 
heterologous expression in Saccharomyces cerevisiae, somatic soya bean embryos 
(Pereira et al., 2004a) and mammalian cells (Chen et al., 2010). So that genetic 
engineering could be applied to obtain stable transgenic P. patens producing a high
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Figure 4.10 A simplified scheme of polyunsaturated fatty acid (PUFA) biosynthesis pathway in lower eukaryotes (modified from Pereira 
et al., 2003). 
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Figure 4.11 Fatty acid profiles of P. patens wild type (WT) and the transgenic lines (C1-6). The 
FAMEs of the total lipids were analyzed by GC. The chromatograms WT and C1-6 show the FAMEs 
of the protonemata grown in liquid BCD medium for 14 days. The additional peak which corresponds 
to the retention time of ADA is indicated by asterisk. 
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Figure 4.12 Fatty acid profiles of P. patens wild type (WT) and the transgenic lines 
(N15, N64, N70 and N77). The FAMEs of the total lipids were analyzed by GC. The 
chromatograms WT, N15, N64, N70 and N77 show the FAMEs of the protonemata 
grown in liquid BCD medium for 14 days. The additional peak which corresponds to 
the retention time of ADA is indicated by asterisk. 
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Figure 4.13 GC-MS analysis of FAMEs of the novel peak identified in P. patens 
carrying pMDC32-PsELO5 or pMDC43-PsELO5. A comparison is shown of the 
mass spectra of the novel peak (a) and an authentic ADA standard (b). 
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Table 4.1 Biomass and polyunsaturated fatty acid (PUFA) production from the wild type (WT) and transgenic P. patens grown in liquid BCD medium for14 days. 
 
Transgenic 
lines no. 
Biomass 
(g/l) 
ω-6 PUFA production (mg/l) ω-3 PUFA production (mg/l) 
LA GLA EDA DHGLA ARA ADA ALA EPA ω-3 DPA 
WT 
C1 
C2 
C3 
C4 
C5 
C6 
N15 
N64 
N70 
N77 
5.53±0.95 
4.07±0.75 
3.83±0.24 
3.77±0.37 
5.17±0.66 
4.40±0.51 
4.83±0.45 
5.43±0.45 
6.00±0.38 
4.97±0.66 
5.03±0.61 
45.58±8.94 
27.14±7.73 
24.67±6.98 
21.17±8.53 
22.76±5.45 
33.65±4.44 
41.33±8.48 
63.24±6.77 
64.36±5.04 
69.49±7.84 
53.22±5.83 
2.96±0.54 
3.81±0.44 
2.88±0.73 
2.98±0.34 
3.45±0.41 
3.95±0.74 
2.88±0.33 
4.68±0.48 
3.85±0.37 
5.67±0.28 
3.62±0.32 
2.50±0.75 
0.41±0.04 
0.45±0.03 
0.41±0.02 
0.53±0.07 
0.66±0.02 
2.05±0.66 
5.80±0.70 
2.52±0.54 
3.10±0.61 
2.52±0.44 
1.27±0.37 
5.45±0.44 
1.61±0.27 
1.61±0.52 
2.13±0.33 
7.02±0.27 
1.45±0.22 
1.90±0.34 
4.35±0.54 
4.25±0.61 
4.78±0.53 
42.89±5.85 
16.52±2.06 
17.32±3.21 
12.63±2.22 
20.28±2.63 
18.20±2.85 
37.25±5.33 
46.08±6.52 
64.17±7.07 
50.53±5.85 
55.00±6.22 
nd 
0.17±0.05 
0.15±0.09 
0.15±0.04 
0.22±0.06 
0.20±0.08 
0.42±0.08 
4.47±0.89 
6.97±0.74 
3.57±0.68 
3.40±0.55 
9.71±1.75 
16.21±2.34 
12.12±1.95 
10.88±3.09 
15.57±1.88 
18.56±2.34 
8.67±1.22 
13.53±2.04 
13.35±1.85 
14.05±2.65 
9.55±1.38 
1.29±0.22 
0.47±0.05 
0.48±0.09 
0.58±0.08 
0.96±0.03 
0.61±0.07 
1.22±0.35 
1.60±0.18 
2.07±0.25 
1.84±0.11 
1.69±0.20 
nd 
nd 
nd 
nd 
nd 
nd 
nd 
nd 
nd 
nd 
nd 
nd, not detected. 
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level of EPA for further ω-3 DPA production. Successful application of such 
techniques should help the increasing amount of EPA substrate in P. patens.  
Expression of the fusion construct in P. patens in this study confirmed 
that ADA, an ω-6 C22-PUFA, was produced from the native ARA substrate, whereas 
ω-3 DPA production was not generated from the endogenous EPA substrate. The ∆5-
elongation conversion efficiency in P. patens for ω-6 PUFAs was higher than for ω-3 
PUFAs, probably due to lesser amount of EPA substrate in P. patens. Recently, the 
cotton ∆12-desaturase (FAD2-4)- and marine microalgae Pavlova viridis C20-
elongase-GFP fusion polypeptides appeared to be functionally expressed in transgenic 
Arabidopsis plants and E. coli, respectively, and were shown to localized in the 
cytoplasmic membrane (Niu et al., 2009; Zhang et al., 2009). These results also 
showed that when PsELO5 was attached to the C-terminal of GFP6, PsELO5 function 
was stronger than with a non-fusion protein. This evidence suggests that the chimeric 
elongase produced has higher activity, better membrane integration, or greater 
stability. Similarly, the functional expression of the human KDEL receptor in 
Lactococus lastis has been improved more than ten times by using GFP fusion to the 
C-terminus (Drew et al., 2001). Whereas a fusion gene between GFP and COP1 
(Constitutively Photomorphogenic 1) exhibited biological activities identical to the 
native protein, as shown by genetic complementation of a lethal cop1 allele in 
transgenic Arabidopsis (Von Arnim et al., 1998). Nevertheless, these provide the 
evidences that GFP does not degrade the function of fusion protein. Furthermore, GFP 
as a reporter gene under regulatory control of 35S promoter, was proved to reduce or 
avoid the gene silencing in transgenic soybean (El-Shemy et al., 2008). Thus the GFP 
gene in a vector system may play a useful role for transgenic evaluation and avoid 
gene silencing in transformed plants. These results indicated that expression of the 
transgene PsELO5 and PsELO5 fused to C-terminus of GFP6, under the control of a 
tandemly duplicated CaMV35S promoter, were therefore successful. The highest 
production of ADA (6.97±0.74 mg/l) from the available endogenous ARA substrate 
was with the transgenic line N64. Although a low level of expression was obtained, 
other stronger promoters might be applied for higher level gene expression in P. 
patens, including complete rice actin (Act1) (Horstmann et al., 2004), wheat early-
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methionine labeled (EM) (Knight et al., 1995), and maize ubiquitin promoters 
(Bezanilla et al., 2003).  
 
4.2.5 Molecular analysis by PCR and Southern blotting 
The specific integration of the transformed DNA into P.patens was 
analyzed by PCR using genomic DNA from the ten transgenic lines (C1, C2, C3, C4, 
C5, C6, N15, N64, N70 and N77) and the wild type (WT). PCR with the primer pair 
PsELO5-For/PsELO5-Rev amplified a fragment of 0.8 kbp pairs (kbp), which 
corresponded to PsELO5 cDNA (Figures 4.14a and b; Figure 4.14d and e) and with 
the primer pair Hygr-For/Hygr-Rev, a fragment of 1.0 kbp corresponded to 
hygromycin resistance coding region from each of the ten transgenic lines (C1, C2, 
C3, C4, C5, C6, N15, N64, N70 and N77) (Figure 4.14a and c; Figure 4.14d and f), 
where as the wild type (WT) gave negative results as presented in Figure 4.14b, c, e 
and f. The length of bands suggested the successful DNA integration, and indicated 
that PsELO5 and hygromycin resistance genes were transferred into the P. patens 
genome. However, a low number of copies of a transgene in a plant chromosome have 
a much lower incidence of instability (Jones, 2005). In addition, stably transformed 
transgenic P. patens usually have multiple numbers of integrated transgenes in the 
genome (Kamisugi et al., 2006). 
To analyze the integration patterns of transgenes, 14 day-old 
protonemata of transgenic lines (C6, N15 and N64) and wild type were assessed by 
Southern blot analysis using probes for the PsELO5 and Hygr genes. Transgenic line 
C6 and lines N15 and N64 were identified as having higher ADA when P. patens 
transformed with pMDC32-PsELO5 and pMDC43-PsELO5, respectively, and were 
therefore chosen for molecular analysis of the transgene. The results showed that 
hybridization of genomic DNA from the transgenic lines C6 and N15 digested with 
EcoRV and probed with the PsELO5 probe detected strong signals of 2.3 and 3.0 (a) 
kbp, respectively (Figure 4.15a2; Figure 4.16a2) and the same size of 2.6 (b) kbp were 
probed with the Hygr probe (Figure Figure 4.15a2; Figure 4.16a2), consistent with the 
predicted sizes of the relevant fragments resulting from EcoRV digestion of 
pMDC32-PsELO5 (Figure 4.15a1) and pMDC43-PsELO5 (Figure 4.16a1), whereas 
weak signals of similar sized DNA of line N15 were obtained from transgenic line
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Figure 4.14 Structure of the linear fragments pMDC32-PsELO5 (a) and pMDC43-
PsELO5 (d) used for P. patens transformation was digested with HindIII and 
verification of PsELO5 and Hygr  by PCR amplification of P. patens wild type (WT) 
compared to transgenic lines C1-6 (b and c), N15, N64, N70 and N77 (e and f). The 
lettered arrows indicate the binding sites of primers used for PCR analysis. The DNA 
sizes in kbp are indicated on the left and right. 
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Figure 4.15 Restriction sites of EcoRV and EcoRI in pMDC32-PsELO5 construct (a1 and b1) and  Southern blotting of P. patens wild 
type (WT) compared with transgenic line (C6) (a2 and b2). DNA sizes in kbp are indicated on the left. 
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Figure 4.16 Restriction sites of EcoRV and NcoI in pMDC43-PsELO5 construct (a1 and b1) and  Southern blotting of P. patens wild 
type (WT) compared with transgenic line (N15 and N64) (a2 and b2). DNA sizes in kbp are indicated on the left. 
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N64 (Figure 4.16a2). Similarly, digestion with EcoRI generated a single strongly 
hybridizing fragment of 0.9 and 9.7 kbp (Figure 4.15b2) in transgenic line C6 when 
hybridized with PsELO5 and Hygr probes, respectively, which are the sizes of 
transgene fragments (Figure 4.15b1). This indicates that line N64 has fewer copies of 
the transgene than lines C6 and N15. 
Digestion with NcoI which cuts at 625 bp site within PsELO5 cDNA, 
produced a high intensity band of 1.1 kbp (*) in transgenic line N15 when hybridized 
with PsELO5 probe, while a lower intensity band was detected in line N64 (Figure 
4.16b2). An additional fragment of 10.5 kbp (**) which is the predicted size of 
fragments generated by NcoI from multiple tandemly repeated copies of pMDC43-
PsELO5, hybridized with either PsELO5 or Hygr probes (Figure 4.16b1 and b2). 
However, hybridization with these probes from transgenic line N15 produced the 
several additional DNA fragments, whereas only one of the flanking sequences was 
detected in line N64 (arrowed). 
These results suggest that line N64 contains only a single copy of the 
expression construct, whereas there are either multiple copies with rearrangements or 
several insertion sites of the construct in line C6 and N15. Therefore both single copy 
and multiple copies of plasmid DNA containing the full length of PsELO5 gene were 
not only integrated into the transgenic P. patens genome and stably inherited to its 
culture, but also led to successful functional expression. The effects of transgenic 
copy number on the level of gene expression are known to be complex. Though it was 
anticipated that the increase of transgene copy number would increase expression 
level (Dai et al., 2001; El-Shemy et al., 2007), it is now known that gene co-
suppression phenomena frequently occur in transgenic plants with repeated transgene 
or an unusual structure such as inverted repeats (Vaucheret et al., 1998). Moreover, an 
increased copy number of transgene can correlate with an increased risk of silencing 
(Lessard et al., 2002). Transgenic line N64 with single copy number improved C22-
PUFA production rather more than the line with multiple copies of transgene (C6 and 
N15), suggesting that lower copy number may permit potentially greater gene 
expression since multiple copy number integration could inhibit transgene expression 
and even lead to transgene silencing in transgenic plants (Stam et al., 1997). 
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However, the chromosomal insertion site was not controlled in this experiment and so 
the differences may result from position effects. 
 
4.3 Optimization of culture medium for biomass and C22 PUFA production using 
RSM 
Although a tandemly duplicated CaMV35S promoter has been used for 
transformation, it might not be strong enough for gene expression (Zeidler et al., 
1996; Horstmann et al., 2004). Apart from using stronger promoters, optimization of 
culture medium is a useful alternative tool for product enhancement. In this study, the 
highest production line (C6) was further optimized by the RSM experiments (Rao et 
al., 2000). The observed responses (biomass or ADA production) of transgenic P. 
patens (C6) for studying the effects of sucrose (A), KNO3 (B) and glutamate (C) are 
summarized in Table 4.2. 
Table 4.3 shows the regression coefficient of each variable in terms of 
linear, quadratic and interaction along with p-value for biomass and ADA production. 
Coefficients with lower p-values (p<0.05) are more significant. The coefficient 
estimates and the corresponding p-values suggest that among test variables used in the 
study, sucrose (A), sucrose2 (A2), KNO32 (B2), glutamate2 (C2) were significant for 
both biomass and ADA production, whereas KNO3 (B) was significant only for 
biomass production. In addition, interactions between sucrose (A) and KNO3 (B); and 
KNO3 (B) and glutamate (C) were also significant for biomass production while 
interaction between sucrose (A) and glutamate (C) was significant for ADA 
production. Other interactions were found to be insignificant. 
The corresponding second-order regression equation provided levels of 
biomass and ADA production can be predicted by Eqs. (2) and (3), respectively. 
 
Ybiomass (g/l) = 16.87 – 0.43A + 0.93B – 0.17C – 0.74A2 – 0.43B2 – 0.46C2 + 0.56AB –
0.22AC + 0.62BC                                                                                   (2) 
 
YADA (mg/l)  = 3.05 – 0.54A + 0.04B + 0.14C – 0.29A2 – 0.26B2 – 0.27C2 + 0.02AB – 
0.61AB + 0.13BC                                                                                   (3) 
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Table 4.2 Effect of sucrose (A), potassium nitrate (B) and glutamate (C) concentrations on biomass and 
ADA production by the transgenic line (C6) using the central composite design technique. 
 
Runs Sucrose 
(A) (g/l) 
Potassium 
nitrate 
(B) (g/l) 
Glutamate 
(C) (g/l) 
Biomass productiona 
(g/l) 
ADA productiona 
(mg/l) 
Actual Predicted Actual Predicted 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
40 (-1) 
80 (1) 
40 (-1) 
80 (1) 
40 (-1) 
80 (1) 
40 (-1) 
80 (1) 
20 (-2) 
100 (2) 
60 (0) 
60 (0) 
60 (0) 
60 (0) 
60 (0) 
60 (0) 
60 (0) 
60 (0) 
60 (0) 
60 (0) 
0.6 (-1) 
0.6 (-1) 
1.0 (1) 
1.0 (1) 
0.6 (-1) 
0.6 (-1) 
1.0 (1) 
1.0 (1) 
0.8 (0) 
0.8 (0) 
0.4 (-2) 
1.2 (2) 
0.8 (0) 
0.8 (0) 
0.8 (0) 
0.8 (0) 
0.8 (0) 
0.8 (0) 
0.8 (0) 
0.8 (0) 
1.0 (-1) 
1.0 (-1) 
1.0 (-1) 
1.0 (-1) 
2.0 (1) 
2.0 (1) 
2.0 (1) 
2.0 (1) 
1.5 (0) 
1.5 (0) 
1.5 (0) 
1.5 (0) 
0.5 (-2) 
2.5 (2) 
1.5 (0) 
1.5 (0) 
1.5 (0) 
1.5 (0) 
1.5 (0) 
1.5 (0) 
15.50 
14.73 
15.63 
16.10 
15.30 
12.67 
16.90 
17.50 
14.77 
12.47 
13.11 
16.57 
15.53 
13.97 
16.80 
16.93 
16.63 
16.60 
16.80 
16.87 
15.88 
14.33 
15.38 
16.07 
14.74 
12.32 
16.71 
16.53 
14.78 
13.05 
13.28 
16.99 
15.39 
14.71 
16.87 
16.87 
16.87 
16.87 
16.87 
16.87 
1.88 
2.02 
2.04 
1.78 
3.62 
1.01 
3.98 
1.61 
2.77 
1.01 
2.06 
1.93 
2.03 
1.86 
3.05 
3.00 
3.00 
3.09 
3.08 
3.04 
2.10 
2.27 
1.95 
2.05 
3.32 
1.07 
3.70 
1.37 
2.98 
0.83 
1.93 
2.09 
1.69 
2.23 
3.05 
3.05 
3.05 
3.05 
3.05 
3.05 
ADA, adrenic acid. 
aThe values given in the table are the means of three dependent experiments. 
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Table 4.3 Analysis of variance (ANOVA) for response surface quadratic model of biomass and ADA production of the transgenic line (C6). 
 
Factor Biomass production ADA production 
C.E.a S.E.b SSc Dfd MSe F-value Probe > P 
P-value 
C.E.a S.E.b SSc Dfd MSe F-value Probe > P 
P-value 
Model 
A 
B
 
C 
AB 
AC 
BC 
A2 
B2 
C2 
16.87 
-0.43 
0.93 
-0.17 
0.56 
-0.22 
0.62 
-0.74 
-0.43 
-0.46 
0.22 
0.14 
0.14 
0.14 
0.20 
0.20 
0.20 
0.11 
0.11 
0.11 
40.58 
3.00 
13.78 
0.47 
2.49 
0.38 
3.04 
13.74 
4.73 
5.22 
9 
1 
1 
1 
1 
1 
1 
1 
1 
1 
4.51 
3.00 
13.78 
0.47 
2.49 
0.38 
3.04 
13.74 
4.73 
5.22 
14.74 
9.82 
45.04 
1.53 
8.15 
1.23 
9.94 
44.90 
15.46 
17.08 
0.0001* 
0.0106* 
< 0.0001* 
0.2449 
0.0171*  
0.2938 
0.0103* 
< 0.0001* 
0.0028* 
0.0020* 
3.05 
-0.54 
0.039 
0.14 
-0.019 
-0.61 
0.13 
-0.29 
-0.26 
-0.27 
0.11 
0.071 
0.071 
0.071 
0.10 
0.10 
0.10 
0.057 
0.057 
0.057 
12.00 
4.64 
0.025 
0.29 
0.002767 
2.97 
0.14 
2.06 
1.69 
1.86 
9 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1.33 
4.64 
0.025 
0.29 
0.002767 
2.97 
0.14 
2.06 
1.69 
1.86 
16.52 
57.47 
0.31 
3.64 
0.034 
36.77 
1.69 
25.49 
21.00 
23.09 
< 0.0001* 
<0.0001* 
0.5905 
0.0853 
0.8568 
0.0001* 
0.2221 
0.0005* 
0.0010* 
0.0007* 
The bold values indicate the significance at or above the 95.0% confidence level. 
*Significant at p < 0.05; aCoefficient estimate;  bStandard error; cSum of squares; dDegree of freedom; eMean squares. 
A, sucrose; B, potassium nitrate; C, glutamate. ADA, adrenic acid. 
104 
 
 
The fit of the model for biomass and ADA production expressed by the 
coefficients of regression R2 which were found to be 0.9299 and 0.9370, respectively, 
indicating that the second-order polynomial model Eqs. (2) and (3) could explain 
92.99% and 93.70% of the total variation, respectively. 
 Three-dimensional and 2-D contour plots are the graphical 
representations of the regression equation and help in the identification of the type of 
interactions between test variables. The maximum predicted value is indicated by the 
surface confined in the smallest ellipse in the contour diagram (Tanyildizi et al., 
2005). The circular contour plots indicate that the interaction between the 
corresponding variables is negligible. An elliptical or saddle nature of the contour 
plots indicates significance of the interactions between the corresponding variables. 
Figure 4.17 and 4.18 depicts the significant interaction between two variables by 
keeping the other variables at their middle levels for biomass and ADA production. 
The interaction effects of sucrose (A)-potassium nitrate (B) and 
potassium nitrate (B)-glutamate (C) on biomass production are presented in Figure 
4.17. At middle sucrose concentration (60 g/l), an increase in biomass production was 
obviously observed with the high level of potassium nitrate (1.00-1.20 g/l) (Figure 
4.17a1 and a2) and glutamate (2.00 g/l) (Figure 4.17b1 and b2) used. The evidence 
from this study suggested that the cell growth was induced by relatively middle 
concentration of sucrose. Recently, it was reported that sucrose plays a central role in 
plant growth and development as a primary transport form of carbon and energy in 
plant cell cultures and also as a regulation of gene expression and signal transduction 
(Smeekens, 2000). However, the optimal sucrose concentration may vary with 
different plant species. e.g., Gertlowski and Petersen (1993) studied the influence of 
sucrose concentration on biomass production in culture of Coleus blumei and found 
that a high initial sucrose concentration of 60 g/l led to a high biomass accumulation 
without an obvious lag phase. Zhong et al. (1994) found that the production of 
biomass increased with an increase of sucrose concentration from 30 to 45 g/l in 
culture medium of Perilla frutescens, while Zhong and Yoshida (1995) and Shinde et 
al. (2009) found that the growth rate increased with an increase of sucrose 
concentration up to 60 and 70 g/l in the culture medium of P. frutescens and Psoralea 
corylifolia, respectively. Moreover, an even higher sucrose concentration of 70-100
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Figure 4.17 Response surface and corresponding contour plots showing the effects of sucrose and potassium nitrate (a1 and a2), 
potassium nitrate and glutamate (b1 and b2) on biomass production of the transgenic line C6.  
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g/l seemed to repress the cell growth. The result suggested that the cell growth was 
repressed by relatively higher concentration of sucrose, which led to a relatively 
higher osmotic pressure (Kimball et al., 1975). 
It has been well known that nitrogen is an important nutrient affecting 
the growth of many organisms such as bacteria, algae, diatom and plant. Nitrate-N is 
widely used as the sole nitrogen source for microalgae culture because there is less 
likelihood of pH shift in the medium compared to ammonium-N (Yongmanitchai and 
Ward, 1991). However, the influence of nitrogen source might be species specific. 
Yongmanitchai and Ward (1991) found that the production of biomass increased with 
an increase of nitrate concentration from 0.25 to 1.00 g/l, but decreased at 
concentration of nitrate of 1.5 g/l in the culture of P. tricornutum. Wen and Chen 
(2001b) indicated that potassium nitrate was the most favorable nitrogen source 
nitrogen source for biomass production by the diatom Nitzschia laevis and found that 
the production of biomass increased with an increasing nitrate concentration from 
0.065 to 0.620 g/l. 
Glutamate is involved in nitrogen metabolism and is required as an 
essential precursor of protein and nucleotide synthesis as well as a substrate for 
energy metabolism in the organism (Wice et al., 1981). In addition, glutamate can 
stimulate aerobic glycolysis (Pellerin and Magistretti, 1994). Therefore, glutamate 
could potentially have a substantial influence on cell growth. Cliquet and Jackson 
(1999) and Yu et al. (2003) reported that glutamate supported biomass accumulations 
of Paecilomyces fumosoroseus and M. alpina, respectively. 
Figure 4.18 shows the significant interaction between sucrose (A) and 
glutamate (C) on ADA production. Maximum ADA production was obtained at 
relatively low concentration (20 g/l) of sucrose and high glutamate concentration 
(2.00-2.50 g/l). In plant cell cultures, sucrose was hydrolyzed to glucose and fructose 
by extracellular and/or cell wall bound invertase (Martinez and Park, 1993). These 
sugars could be converted directly to acetyl-CoA used for fatty acids synthesis and 
provided additional reducing power, NADPH, for the various desaturation enzymes 
needed to produce ARA (Jin et al., 2008; Jin et al., 2009), which is precursor of ADA 
biosynthesis. Glutamate was demonstrated to have a role in activating acetyl-CoA 
carboxylase (ACC; EC 6.4.1.2). ACC catalyzes the formation of malonyl-CoA, an
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Figure 4.18 Response surface (a) and corresponding contour plots (b) showing the 
effects of sucrose and glutamate on ADA production of the transgenic line (C6). 
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essential substrate for fatty-acid synthase and for fatty acyl chain elongation systems 
(Kowluru et al., 2001). Furthermore, glutamate can be utilized for fatty acid synthesis, 
either directly through the generation of keto acids or acetyl-CoA (Albers et al., 
1996). Yu et al. (2003) studied the influence of glutamate concentration on total lipids 
and ARA production and found that supplementation of less than 0.8 g/l glutamate 
could increase total lipids and ARA production. However, supplementation of greater 
than 0.8 g/l glutamate led to a decrease in the total lipids in biomass as well as ARA 
production. Singh and Ward (1998) found that glutamate was the best nitrogen 
sources for DPA production by Pythium acanthicum. Certik et al. (1999) reported that 
glutamate was one of the potentially available nitrogen sources for increasing G6PDH 
activities and enhancing PUFA biosynthesis. However, when glutamate concentration 
is too high (greater than 0.8 g/l), glutamate will be converted to proline accompanied 
by NADPH consumption (Andarwulan and Shetty, 1999), which is necessary for 
ARA biosynthesis. 
 
4.4 Experimental validation of the optimized conditions 
The information from the equation models (Eqs. 2 and 3) and the plots 
(Figure 4.17 and 4.18), relating to the optimal levels of sucrose (A), potassium nitrate 
(B) and glutamate (C) for maximum biomass (Experiment A) and ADA (Experiment 
B) production are summarized in Table 4.4. The predicted and actual experimental 
responses (biomass and ADA production) for each set of variables are also presented. 
Maximum production rates of 17.15 g/l DCW and 1.77 mg/l ADA, and 13.05 g/l 
DCW and 4.48 mg/l ADA, were obtained from experiments A and B, respectively.  
This represents 90-97 and 81-99% validity of the prediction models, 
respectively. This study therefore suggests that the final optimal culture conditions 
would be sucrose 61.79 and 22.06 g/l; potassium nitrate 1.18 and 1.00 g/l; glutamate 
2.05 and 2.35 g/l; These conditions would lead to maximum production of biomass of 
17.15 g/l and ADA of 4.48 mg/l, respectively, which is 3.55-fold and 10.66-fold 
higher, respectively, than production rates in the non-optimization study (4.83 g/l 
biomass and 0.42 mg/l ADA). 
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Table 4.4 Predicted and actual biomass and ADA production by P. patens suspension cultures using various culture conditions. 
 
Experimentsa Sucrose 
(A) (g/l) 
Potassium 
nitrate 
(B) (g/l) 
Glutamate 
(C) (g/l) 
Biomass productionb 
(g/l) 
 
 
ADA productionb 
(mg/l) 
Actual Predicted %validity  Actual Predicted %validity 
A 
 
B 
61.79 
 
22.06 
1.18 
 
1.00 
2.05 
 
2.35 
17.15 
 
13.05 
 
17.65 
 
14.38 
 
90 
 
97 
 
 
 
 
 
1.77 
 
4.48 
 
2.16 
 
4.51 
 
81 
 
99 
 
The cells were cultured in 250-ml shake-flasks containing the total volume of 100 ml final production liquid medium with 4 g inoculums 
and incubated for 14 days. 
aA and B, experiments based on maximum growth and ADA production conditions, respectively. 
bRepresents mean of the responses (biomass and ADA production) based on three separate experiments. 
ADA, adrenic acid. 
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4.5 Effects of EPA and oil supplementation on biomass, ADA and ω-3 DPA in 
transgenic P. patens  
Although only ADA, an ω-6 C22-PUFA was initially produced in the 
transgenic lines, the further experiments were carried out to manipulate ω-3 DPA, an 
ω-3 C22-PUFA production in P. patens by EPA and vegetable oil supplementation. In 
general, EPA is a directly precursor for ω-3 DPA and vegetable oils contain various 
fatty acids that serve as precursors of long chain fatty acid (LC-FA) biosynthesis. In 
addition, it has been reported that supplementation with 1% oil improve biomass and 
PUFA production in M. alpina (Jang et al., 2005). Therefore the five highest ADA 
producing lines (C6, N15, N64, N70 and N77) were grown in the previously 
optimized medium (liquid BCD medium containing 22.06 g/l of sucrose, 1.00 g/l of 
potassium nitrate and 2.35 g/l glutamate, supplemented with 0.1 mM of EPA (Figure 
4.19) or 1.0% vegetable oil mixture comprising linseed oil, soybean oil, sunflower oil, 
corn oil, and palm oil (0.2% of each oil) (Figure 4.20). An additional peak (RT = 15.7 
min) was detected which was identical to the retention time of authentic ω-3 DPA 
from both experiments (Figure 4.19 and 4.20). This compound also showed a 
molecular ion of 344 m/z, which is the expected molecular ion of methyl ester of ω-3 
DPA as well as a fragmentation pattern identical to that of the authentic ω-3 DPA 
methyl ester (Figure 4.21). This event can be concluded that ω-3 DPA was 
successfully activated in P. patens by exogenous substrate supplementation. 
This study also confirmed that PsELO5 is specific only for ARA and 
EPA which are C20 PUFA, without any activity toward C16 and C18 fatty acids, which 
is in agreement with the previous report (Pereira et al., 2004b). Based on the 
specificity to substrate fatty acids, ELO-like enzymes can be classified broadly into 
three groups: one is specific to saturated and monounsaturated fatty acid (SFA and 
MUFA), another to PUFA of fixed chain-length (“single-step”), and the other is to 
PUFA with variable chain-lengths (“multi-step”) (Meyer et al., 2004). PsELO5 
showed specificity only to C20 PUFA (Pereira et al., 2004b); this specificity also seen 
with algal ∆5-elongases from Ostreococcus tauri, Thalassiosira pseudonana (Meyer 
et al., 2004), and liverwort Marchantia polymorpha (Kajikawa et al., 2006), and thus 
PsELO5 belongs to the second group (“PUFA single-step”).   
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Figure 4.19 Gas chromatographic analysis of fatty acid methyl esters (FAMEs) from 14 day-old 
protonemata P. patens wild type (WT) and transgenic lines (C4 and C6). The protonemata is grown in 
optimized liquid BCD medium containing 22.06 g/l of sucrose, 1.00 g/l of potassium nitrate and 2.35 
g/l glutamate and supplemented with 0.1 mM EPA. The additional peaks which correspond to the 
retention time of ADA and ω-3 DPA are indicated by single asterisk and double asterisks, respectively. 
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Figure 4.20 Gas chromatographic analysis of fatty acid methyl esters (FAMEs) from 14 day-old 
protonemata P. patens wild type (WT) and transgenic lines (C6, N15, and N64). The protonemata is 
grown in previously optimized liquid BCD medium containing 22.06 g/l of sucrose, 1.00 g/l of 
potassium nitrate and 2.35 g/l glutamate and supplemented with a total of 1.0% vegetable oils including 
linseed oil, soybean oil, sunflower oil, corn oil, and palm oil (0.2% of each oil). The additional peaks 
which correspond to the retention time of ADA and ω-3 DPA are indicated by single asterisk and 
double asterisks, respectively. 
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Figure 4.21 GC-MS analysis of FAMEs of the novel peak identified in P. patens 
carrying pMDC32-PsELO5 or pMDC43-PsELO5. A comparison is shown of the 
mass spectra of the novel peak (a) and an authentic ω-3 DPA standard (b). 
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The effect of the vegetable oil supplement on the biomass and PUFA 
production of transgenic P. patens plants compared with the wild type is illustrated in 
Table 4.5. Supplementation with a total of 1.0% vegetable oils increased biomass 
2.24-fold and PUFAs 4.04-9.03-fold, compared to the amounts detected in the wild 
type in the previously optimized liquid BCD medium without oil supplement. In the 
same way, the addition of oils enhanced biomass and PUFAs in transgenic P. patens 
(C6, N15, N64, N70 and N77) especially C22-PUFAs, ADA and ω-3 DPA (Figure 
4.22a and b; Table 4.5), whereas EDA decreased in those transgenic lines. Vegetable 
oils generally contain high levels of C18-fatty acid, precursors for LC-FA 
biosynthesis. For example, LA is the major fatty acid in soybean oil, corn oil and 
sunflower oil (56-85%), ALA is the major fatty acid in linseed oil (58%) (Jang et al., 
2005), and oleic acid (OA) is rich in palm oil (30-45%) (Mhanhmad et al., 2011). 
Therefore the addition of oils allowed moss to convert C18-fatty acid substrates to LC-
PUFAs. Shinmen et al. (1989) showed that olive oil and soybean oil addition 
increased the accumulation of ARA in Mortierella fungi and supplementation of oils 
stimulates cell growth, EPA, DHA and total PUFA production in M. alpina (Jang et 
al., 2005). The decrease in EDA levels observed in the transgenic P. patens was 
probably due to the presence of PsELO5-encoded elongase.  
Therefore, metabolic engineering with PsELO5 and PsELO5-GFP6 
fusion together with oil supplementation successfully activated both ω-6 and ω-3 C22-
elongation products, ADA and ω-3 DPA, in transgenic lines from 11.2 to 24.3 and 6.3 
to 11.7 mg/l, respectively. These results indicate the maximum accumulation of ADA 
(2.3% of total fatty acids) and ω-3 DPA (1.1% of total fatty acids) in transgenic line 
N64 (Table 4.6), 2-11 times higher than other similar studies performed by 
heterologous expression of multiple PUFA synthesizing genes in higher plants (0.1-
1.2% of total fatty acids) (Tables 4.6 and 4.7). This is the first report on producing an 
ω-3 DPA, DHA precursor, in non-seed lower plant. 
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Table 4.5 Biomass and polyunsaturated fatty acid (PUFA) production from the wild type (WT) and transgenic P. patens expressing PsELO5 grown for 14 days. 
 
Line Biomassa 
(g/l) 
Biomassb 
(g/l) 
ω-3 PUFA production (mg/l) 
ALAa ALAb EPAa EPAb ω-3 DPAa ω-3 DPAb 
WT 
C6 
N15 
N64 
N70 
N77 
5.53±0.95 
4.83±0.45 
5.43±0.45 
6.00±0.38 
4.97±0.66 
5.03±0.61 
12.43±0.85 
9.60±0.63 
9.37±0.52 
9.03±0.98 
9.33±0.73 
9.70±0.57 
9.71±1.75 
8.67±1.22 
13.53±2.04 
13.35±1.85 
14.05±2.65 
9.55±1.38 
39.60±3.75 
13.94±1.84 
20.48±0.94 
15.36±0.87 
16.20±2.73 
16.03±3.08 
1.29±0.22 
1.22±0.35 
1.60±0.18 
2.07±0.25 
1.84±0.11 
1.69±0.20 
7.71±0.41 
0.96±0.15 
1.83±0.08 
1.45±0.07 
1.04±0.05 
0.92±0.12 
nd 
nd 
nd 
nd 
nd 
nd 
nd 
6.35±0.43 
10.27±0.32 
11.75±0.41 
7.60±0.21 
8.56±0.18 
Line  ω-6 PUFA production (mg/l) 
LAa LAb GLAa GLAb EDAa EDAb DHGLAa DHGLAb ARAa ARAb ADAa ADAb 
WT 
C6 
N15 
N64 
N70 
N77 
45.58±8.94 
41.33±8.48 
63.24±6.77 
64.36±5.04 
69.49±7.84 
53.22±5.83 
210.68±20.75 
88.68±8.39 
70.35±12.95 
144.90±19.76 
86.98±16.85 
111.51±15.96 
2.96±0.54 
2.88±0.33 
4.68±0.48 
3.85±0.37 
5.67±0.28 
3.62±0.32 
11.96±0.87 
9.09±1.55 
5.06±0.74 
10.86±1.56 
13.36±1.37 
14.29±1.83 
2.50±0.74 
2.05±0.66 
5.80±0.70 
2.52±0.54 
3.10±0.61 
2.52±0.44 
10.74±1.28 
0.90±0.14 
2.17±0.37 
0.73±0.12 
0.61±0.08 
0.28±0.04 
1.27±0.37 
1.45±0.22 
1.90±0.34 
4.35±0.54 
4.25±0.61 
4.78±0.53 
11.85±0.87 
2.64±0.32 
5.86±0.54 
5.21±0.24 
5.27±0.11 
4.83±0.77 
42.89±5.85 
37.25±5.33 
46.08±6.52 
64.17±7.07 
50.53±5.85 
55.00±6.22 
196.88±13.96 
46.85±4.85 
53.56±3.86 
73.41±4.73 
60.27±2.79 
59.83±6.40 
nd 
0.42±0.08 
4.47±0.89 
6.97±0.74 
3.57±0.68 
3.40±0.55 
nd 
11.18±0.75 
13.31±0.84 
24.31±0.43 
12.59±0.63 
16.23±0.73 
aPUFA production from P. patens grown for 14 days in liquid BCD medium. 
bPUFA production from P. patens grown for 14 days in optimized liquid BCD medium supplemented with a total of 1.0% vegetable oils including linseed oil, soybean oil, sunflower 
oil, corn oil, and palm oil (0.2% of each oil). 
nd, not detected. 
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Figure 4.22 Comparisons of ADA (a) and ω-3 DPA (b) production from 14 day-old protonemata P. patens wild type (WT) and 
transgenic lines (C6, N15, N64, N70 and N64) grown in basal liquid BCD medium, and in previously optimized liquid BCD medium 
containing 22.06 g/l of sucrose, 1.00 g/l of potassium nitrate and 2.35 g/l of glutamate and supplemented with a total of 1.0% vegetable 
oils including linseed oil, soybean oil, sunflower oil, corn oil, and palm oil (0.2% of each oil). 
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Table 4.6 Total fatty acid and new C22 PUFA production from the wild type (WT) and transgenic P. patens expressing PsELO5 grown for 14 days. 
 
Line SA and MUFA (mg/l) 
16:0a 16:0b 16:1a 16.1b 18:0a 18:0b 18:1a 18:1b 
WT 
C6 
N15 
N64 
N70 
N77 
85.20±11.75 
79.82±13.85 
82.14±11.54 
86.98±11.00 
89.56±10.57 
79.30±19.01 
361.79±15.95 
329.25±22.72 
572.76±18.05 
433.38±20.32 
297.33±9.98 
507.18±12.02 
1.72±0.17 
2.17±0.12 
1.63±0.31 
1.37±0.16 
2.78±0.39 
1.15±0.06 
33.71±4.85 
34.97±5.06 
27.21±3.94 
42.20±3.61 
26.09±2.30 
33.51±4.37 
1.25±0.07 
2.40±0.50 
1.09±0.13 
1.17±0.13 
2.48±0.49 
0.92±0.16 
24.48±2.23 
20.57±1.95 
17.92±5.33 
32.05±3.31 
25.34±1.45 
37.31±2.99 
14.08±1.81 
7.62±1.47 
11.94±1.78 
15.78±2.06 
6.98±1.67 
10.18±2.31 
101.37±9.83 
206.42±16.93 
157.64±7.94 
242.23±35.64 
227.81±16.48 
255.72±20.62 
Line Fatty acid production (mg/l)  Total fatty acid production 
(mg/l) 
 C22 PUFA (% total fatty acids ) 
SFAa SFAb MUFAa MUFAb PUFAa PUFAb  Totala Totalb  ADAa ADAb DPAa DPAb 
WT 
C6 
N15 
N64 
N70 
N77 
86.45±11.71 
82.22±14.08 
83.22±11.60 
88.16±10.90 
92.04±10.31 
80.22±19.17 
386.27±13.73 
349.83±22.39 
590.67±12.81 
465.43±22.99 
322.67±10.43 
544.48±15.01 
15.80±1.93 
9.79±1.52 
13.57±1.54 
17.14±2.21 
9.76±1.80 
11.33±2.37 
135.08±5.34 
241.39±20.03 
184.85±4.48 
284.43±39.24 
253.90±16.90 
289.24±16.26 
106.13±26.62 
94.96±19.55 
141.51±30.52 
161.71±13.73 
152.57±28.92 
133.78±4.25 
489.69±36.13 
180.83±33.47 
183.17±38.83 
288.06±56.86 
204.27±50.38 
232.73±22.52 
 
 
 
 
 
 
208.38±37.93 
186.97±15.96 
238.30±17.45 
267.01±0.88 
254.37±20.34 
225.34±16.50 
1011.04±39.11 
772.05±33.04 
958.70±22.87 
1037.91±60.88 
780.84±52.98 
1066.45±15.95 
 
 
 
 
 
 
nd 
0.22±0.03 
1.87±0.30 
2.61±0.31 
1.39±0.16 
1.51±0.07 
nd 
1.46±0.33 
1.39±0.23 
2.33±0.32 
1.62±0.29 
1.52±0.26 
nd 
nd 
nd 
nd 
nd 
nd 
nd 
0.82±0.16 
1.07±0.17 
1.13±0.22 
0.97±0.15 
0.80±0.10 
aPUFA production from P. patens grown for 14 days in liquid BCD medium. 
bPUFA production from P. patens grown for 14 days in optimized liquid BCD medium supplemented with a total of 1.0% vegetable oils including linseed oil, soybean oil, sunflower 
oil, corn oil, and palm oil (0.2% of each oil). 
nd, not detected. 
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Table 4.7 Examples of polyunsaturated fatty acid (PUFA) production in transgenic plants. 
 
Plant host Target gene New fatty acid production  
(% of total fatty acid) 
Reference 
Arabidopsis thaliana 
 
 
Brassica juncea 
 
 
 
 
 
Nicotiana benthamiana 
 
N. benthamiana 
 
N. benthamiana 
 
N. benthamiana 
 
 
Physcomitrella patens 
Danio rerio ∆5/∆6-desaturase, Caenorhabditis elegans  
∆
6
-elongase, Pavlova salina ∆5-elongase and  
P. salina ∆4-desaturase 
Pythium irregulare ∆6-desaturase, Thraustochytrium sp.  
∆
5
-desaturase, P. patens ∆6-elongase, Calendula officinalis  
∆
12
-desaturase, Thraustochytrium sp. ∆6-elongase,  
P. irregulare ω3-desaturase, Thraustochytrium sp. ∆4 
desaturase, Thraustochytrium sp. lysophosphatidyl 
acyltransferase, Oncorhynchus mykiss elongase 
Micromonas pusilla ∆6-desaturase, Pyramimonas cordata  
∆
6
-elongaseaa and P. salina ∆5-desaturase 
Echium plantagineum ∆6-desaturase, P. cordata  
∆
6
-elongaseaa and P. salina ∆5-desaturase 
Ostreococcus tauri ∆6-desaturase, P. cordata  
∆
6
-elongaseaa and P. salina ∆5-desaturase 
P. salina ∆9-elongase, ∆8-desaturase,  
∆
5
-desaturase, ∆5-elongase and ∆4-desaturase 
 
Pavlova sp. ∆5-elongase 
GLA (0.4%), SDA (1.5%), DHGLA (1.5%),  
ETA (0.8%), ARA (1.0%), EPA (2.4%),  
ω-3 DPA (0.1%), DHA (0.5%) 
GLA (27.3%), SDA (2.2%), DHGLA (1.9%),  
ETA (1.1%), ARA (4.0%), EPA (8.1%),  
ω-3 DPA (0.1%), DHA (0.2%) 
 
 
 
GLA (2.1%), ARA (0.6%), SDA (1.5%),  
ETA (0.6%), EPA (10.7%), ω-3 DPA (0.3%) 
GLA (4.4%), ARA (1.3%), SDA (2.4%),  
ETA (0.1%), EPA (3.4%), ω-3 DPA (0.2%) 
GLA (5.8%), ARA (1.2%), SDA (1.1%),  
ETA (0.4%), EPA (9.6%), ω-3 DPA (0.2%) 
EDA (1.7%), DHGLA (0.5%), ARA (2.4%),  
ADA (1.2%), ETrA (1.5%), ETA (0.2%),  
EPA (1.2%), ω-3 DPA (0.6%), DHA (0.7%) 
ADA (2.3%), ω-3 DPA (1.1%) 
Robert et al., (2005) 
 
 
Wu et al., (2005a) 
 
 
 
 
 
Petrie et al., (2010c) 
 
Petrie et al., (2010c) 
 
Petrie et al., (2010c) 
 
Petrie et al., (2010b) 
 
 
Current study 
a P. cordata ∆6-elongase displays some ∆5-elongase activity. 
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CHAPTER 5 
 
CONCLUSIONS 
 
The ∆5-elongase gene has been cloned from marine algae Pavlova sp. 
The open reading frame (ORF) of the cloned PsELO5 cDNA is 834 bp from an ATG 
start to a TAA stop codons and codes for 277 amino acids. This amino acid 
polypeptides contained four conserved motifs KxxExxDT (Box 1), QxxFLHxYHH 
(Box 2) the extended histidine-rich box, NxxxHxxMYxYY (Box 3), and a tyrosine-
rich box, TxxQxxQ (Box 4) and the secondary structure analysis of PsELO5 gene 
showed that the encoded polypeptides contained six putative transmembrane domains. 
    Heterologous expression of PsELO5 and PsELO5-GFP6 fusion in P. 
patens resulted in the production of C22-PUFA, ADA (0.15±0.04-6.97±0.74 mg/l) 
without any exogenous ARA substrate addition. The four pMDC43-PsELO5 
transgenics with the highest ADA production lines (N15, N64, N70 and N77) 
obviously produced 22.6-46.4 times higher levels of ADA compared to the six 
transgenic line (C1-C6) containing the pMDC32-PsELO5 construct, while no ADA 
was detected in the control wild type. However, an ω-3 DPA was not detected from 
any transgenic lines cultivated in BCD media. The highest production of ADA 
(6.97±0.74 mg/l) from the available endogenous ARA substrate was with the 
transgenic line N64. 
  Molecular analysis (PCR and Southern Blotting) confirmed that 
Pavlova sp. ∆5-elongase was transferred into P. patens genome. Both single copy and 
multiple copies of the expression construct were observed in transgenic P. patens 
genome. 
  Optimization of biomass and ADA production in transgenic P. patens 
by statistically based experimental design, RSM indicated that sucrose, KNO3 and 
glutamate significantly influenced on biomass production, whereas sucrose and 
glutamate considerably affected to ADA production. The optimal culture conditions 
studied by CCD would be 61.79 g/l sucrose, 1.18 g/l KNO3 and 2.05 g/l glutamate for 
biomass production and 22.06 g/l sucrose, 1.00 g/l KNO3 and 2.35 g/l glutamate for 
ADA production. This optimized conditions led to the maximum biomass and ADA 
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production of 17.15 g/l and 4.48 mg/l, respectively, which were 3.55-fold and 10.66-
fold higher, respectively, than production rates in the non-optimization study (4.83 g/l 
DCW and 0.42 mg/l ADA). 
  In addition, metabolic engineering with PsELO5 and PsELO5-GFP6 
fusion together with oil supplementation successfully activated both ω-6 and ω-3 C22-
elongation products, ADA and ω-3 DPA, in transgenic lines from 11.18±0.75 to 
24.31±0.43 and 6.35±0.43 to 11.75±0.41 mg/l, respectively. The maximum 
accumulation of ADA (2.3% of total fatty acids) and ω-3 DPA (1.1% of total fatty 
acids) was achieved in transgenic line N64. 
  The efficient biosynthesis of C22 LC-PUFAs in transgenic P. patens 
plants has now been conclusively demonstrated in this study, using reverse-
engineering and nutritional supplementation approaches. This heterologous 
expression system has not only realized the possibility of producing the important 
nutritional compounds in transgenic plants, but also provided a new experimental tool 
with which to better investigate plant lipid metabolism. Finally, P. patens is therefore 
served as an alternative source of further ω-6 DPA and DHA production.   
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APPENDIX A 
 
Solutions and media for moss tissue culture and protoplast transformation 
 
Stock solution for media making (Knight et al., 2002) 
Solution B 
- MgSO4·7H2O 
- Distilled H2O to 
 
25 
1000  
 
g 
ml 
Solution C 
- KH2PO4 
- Distilled H2O to 
 
25  
1000  
 
g 
ml 
Solution D 
- KNO3 
- FeSO4·7H2O 
- Distilled H2O to 
 
101  
1.25  
1000 
 
g 
g 
ml 
Trace element solution 
- H3BO3 
- Al2(SO4)3·K2SO4·24H2O 
- CuSO4·5H2O 
- KBr 
- LiCl 
- Na2MoO4·2H2O 
- MnCl2·4H2O 
- CoCl2·6H2O 
- ZnSO4·7H2O 
- KI 
- SnCl2·2H2O 
- NiCl2·6H2O 
- Distilled H2O to 
 
614 
55 
55 
28 
28  
25  
389  
55  
55  
28  
28  
59  
1000  
 
mg 
mg 
mg 
mg 
mg 
mg 
mg 
mg 
mg 
mg 
mg 
mg 
ml 
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Moss media recipes 
Routine basal medium (BCD) 
- Stock B 
- Stock C 
- Stock D 
- Di-ammonium (+)-tartrate 
- Trace element solution 
- Agar 
- Distilled H2O to 
- Sterilization by autoclaving and CaCl2 was added 
immediately before pouring plates 
 
10 
10 
10 
920 (5) 
1 
8 
1000 
1 
 
ml 
ml 
ml 
mg (mM) 
ml 
g 
ml 
mM 
Protoplast regeneration medium-bottom layer 
(PRMB) 
- Stock B 
- Stock C 
- Stock D 
- Di-ammonium (+)-tartrate 
- Trace element solution 
- D-mannitol 
- Agar 
- Distilled H2O to 
- Sterilization by autoclaving and CaCl2 was added 
immediately before use 
 
10 
10 
10 
920 (5) 
1 
60 
8 
1000 
10 
 
ml 
ml 
ml 
mg (mM) 
ml 
g 
g 
ml 
mM 
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Protoplast regeneration medium-top layer (PRMT) 
- Stock B 
- Stock B 
- Stock B 
- Di-ammonium (+)-tartrate 
- Trace element solution 
- D-mannitol 
- Agar 
- Distilled H2O to 
- Sterilization by autoclaving and CaCl2 was 
added immediately before use 
 
10 
10 
10 
920 (5) 
1 
80 
8 
1000 
10 
 
ml 
ml 
ml 
mg (mM) 
ml 
g 
g 
ml 
mM 
 
Solutions for protoplast transformation  
8% D-mannitol solution 
- D-mannitol 
- Distilled H2O to 
- Sterilization by autoclaving 
 
80 
1000 
 
g 
ml 
Calcium protoplast wash (CaPw) 
- D-mannitol 
- CaCl2·2H2O 
- Distilled H2O to 
- Sterilization by autoclaving 
 
80 
10.95 
1000 
 
g 
g 
ml 
1M MgCl2 
- MgCl2·6H2O 
- Distilled H2O to 
- Sterilization by autoclaving 
 
203.3 
1000 
 
g 
ml 
1% MES pH 5.6 
- N-morpholino ethanesulphonic 
- Adjust to pH 5.6 with 0.1 M KOH 
- Distilled H2O to 
- Sterilization by autoclaving 
 
1 
 
100 
 
g 
 
ml 
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1M Ca(NO3)2 
- Ca(NO3)2·4H2O 
- Distilled H2O to 
- Sterilization by autoclaving 
 
236.1 
1000 
 
g 
ml 
D-mannitol/MgCl2/MES solution (MMM) 
- D-mannitol 
- 1M MgCl2 solution 
- 1% MES pH 5.6 solution 
- Distilled H2O to 
- Filter sterilization 
 
910 
150 
1 
8.85 
 
mg 
µl 
ml 
ml 
D-mannitol/Ca(NO3)2 solution 
- 8% D-mannitol solution 
- 1M Ca(NO3)2 solution 
- 1M Tris buffer pH 8.0 
- Filter sterilization 
 
9 
1 
100 
 
ml 
ml 
µl 
PEG solution 
- Polyethylene glycol (PEG) 6000 
- Autoclave in a glass universal bottle 
- On day of transformation, melt PEG in microwave 
- Add D-mannitol/Ca(NO3)2 solution and mix well 
- Filter sterilization 
- Leave at room temperature for about 2 h before use 
 
2 
 
 
5 
 
g 
 
 
ml 
0.5% Driselase solution 
- Driselase 
- 8% D-mannitol solution 
- Gently mix (do not shake vigorously) 
- Leave to stand at room temperature for 15 min 
- Centrifuge at 2,500g for 5 min 
- Filter sterilization 
 
0.125 
25 
 
g 
ml 
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Genomic DNA extraction 
Shortly extraction buffer 
- Tris-(hydroxymethyl) aminomethane 
hydrochloride (Tris-HCl, pH 9.0)  
- LiCl 
- Ethylenediaminetetraacetic acid (EDTA) 
- Sodium dodecyl sulfate (SDS) 
- Distilled H2O to 
- Sterilization by autoclaving 
 
0.2 
 
0.4 
25 
10 
1000 
 
M 
 
M 
mM 
g 
ml 
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APPENDIX B 
 
Standard curve of fatty acid methyl ester 
 
Preparation of fatty acid standard solutions 
  Stock solutions of the reference standards, LA methyl ester (1 mg), 
ALA methyl ester (1 mg), GLA methyl ester (1 mg), EDA methyl ester (1 mg), 
DHGLA methyl ester (0.5 mg),  ARA methyl ester (0.2 mg), EPA methyl ester (0.1 
mg), ADA methyl ester (0.5 mg) and ω-3 DPA methyl ester (0.5 mg) were made by 
dissolving in heptane and these stock solutions were two-fold serial dilution to six 
concentrations.  
Fatty acid methyl esters (FAMEs), LA, ALA, GLA and EDA methyl 
esters ranging from 31-1,000 µg/ml, DHGLA, ADA and ω-3 DPA methyl esters 
ranging from 15-500 µg/ml, ARA methyl ester ranging from 6-200 µg/ml and EPA 
methyl ester ranging from 6-100 µg/ml were used for construction of calibration 
curves.   
  GC analysis of FAMEs was conducted using an Agilent 6890N 
equipped with an HP-INNOWax capillary column (0.25 mm x 30 m x 0.25 µM), a 
flame ionization detector, using helium as the carrier gas. An aliquot (2 µl) of each 
sample extract was injected onto the GC column using the injector in the split mode. 
The initial column temperature was 185oC (0.5 min) and was increased at a rate of 
3.5oC/min to 235oC (14.3 min), and then maintained at 235oCfor 1.0 min. Calibration 
curves were established by analysis of the standard compounds at six concentrations 
and plotted peak area against the concentration of each reference standards. 
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Figure 1B Standard curve of LA methyl ester (Retention time = 6.8 min). 
 
 
Figure 2B Standard curve of GLA methyl ester (Retention time = 7.1 min). 
 
 
Figure 3B Standard curve of ALA methyl ester (Retention time = 7.4 min). 
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Figure 4B Standard curve of EDA methyl ester (Retention time = 9.2 min). 
 
 
Figure 5B Standard curve of DHGLA methyl ester (Retention time = 9.7 min). 
 
 
Figure 6B Standard curve of ARA methyl ester (Retention time = 10.2 min). 
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Figure 7B Standard curve of EPA methyl ester (Retention time = 11.4 min). 
 
 
Figure 8B Standard curve of ADA methyl ester (Retention time = 14.7 min). 
 
 
Figure 9B Standard curve of ω-3 DPA methyl ester (Retention time = 15.7 min). 
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APPENDIX C 
 
Gateway cloning technology 
 
A GatewayTM cloning vector set for high-throughput functional analysis of genes 
in planta (Curtis and Grossniklaus, 2003) 
 
1. 35S induction construct (pMDC32) 
 - Backbone pCambia 1300  
- Kanr in bacteria  
- Hygr in plants 
 
 
 
2. GFP C-terminal fusions (pMDC43) 
- Backbone pCambia 1300  
- Kanr in bacteria  
- Hygr in plants 
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